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Abstract 
The maintenance of mature peripheral B cells depends on at least two 
survival cues, tonic signaling from the B cell receptor (BCR) complex and the 
extracellular cytokine B cell activating factor of the TNF family (BAFF). In 
addition to enhancing viability, BAFF controls the functional efficiency of the 
peripheral B cell pool by regulating complex physiological processes including 
cell growth, metabolism, energy homeostasis and entry into the cell cycle. 
BAFF-mediated induction of two molecular mechanisms, namely activation of 
the Akt signal transduction pathway and upregulation of the oncogenic kinase 
Pim-2 results in the modification of effector proteins including transcription 
factors and regulators of protein synthesis which are capable of executing the 
observed cellular physiological changes. The classic protein kinase C β is 
instrumental in BAFF-induced Akt-activation and PKCβ-deficient B cells and 
mice show signs of partial refractiveness to BAFF. The protein tyrosine kinase 
Syk plays a role in early B cell development and is activated in mature B cells 
by immunogenic BCR-stimulation. Inducible ablation of Syk in mice results in 
the loss mature B cells from the peripheral lymphoid organs and reveals an 




Die Langlebigkeit reifer periphärer B Zellen ist abhängig von mindestens zwei 
Überlebenssignalen, einem tonischen Signal, welches vom B Zellrezeptor 
ausgeht und dem Zytokin B Zell aktivierender Faktor der TNF-Familie (BAFF). 
BAFF fördert nicht nur das Überleben von reifen B Zellen, sondern kontrolliert 
auch deren Funktionstüchtigkeit, indem es vielschichtige physiologische 
Prozesse wie Zellwachstum und –metabolismus, Energiehaushalt und Eintritt 
in den Zellzyklus reguliert. Zwei BAFF-induzierte molekulare Mechanismen, 
zum einen die Aktivierung des Akt Signaltransduktionsweges sowie die 
erhöhte Expression der onkogenen kinase Pim-2 zum anderen, führen zu 
Veränderungen in Effektorproteinen welche in der Lage sind diese 
physiologischen Zellveränderungen auszulösen. Die BAFF-induzierte 
Aktivierung von Akt hängt von der klassischen Proteinkinase C (PKC) β ab 
und sowohl PKCβ-defiziente B Zellen als auch Mäuse zeigen Anzeichen von 
Unsensitivität gegenüber BAFF-Stimulation. Die Proteintyrosinkinase Syk 
spielt eine Rolle während der frühen B Zellentwicklung und wird in reifen B 
Zellen durch Stimulation des B Zellrezeptors aktiviert. Induzierbare 
Inaktivierung von Syk in Mäusen führt zum Verschwinden reifer B Zellen aus 
den periphären lymphoiden Organen, was auf eine unverzichtbare Funktion 
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Standard abbreviations used throughout this work include chemical symbols, 
SI units as well as one and three letter amino acid codes. 
Non-standard abbreviations are explained in the text upon first citation and 
are listed in the following: 
 
4E-BP1 4E binding protein 1 
A1 BCL2-related protein A1 
Act1 NF-κB activator 1 
AMP Adenosine monophosphate 
AMPK AMP-activated protein kinase 
APRIL a proliferation-inducing ligand 
ATM ataxia telangiectasia mutated 
ATP Adenosine triphosphate 
Bad Bcl-2-associated death promoter 
BAFF B cell activating factor of the TNF family 
BAFF-R BAFF receptor 
Bak BCL2-antagonist/killer 
Bax Bcl2-associated X protein 
Bcl-2 B-cell lymphoma 2 
Bcl-xL Bcl2-like 1 
Bcl10 B-cell lymphoma 10 
BCMA B-Cell Maturation Antigen 
BCR B cell receptor 
Bid BH3 interacting domain death agonist 
Bim Bcl-2 interacting mediator of cell death 
BLAST basic logical alignment search tool 
BLNK B cell linker protein 
BrdU bromodeoxyuridine 
BSS Hanks Balanced Salt Solution 
Btk Bruton’s tyrosine kinase 
Carma1 caspase-recruitment domain membrane-associated guanylate 
kinase  protein 1 
Cbl Casitas B-lineage lymphoma 
CCCP carbonyl cyanide m-chlorophenyl hydrazone 
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CD Cluster of Differentiation 
Cdc cell division cycle 
Cdk cyclin-dependent kinase 
CFDA-SE carboxyfluorescein diacetate succinimidyl ester 
CFSE carboxyfluorescein succinimidyl ester 
CHX cycloheximide 
CLL chronic lymphocytic leukemia 
CRD Cystein-Rich Domain 
Cre Cyclization recombination 
Csk C-terminal src-kinase 
DAG diacylglycerol 
DNA deoxyribonucleic acid 
DNA-PK DNA-dependent protein kinase 
EDTA ethylenediamine tetraacetic acid 
EGTA ethylene glycol tetraacetic acid 
eIF4E eukaryotic translation initiation factor 4E 
Erk extracellular signal-regulated kinase 
ES embryonic stem 
FACS fluorescence activated cell sorting 
FBS fetal bovine serum 
Fc fragment crystallizable 
FITC fluorescein isothiocyanate 
FoxO Forkhead box O 
G1 Gap1 
GAP GTPase activating protein 
GC germinal center 
GFP green fluorescent protein 
Gsk-3 gycogen synthase kinase 3 
Gst Glutathione S-transferase 
HA hemagglutinin 




ILK integrin-linked kinase 1 
 V 
IκB inhibitor of nuclear factor-κB 
IKK IκB kinase 
IP3 inositol-1,4,5-trisphosphate 
IPTG isopropyl-β-D-thiogalactopyranoside 
ITAM immunoreceptor tyrosine-based activation motif 
ITIM immunoreceptor tyrosine-based inhibitory motif 
Jnk Jun N-terminal kinase 
LB Luria-Bertani 
loxP locus of X-over of P1 
MACS magnetic cell sorting 
MALT1 (mucosa-associated-lymphoid-tissue lymphoma-translocation 
gene 1 
MAPK mitogen-activated protein kinase 
Mcl-1 myeloid cell leukemia sequence 1 
Mcm minichromosome maintenance deficient 
mTOR mammalian target of rapamycin 
MZ marginal zone 
neo neomycin 
NFAT nuclear factor of activated T cells 
NF-κB nuclear factor-κB 
PBS phosphate-buffered saline 
PCR polymerase chain reaction 
PIP3 phosphatidylinositol-3,4,5-triphosphate 
PDK1 3-phosphoinositide-dependent kinase 1 
PE Phycoerythrin 
PH pleckstrin homology 
PHLPP PH domain leucine-rich repeat phosphatases 
PI3K phosphoinositide-3 kinase 
PIKK phosphoinositide-3-kinase-related kinase 
PIP3 phosphatidylinositol (3,4,5)-trisphosphate
PKC protein kinase C 
PLC phospholipase C 
Plk Polo-related kinase 
PRAS40 proline-rich Akt substrate 40kD 
PTEN phosphatase and tensin homolog deleted from chromosome 10 
 VI 
RA rheumatoid arthritis 
Rb retinoblastoma 
Rheb Ras-homolog enriched in brain 
RNA ribonucleic acid 
ROS reactive oxygen species 
S6 ribosomal S6 protein 
S6K ribosomal S6 kinase 1 
SDS sodium dodecyl sulfate 
SLE systemic lupus erythematosus 
SH2 Src-homology 2 
SHP-1 SH2-domain containing protein tyrosine phosphatase 1 
Sos Son of sevenless 
Src Rous sarcoma oncogene 
Syk spleen tyrosine kinase 
T1 transitional 1 
T2 transitional 2 
TACI Transmembrane Activator and CAML Interactor 
TCA trichloroacetic acid 
TCR T cell receptor 
TEV Tobacco Etch Virus 
THD TNF-homology domain 
TNF tumor necrosis factor 
Tk thymidine kinase 
TMRE tetramethylrhodamine ethyl ester 
TRAF TNF receptor associated factor 
TSC tuberous sclerosis 
ZAP-70 zeta-chain associated protein kinase, 70kD 
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1 Introduction 
The pool of peripheral B lymphocytes in mice consists of approximately a 
hundred million cells, the majority of which are mature, follicular B cells with a 
life-span ranging from several weeks to months (Forster and Rajewsky, 
1990). Most of these cells are circulating the periphery in a quiescent state 
without actively contributing to an acute immunogenic response. This vast 
number of resting cells has to be sustained in order to assure the presence of 
a diverse B cell repertoire with the capacity to recognize foreign antigens. 
Lasting B cell persistence in the periphery has to be actively maintained and 
is dependent on survival signals which are transduced by cell surface 
receptors. An indispensable survival function has been established for two 
independent signals, the B cell receptor (BCR) complex and the cytokine B 
cell activating factor of the TNF-family (BAFF). The aim of this study was to 
illuminate the mechanism by which these signals accomplish the long-term 
survival and functional efficiency of mature B cells in the periphery. 
 
1.1 Brief overview of B cell development 
The pool of mature peripheral B cells in adult mice is replenished by ongoing 
lymphopoesis in the bone marrow. The purpose of this process is the release 
of cells, each carrying a single type of functional antigen receptor whose 
specificity is unique among all others within the B cell repertoire. This aim is 
accomplished in an astounding combination of stochastic yet tightly 
coordinated events encompassing the random generation of diversity and 
allelic exclusion (for a comprehensive review, see (Janeway, et al., 2001). B 
lineage commitment begins with the differentiation of pro B cells from 
hematopoietic progenitors (Hardy and Hayakawa, 2001). Pro B cells are 
characterized by expression of the BCR accessory chains immunoglobuline α 
(Igα) and Igβ and by ongoing rearrangement at the Ig µ heavy chain locus 
(figure 1). Immunoglobuline gene recombination begins with diversity (D)- to 
junction (JH)- gene segment fusion followed by rearrangement of DJ  to 
variable (V ) gene segments. Productive V DJ  recombination 
H
H H H inhibits 
potential processing of the second heavy chain allele and allows for the 
presentation of the transmembrane heavy chain molecule on the cell surface 
in conjunction with a surrogate light chain, VpreB or λ5, forming the pre-BCR. 
An adequate signal from the pre-BCR induces pre-B cell expansion and 
allows for VL- to JL- rearrangement of κ and, if necessary, λ light chain genes. 
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Once a functional BCR, composed of a µ heavy and κ or λ light chains and 
lacking self-reactive specificity, is expressed on the surface, the newly-formed 
B cells exit the bone marrow into the periphery where they have to compete 
with the existing B cells for entry into the stable pool of mature naive B 
lymphocytes in the secondary lymphoid organs. In the spleen, B cells newly 
immigrated from the bone marrow undergo further maturation through distinct 
stages which can be distinguished by surface marker expression (Loder, et 
al., 1999) and figure 1). With few exceptions, cell surface molecules on 
leukocytes are named after the CD nomenclature where CD denotes “Cluster 
of Differentiation” (Morse, 1992). Newly immigrated splenic B cells go from the 
IgM high CD21/35-negative (IgMhi CD21/35-) transitional 1 stage (T1) to the 
IgM high CD21/35 high (IgMhi CD21/35hi) T2 stage, whereas the mature 
follicular  B cell compartment (M) is characterized by an intermediate 
expression level of both surface proteins (IgMint CD21/35int). A second 
 
 
Figure 1: Overview of murine B cell development and maturation in the bone marrow 
and spleen. Diagrams represent different B cell developmental stages including the 
composition of the respective BCR. Abbreviations underneath indicate the state of the 
heavy (top) and light (bottom) chain immunoglobuline regions. The expression of 
selected surface markers commonly used to distinguish the different B cell 
developmental stages, is indicated at the bottom. See text for details (modified from 
Hardy and Hayakawa, 2001). GL = germline formation, T1 = transitional stage 1, T2 = 
transitional stage 2, FO = follicular B cells, MZ = marginal zone B cells 
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subtype of splenic B cells which resides in the marginal zone (MZ) 
surrounding the lymphatic follicles and is hence named MZ B cells is also 
CD21/35hi IgMhi, but differs from T2 cells in the low expression of the surface 
marker CD23. The lineage commitment of the latter splenic B cell subset has 
not been entirely resolved, but it appears increasingly likely that follicular and 
MZ B cells originate from a common transitional B cell precursor (Pillai, et al., 
2005). 
While signals originating from the surface expressed BCR or pre-BCR 
regulate the survival of B cells throughout their development, it is at the T2 
stage that they become simultaneously sensitive to as well as dependent on 
the cytokine BAFF for viability (see below). 
The developmental pathway described above applies for conventional B-2 
lineage cells which constitute the vast majority of the mature peripheral B cell 
pool and represent the B cell component of the adaptive immune system. In 
contrast, B-1 cells originate from a different source whose nature is still largely 
elusive. The fraction of B-1 cells is low in lymphoid compartments including 
spleen, lymph nodes and peripheral blood, but they constitute a significant 
portion of lymphocytes in the peritoneum and an important component of the 
innate immune response (Hardy, 2006). 
 
1.2 Mature B cell survival through tonic BCR signaling 
1.2.1 Composition of the BCR-complex and its signaling 
mechanisms 
Signaling from the BCR or pre-BCR has the astounding capacity to induce 
dramatically different cell fates. In mature naive B cells, BCR engagement 
with a foreign antigen represents the first step towards the induction of an 
immunogenic program which comprises clonal expansion, BCR maturation 
through class-switch recombination and somatic hypermutation as well as B 
cell differentiation into memory B or antibody-secreting plasma cells 
(Janeway, et al., 2001). Conversely, triggering of the same type of receptor by 
an auto-antigen has the opposite effect. Depending on the developmental 
stage and co-stimulatory signals, B cell encounter with a self-antigen leads to 
deletion, tolerance induction or alteration of receptor specificity through 
receptor editing (Healy and Goodnow, 1998). Importantly, some crucial 
signals originate from the BCR even in the absence of a discernable receptor 
ligand. This so-called tonic BCR-signal is critical to the survival of mature 
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naive B cells in the periphery (see below). 
In mature naive B cells, the BCR complex is composed of a transmembrane 
Ig heavy chain of the µ or δ type (IgM or IgD) which is covalently linked to Ig 
light chains. Together, heavy and light chains form the antigen-binding unit of 
the BCR whose specificity is identical between all the receptors of a single B 
cell, but unique among all other receptors in the peripheral B cell pool. The 
BCR’s signal transduction capacity is conveyed through the non-covalently 
associated BCR-accessory chains Igα and Igβ. Each chain contains a single 
immunoreceptor tyrosine-based activation motif (ITAM) in which two tyrosine 
residues are surrounded by a characteristic consensus sequence. Receptor 
cross-linking causes phosphorylation of the Igα-Igβ heterodimer on ITAM-
tyrosines by cytoplasmic protein tyrosine kinases, creating docking sites for a 
plethora of Src homology 2 (SH2)-domain containing proteins (figure 2 and 
(Kurosaki, 2002: ; Monroe, 2006). Ligand-induced ITAM-phosphorylation is 
carried out by cytoplasmic protein tyrosine kinases of the Src- and Syk-family. 
In B cells, the most prominent members of theses families are Lyn and Syk, 
respectively. Although Lyn is placed upstream of Syk in most BCR-signaling 
models, both are capable of ITAM-phosphorylation in vitro and in vivo (see 
below). In any case, both appear to play a crucial role since the sole absence 
of either one compromises BCR-mediated signal transduction (Takata, et al., 
1994). The kinase activities of Syk and Lyn are themselves stimulated by 
binding of phospho-ITAMs to their respective SH2-domains. ITAM-
phosphorylation and proximal tyrosine kinase activation lead to the formation 
of multi-protein signaling complexes, sometimes called signalosomes, which 
ultimately relay the signal to changes in cellular architecture and gene 
expression. The adaptor protein B cell linker protein (BLNK, also known as 
SLP-65) has a major role in orchestrating the activation of Bruton’s tyrosine 
kinase (Btk) and phospholipase C γ 2 (PLCγ2) and thus in the generation of 
second messengers inositol-1,4,5-trisphosphate (IP3) and diacylglycerol 
(DAG). BLNK also functions in the activation of guanine nucleotide exchange 
factors Vav and Son of sevenless (Sos) which are instrumental for 
cytoskeletal rearrangements and for triggering of the mitogen-activated 
protein kinase (MAPK) pathway, respectively. IP3 signals the release of Ca2+-
ions from intracellular stores and mediates activation of the Ca2+-sensitive 
transcription factor nuclear factor of activated T cells (NFAT) and the Ca2+-
dependent protein kinase C (PKC) isoforms. DAG also functions in PKC-
activation and this has been linked to the activation of the nuclear factor-κB 
(NF-κB) family of transcription factors. Another cluster of adaptor proteins 
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composed of BCL-10 (B-cell lymphoma 10), CARMA1 (caspase-recruitment 
domain membrane-associated guanylate kinase protein 1) and MALT1 
(mucosa-associated-lymphoid-tissue lymphoma-translocation gene 1) 
functions in the activation of the IKK (inhibitor of nuclear factor-κB (IκB) 
kinase) complex, a prerequisite for NF-κB-activation. BCR-ligation also 
enhances the formation of the lipid second messenger phosphatidylinositol 
(3,4,5)-trisphosphate (PIP3) through activation of phosphoinositide-3 kinase 
(PI3K). This is a key event for the activation of many pleckstrin homology 




Figure 2: Overview of BCR-signaling. See text for details (modified from Monroe, 2006). 
In addition to the BCR core elements surface Ig and Igα-Igβ heterodimer, the 
complex can contain several co-receptors which have the capacity to 
modulate BCR-induced signaling (Nitschke, 2005: ; Poe, et al., 2001). 
Examples for important co-stimulants are CD19, CD21/35 and CD45, 
whereas CD22 and CD72 transduce inhibitory signals through motives termed 
immunoreceptor tyrosine-based inhibitory motifs (ITIMs) in analogy to the 
ITAMs. ITIMs function in the recruitment of SH2-domain containing protein 
tyrosine phosphatases which are not only important in the down-regulation 
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and termination of the BCR-induced response, but which also possess the 
important capacity to modulate the strength of the BCR-mediated signal by 
directly opposing the action of proximal protein tyrosine kinases. 
Signaling form the BCR or pre-BCR can direct dramatically different cell fates 
ranging from survival and proliferation to anergy and cell death. Despite the 
wealth of information on BCR-induced signaling pathways, establishing a 
certain cellular outcome as the consequence of specific molecular events has 
proven challenging. It is likely that key signaling factors are important for 
several potential cell fates, but there could be specific differences in their 
respective regulation through feedback interactions or signaling input from 
additional receptors. Conversely, some components of the BCR-related 
signaling web could function as unique features in promoting a specific 
cellular destiny. Most likely, a combination of both quantitative and qualitative 
differences enables the diversification from a single inducer to a range of 
cellular outcomes. For example, the MAPK Erk (extracellular signal-regulated 
kinase) and the transcription factor NFAT are responsive to antigenic 
stimulation in both naive and auto-reactive B cells, albeit to a different extend, 
whereas activation of the MAPK Jnk (Jun N-terminal kinase) and the 
transcription factor NF-κB occurs only in naive cells (Healy and Goodnow, 
1998). These unique BCR-induced signaling profiles coincide with opposing 
cell fates, namely the clonal expansion of activated versus the inactivation 
and deletion of auto-reactive cells.  
Several lines of evidence strongly suggest that the BCR complex has a critical 
signaling function even in the absence of ligand binding. Loss of the Ig portion 
of the BCR complex on mature B cells causes their demise and 
disappearance from the peripheral B cell pool (Lam, et al., 1997). The same is 
true for ablation of the ITAM-containing signaling portion of the Igα and Igβ 
accessory chains (Kraus, et al., 2004: ; Meffre and Nussenzweig, 2002). 
Conversely, expression of a plasma membrane targeted chimeric Igα-Igβ 
protein in bone marrow progenitor cells which lack a functional Ig heavy chain 
coding region, is sufficient to generate peripheral follicular B cells which 
persist in the absence of surface BCR-expression (Bannish, et al., 2001). 
These studies demonstrate that the maintenance of mature resting B cells in 
the periphery requires a constitutive survival signal which originates from the 
signaling portion of the BCR-complex and the expression of this segment is 
the minimal unit required to sustain peripheral B cell development and 
viability. 
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Several hypotheses have been put forward to explain the nature of the so-
called tonic BCR-mediated survival signal(Monroe, 2006). It has been 
proposed that a potential oligomeric assembly of BCR-complexes on the cell 
surface even in the absence of a cross-linking agent may be sufficient to 
generate a transducible event through the physical vicinity of signaling 
modules (Schamel and Reth, 2000). However, most of the current data 
suggest that BCR-complexes are rather dispersed throughout the plasma 
membrane in a monomeric state in resting naive cells, whereas stimulation 
causes their clustering, cap formation and eventual internalization (Tolar, et 
al., 2005). An alternative model focuses on BCR-localization in specialized 
ganglioside-rich membrane domains called lipid rafts. These membrane 
micro-domains are believed to function as signaling platforms and BCR-
aggregation into lipid-raft localized clusters occurs upon receptor cross-
linking. As a fraction of BCR-complexes is lipid-raft associated in resting 
unstimulated B cells, they might represent the source of the tonic BCR-signal 
(Guo, et al., 2000). This model is complicated by the observation that many of 
the signaling proteins believed to be essential for BCR-mediated signaling, 
including Syk and PLCγ2, only localize to lipid rafts upon receptor cross-
linking. Furthermore, BCR-localization in lipid rafts appears to be dispensable 
for its tonic signaling to occur (Fuentes-Panana, et al., 2005).  
Finally, Monroe and others have proposed the homeostatic equilibrium model. 
Tonic BCR-signaling in this model represents a steady-state balance between 
stochastic phosphorylation of BCR-ITAMs by receptor-associated protein 
tyrosine kinases and its reversal by protein tyrosine phosphatases recruited 
by inhibitory BCR co-receptors. More specifically, a basal enzymatic activity of 
Lyn and Syk could account for random transient BCR-ITAM-phosphorylation 
which constitutes the origin of the tonic BCR survival signal. At the same time, 
full-blown receptor signaling is prevented by the activity of CD22-associated 
SH2-domain containing protein tyrosine phosphatase 1 (SHP-1). This model 
is in line with the effects of CD22- or SHP-1-deficiency on BCR-signaling 
(Cyster and Goodnow, 1995: ; Pani, et al., 1995), although the actual 
mechanism in vivo may be more complex and involve additional factors. BCR-
stimulation with antigen would tip the balance between positive and negative 
signaling events within the complex towards productive phosphorylation. This 
could be achieved through the physical exclusion of inhibitory receptor 
components from the lipid-raft localized BCR-clusters and/or by transient 
inactivation of protein tyrosine phosphatases through the generation of 
reactive oxygen species. While this model makes a very coherent suggestion 
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regarding the initiation of tonic versus immunogenic BCR signaling, the nature 
of the downstream events continues to be unknown. Specifically, it remains to 
be determined how transient ITAM-phosphorylation is translated to cell 
survival versus the multitude of cellular changes in response to BCR-
stimulation. This could be due to a quantitative difference in the signaling 
strength or a qualitative difference involving a distinct set of signaling factors 
or a combination of both. To date, any specific differences between tonic and 
ligand-induced BCR-signaling on a molecular level, qualitatively or 
quantitatively, have remained elusive.  
 
1.2.2 The role of Syk in B cell biology 
Syk was first purified as a tyrosine kinase activity from porcine spleen, hence 
the name for spleen tyrosine (Y) kinase (Kobayashi, et al., 1990: ; Sakai, et 
al., 1988: ; Taniguchi, et al., 1991). It forms a subgroup of cytoplasmic 
tyrosine kinases together with the closely related protein ZAP-70 (zeta-chain 
associated protein kinase, 70kD). Syk is expressed widely throughout the 
lymphoid and myeloid lineage as well as in some non-hematopoietic cell types 
including fibroblasts and epithelial cells (Turner, et al., 2000: ; Yanagi, et al., 
2001). 
Syk plays a critical role in signaling downstream of various receptors in 
different cell types. In B cells, Syk is rapidly activated upon cross-linking of the 
BCR (Hutchcroft, et al., 1991: ; Law, et al., 1994: ; Yamada, et al., 1993). 
Furthermore, BCR-induced signaling responses are abrogated in a Syk-
deficient variant of the chicken B cell line DT40, indicating an indispensable 
function of Syk in BCR-mediated signal transduction (Takata, et al., 1994). In 
addition to its function in B cells, Syk plays a role in signaling from various 
types of Fc receptors through which immune cells bind and respond to soluble 
antibodies. Fc stands for “fragment, crystallizable” and corresponds to the 
constant region of an antibody molecule (Janeway, et al., 2001). In mast cells, 
Syk mediates the response to IgE via FcεRI and is required for degranulation 
and cytokine release (Costello, et al., 1996: ; Taylor, et al., 1995: ; Zhang, et 
al., 1996). Similarly, Syk is involved in antibody-dependent cell-mediated 
cytotoxicity in response to FcγRIII cross-linking in natural killer (NK) cells 
(Brumbaugh, et al., 1997: ; Colucci, et al., 1999) and FcγR-mediated 
phagocytosis in macrophages (Crowley, et al., 1997: ; Kiefer, et al., 1998). 
Syk is also expressed in double-negative thymocytes and a role for Syk in 
pre- T cell receptor (TCR) signaling has been suggested based on its ability to 
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interact with the phosphorylated TCRζ chain in thymocytes and Jurkat T cells 
(Chan, et al., 1994: ; Thome, et al., 1995: ; van Oers and Weiss, 1995). A 
major role for Syk in mature T cells is unlikely based on its low expression 
level (Chu, et al., 1999). However, enforced Syk-expression is able to restore 
the impaired T cell development ensuing from a lack of ZAP-70 in mice 
(Gong, et al., 1997), indicating that the functions of Syk and ZAP-70 may be 
partially interchangeable and differences may mainly be bestowed by a 
differential expression pattern. In support of this hypothesis, enforced 
expression of ZAP-70 restores BCR-signaling in Syk-deficient DT40 B cells 
(Kong, et al., 1995). 
Both Syk and ZAP-70 are composed of an N-terminal tandem SH2-domain 
followed by a linker region and a C-terminal kinase domain (figure 3). The 
main difference between the two proteins is found in the linker region, which 
contains a 23 residues insertion in Syk as compared to ZAP-70. Interestingly, 
a deletion of the same region occurs in SykB which arises from alternative 
splicing of the full-length Syk transcript. This difference has functional 
consequences as full-length Syk displays a higher affinity to phosphorylated 
ITAMs and mediates more efficient signaling from the FcεRI receptor (Latour, 
et al., 1998).  
 
 
Figure 3: Domain structure of Syk, SykB and ZAP-70. The positions of the structural 
domains as well as of tyrosine residues are indicated. Residue numbering is based on 
the full-length murine Syk protein. Asterisks denote residues whose phosphorylation 
has only been observed in vitro (modified from Turner et. al. 2000). 
 
Syk-activation downstream of the BCR, pre-TCR and Fc-receptors most likely 
occurs through a shared mechanism which depends on the ITAMs present in 
all these receptor complexes. Syk has the capacity to bind phosphorylated 
ITAMs via its tandem SH2-domain (Johnson, et al., 1995: ; Law, et al., 1994: ; 
Law, et al., 1993: ; Saouaf, et al., 1994). This induces a conformational 
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change in the protein which likely enables kinase activity, resulting in the 
phosphorylation of  
downstream targets as well as Syk itself (Kimura, et al., 1996: ; Rowley, et al., 
1995). Initial BCR ITAM-phosphorylation was originally believed to be 
accomplished by Src-family tyrosine kinases, although later evidence 
suggested that Syk-activation does not require prior Src-kinase activity and 
Syk itself is capable of ITAM-phosphorylation (Kurosaki, et al., 1994: ; Zoller, 
et al., 1997). The order of proximal signaling events downstream of the BCR 
is therefore not entirely clear and it is not known, how potential Syk-activity on 
BCR-ITAMs is regulated in the absence of stimulation. Finally, alternative 
ITAM-independent mechanisms of Syk activation may exist as Syk also plays 
in role in signaling downstream of non-ITAM receptors, for example integrins, 
although it is possible that such receptors require ITAM-containing adaptor 
molecules (Gao, et al., 1997: ; Mocsai, et al., 2006: ; Woodside, et al., 2001). 
Syk contains multiple tyrosine residues whose phosphorylation has been 
observed in vitro and in vivo (Furlong, et al., 1997: ; Keshvara, et al., 1998). 
Upon BCR-cross linking, Syk-phosphorylation can be detected on Y130 
located between the two SH2-domains, the linker region residues Y317, Y342 
and Y346 as well as Y519 and Y520 within the kinase domain (figure 3). 
Phosphorylation of Y130 and the kinase domain tyrosines is accomplished 
through auto-phosphorylation. Y519 and Y520 autophosphorylation is 
essential to Syk catalytic activity whereas the modification of Y130 appears to 
play a role in modulating Syk binding to the BCR (Couture, et al., 1997: ; 
Keshvara, et al., 1997: ; Kurosaki, et al., 1995). Phosphorylation of the linker 
region tyrosines is presumably mediated by Lyn and serves important 
biological functions. On the one hand, it appears to play a role in the binding 
of Syk to downstream targets such as PLCγ1 and Vav (Deckert, et al., 1996: ; 
Law, et al., 1996). On the other hand, phosphorylation of Y317 is critical for 
Syk recognition by the ubiquitin-ligase Cbl (Casitas B-lineage lymphoma). 
Cbl-mediated proteolytic degradation of Syk constitutes an important 
mechanism in the down regulation of Syk-activity (Lupher, et al., 1998: ; Sohn, 
et al., 2003: ; Yankee, et al., 1999). In addition to the sites mentioned above, 
Syk-phosphorylation on Y290, Y358, Y624 and Y625 has been observed in 
vitro (Furlong, et al., 1997). The potential modification of the C-terminal 
residues Y624 and Y625 is particularly intriguing due to a potentially 
analogous mechanism in tyrosine kinases of the Src-family. Here, 
phosphorylation of C-terminal tyrosine residues by C-terminal Src kinase 
(Csk) triggers kinase inactivation (Nada, et al., 1991). Indeed, the conversion 
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of Syk C-terminal tyrosine residues to phenylalanines creates a gain-of-
function Syk mutant (Zeitlmann, et al., 1998). Yet, neither a mechanism of 
Syk-inactivation through C-terminal phosphorylation nor a potential C-terminal 
Syk kinase has been described to date.
Syk-deficiency in mice results in perinatal lethality due to excessive 
hemorrhaging (Cheng, et al., 1995: ; Turner, et al., 1995). This is caused by a 
failure in the segregation of lymphatic and blood vessels during embryonic 
development (Abtahian, et al., 2003). The potential function of Syk in the 
immune system has been assessed through adoptive transfer of fetal liver 
which is the site of fetal hematopoiesis, from Syk-deficient embryos into 
immunodeficient hosts. The resulting chimeric mice exhibit a grossly normal T 
cell compartment and various functional deficits in myeloid cell types. The 
most dramatic effect is observed in the B cell compartment. Lack of Syk 
causes a severe block in early B cell development in the bone marrow at the 
transition from the pro B to the pre B stage, resulting in a near absence of B 
cells in the peripheral lymphoid organs. This demonstrates an obligatory role 
for Syk at the onset of B lymphopoiesis. A similar phenotype in mutant mice 
which are genetically unable to express a functional BCR can be overcome by 
the expression of a rearranged BCR-transgene, but this is not possible in the 
absence of Syk (Rajewsky, 1996); (Cornall, et al., 2000: ; Turner, et al., 1997). 
In the latter case, the fraction of IgM-positive cells in the bone marrow is 
increased by expression of a transgenic BCR. However, these cells remain 
phenotypically immature, are refractive to BCR-stimulation and are unable to 
exit the bone marrow and persist in the periphery. Similarly, extension of B 
cell survival by ectopic expression of B-cell lymphoma 2 (Bcl-2) does not 
rescue B cell maturation in the absence of Syk (Turner, et al., 1997). These 
results argue for an indispensable signaling function for Syk downstream of 
the BCR.  
The early developmental block in the absence of Syk precludes an 
assessment of its function at later B cell stages including the survival, 
activation and differentiation of mature naive B cells. In an attempt to 
circumvent this problem, a conditional Syk knock-out was generated (Saijo, et 
al., 2003) and figure 4A). A targeting vector was constructed from genomic 
DNA of 129/Sv origin encompassing the first two exons of the murine Syk 
locus. The first exon was flanked with a single loxP site on the one side and 
with a loxP-flanked neomycin resistance cassette (neor) on the other. E14.1 
embryonic stem (ES) cells were transfected with the targeting vector and 
screened for homologous recombination by Southern blotting of genomic DNA 
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Figure 4: Conditional Syk inactivation in mice. A. Gene targeting strategy for 
conditional Syk inactivation. The domain structure of the Syk protein is shown 
together with part of the Syk genomic locus, the targeting vector and part of the Syk 
locus before and after Cre-mediated recombination. Black squares denote exons I and 
II. Open triangles represent loxP sites. Gray bars denote expression cassettes for the 
neomycin resistance (neor) and herpes simplex thymidine kinase (tk) genes with the 
arrows indicating the transcriptional orientation. Essential elements of the Southern 
blot strategies used in the characterization of the various loci forms, are indicated as 
follows: Probes A and B as thick black lines, genomic fragments as thin black lines 
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between endonuclease restriction sites. LAH = long arm of homology, SAH = short arm 
of homology, pBS = pBluescript. Modified from Saijo et. al., 2003. B. Southern blot 
analysis of genomic DNA isolated from mouse tail tips. left: floxed (fl, 8 kb) and deleted 
(∆, 7 kb) alleles using BamHI restriction digestion and probe A; right: wild-type (+, 8 
kb), floxed (fl, 6.2 kb) and deleted (∆, 5.1 kb) alleles using BamHI-XhoI double digestion 
and probe B. 
 
after EcoRI digestion using the external probe A. The neor cassette was 
removed from positive clones through transfection with a Cre-recombinase 
expression vector and newly neomycin-sensitive clones were screened for 
correct excision of only the neor-cassette by Southern blot using BamHI-XhoI 
double digestion and probe B. ES cell clones containing the correctly targeted 
locus were injected into C57BL/6 blastocysts and the resulting chimeras were 
bred to C57BL/6 mice for germline transmission of the floxed Syk allele. The 
floxed Syk allele is functionally indistinguishable from a wild-type allele (my 
unpublished observation) and can be converted to a null allele through Cre-
recombinase mediated excision of the first exon which contains the translation 
start codon. Genotyping of mice or cells is feasible through two different 
Southern blot strategies: use of probe A on BamHI-digested genomic DNA 
distinguishes the deleted allele from the wild-type or floxed allele, whereas 
probe B on BamHI-XhoI double-digested genomic DNA separates all three 
different alleles (figure 4B). The spatiotemporal regulation of Syk inactivation 
is determined by the pattern of Cre-expression. Different mouse Cre-strains 
are available in which Cre-expression is inducible by an external signal or 
targeted to a specific cell type. 
 
1.3 Mature B cell survival through BAFF signaling 
1.3.1 The BAFF-related protein network 
It was long believed that tonic BCR signaling is the principle or even sole 
factor in mature B cell maintenance until a cytokine was discovered which 
dramatically increased the survival of B cells in vitro and in vivo (Batten, et al., 
2000: ; Do, et al., 2000: ; Gross, et al., 2000: ; Khare, et al., 2000: ; Mackay, 
et al., 1999: ; Moore, et al., 1999: ; Mukhopadhyay, et al., 1999: ; Rolink, et 
al., 2002: ; Schneider, et al., 1999: ; Shu, et al., 1999: ; Thompson, et al., 
2000). BAFF, also known as BLyS, TALL-1, THANK, zTNF4 and TNFSF 13b, 
increases B cell viability in culture and causes B cell hyperplasia and 
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autoimmunity when ectopically expressed in mice. In contrast to potent B cell 
mitogenic stimuli such as BCR cross-linking, CD40-ligand or endotoxin, BAFF 
exclusively enhances B cell viability without inducing proliferation. 
Together with a related protein called a proliferation-inducing ligand (APRIL) 
BAFF forms a subgroup within the tumor necrosis factor (TNF) family. As 
such, BAFF is synthesized as a type II transmembrane protein which 
homotrimerizes via its C-terminal TNF-homology domain (THD). Soluble 
BAFF is the result of cleavage by furin family proteases, releasing a 138 
residues product from the full-length (309 residues) pre-curser (Schneider, et 
al., 1999). BAFF contains putative N-linked glycosylation sites in its 
extracellular domain and its sensitivity to treatment with peptide N-glycanase 
indicates BAFF-glycosylation in vivo. Mouse and human BAFF are 59% 
identical in their amino acid sequence, the main difference being a 31 
residues insertion in mouse BAFF between the proteolytic cleavage site and 
the conserved THD-fold. Heterotrimers between BAFF and ARPIL are 
possible when the two proteins are co-expressed and have been found in the 
serum of patients with systemic rheumatic disease (Roschke, et al., 2002). A 
second BAFF isoform termed ∆BAFF arises from alternative splicing of the 
BAFF-transcript and can form multimers together with full-length BAFF. The 
biochemical properties of ∆BAFF vary significantly from the full-length protein 
in its poor release through protease-mediated cleavage and its decreased 
receptor affinity (Gavin, et al., 2003). Accordingly, ∆BAFF opposes full-length 
BAFF activity and cannot functionally substitute for loss of BAFF in vivo 
(Gavin, et al., 2005). BAFF-trimers can assemble into a 60-mer which forms a 
virus-like structure (Cachero, et al., 2006: ; Liu, et al., 2002). This form of 
BAFF is biologically active, although the significance of this particular 
assembly remains unknown (Zhukovsky, et al., 2004). 
Three TNF receptor proteins have been found to bind BAFF although their 
ligand specificity partially overlaps with APRIL (figure 5). Transmembrane 
Activator and CAML Interactor (TACI) and B-Cell Maturation Antigen (BCMA) 
bind both BAFF and APRIL while BAFF is the sole ligand for BAFF receptor 
(BAFF-R) (reviewed in (Bodmer, et al., 2002: ; Bossen and Schneider, 2006: ; 
Mackay, et al., 2003). All three receptor proteins are untypical members of the 
TNF receptor family in that they are type III transmembrane proteins and their 
intracellular portion lacks a death domain. The extracellular domains contain 
one or more Cystein-Rich Domains (CRDs), the ligand binding unit of the 
receptor, although its canonical motif is only partially conserved in the case of 
BAFF-R. Additional complexity to this receptor-ligand system is afforded by 
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Figure 5: The BAFF protein family. Ligands BAFF, ∆BAFF and APRIL are shown 
together with the receptor proteins BAFF-R, BCMA and TACI as well as the 
proteoglycan moiety of other cell surface-expressed proteins. Boxes in the receptors 
denote cystein rich domains (CRDs). Ligand-receptor interactions are indicated by thin 
black lines. Note that the oligo- or multimeric nature of ligand and receptor complexes 
is not represented in this diagram. 
 
1.3.2 The functions of BAFF and BAFF-R in B cell survival and 
beyond 
The function of the BAFF-related protein network has been investigated using 
mouse models which lack individual components of the ligand-receptor 
system. In line with its dramatic impact on B cell viability, loss of BAFF 
diminishes the peripheral B cell compartment in mice. While early B cell 
development in the bone marrow proceeds largely unimpaired, a 
characteristic block ensues during peripheral B cell maturation in the spleen 
from the T1 to the T2 stage. Consequently, mature B cells are largely absent 
from the periphery of BAFF-deficient mice (Gross, et al., 2001: ; Schiemann, 
et al., 2001: ; Schneider, et al., 2001). A very similar phenotype, albeit 
somewhat less severe, is observed in the natural mouse mutant A/WySnJ 
(Lentz, et al., 1996: ; Miller and Hayes, 1991). This lead to the identification of 
BAFF-R as the principle receptor protein involved in BAFF-mediated B cell 
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survival. A/WySnJ mice harbor a transposon insertion in the BAFF-R locus 
which alters the C-terminal eight amino acids of the receptor and presumably 
impairs its signaling capacity (Thompson, et al., 2001: ; Yan, et al., 2001). 
Subsequent BAFF-R ablation by gene targeting provided additional support 
for the vital role of BAFF-R in BAFF-mediated survival of peripheral B cells 
from the T2 stage on (Sasaki, et al., 2004: ; Shulga-Morskaya, et al., 2004). 
This BAFF-dependency is not only restricted to conventional follicular B cells, 
but likely includes MZ B cells. The analysis of this question has been 
complicated by the fact that BAFF regulates the expression of CD21/35 and 
CD23 which are commonly used surface markers in the identification of 
splenic B cell subsets (Gorelik, et al., 2004). It appears that some MZ B cells 
are present in BAFF null and A/WySnJ mice, whereas none are detected in 
BAFF-R null mice and those expressing a TACI-Ig transgene (Amanna, et al., 
2003: ; Gorelik, et al., 2004: ; Sasaki, et al., 2004: ; Tardivel, et al., 2004). 
Overall, these results indicate that some level of BAFF-signaling is required 
for MZ B lymphopoiesis or maintenance or both. This conclusion is also 
supported by an expansion of the MZ B cell compartment in BAFF-transgenic 
mice (Gross, et al., 2000: ; Khare, et al., 2000: ; Mackay, et al., 1999). Quite 
surprisingly, despite the near absence of mature B cells in the absence of 
BAFF signaling, it is not required for some secondary B cell immune 
responses including the formation of germinal centers (GCs) and BCR affinity 
maturation. Yet, it does contribute to GC stability and BCR class-switch 
recombination to selected isotypes (Kalled, 2006). Most reports have 
concluded that BAFF signaling does not have an impact on the B-1 subset of 
B cells, although one study documented a modulation of B-1 cell numbers by 
decrease or increase in BAFF (Gavin, et al., 2005). In addition to its most 
prominent role in B cell biology, BAFF modulates the T cell compartment in 
several ways (reviewed in (Mackay and Leung, 2006). BAFF can directly 
stimulate BAFF-R-expressing T cell subpopulations including activated and 
regulatory T cells. BAFF provides a direct co-stimulatory signal to anti-CD3-
triggered T cells through an autocrine loop by which activated T cells 
synthesize BAFF and increase BAFF-R expression. BAFF-costimulation of T 
cells enhances cytokine release and their differentiation into effector T cells. 
In vivo, BAFF-influences T cell-mediated allograft rejection, although it is not 
established whether this is due to direct BAFF-signaling on T cells.  
The essential function of BAFF in B cell homeostasis is revealed not only by 
lack of but also by excess BAFF-signaling. Ectopic BAFF-expression in mice 
leads to B cell hyperplasia, elevated serum Ig titers and the manifestation of 
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systemic autoimmunity (Gross, et al., 2000: ; Khare, et al., 2000: ; Mackay, et 
al., 1999). Correspondingly, elevated levels of BAFF have been measured in 
the serum of autoimmune-prone mice and in patients suffering form various 
autoimmune disorders including systemic lupus erythematosus (SLE), 
rheumatoid arthritis (RA) and primary Sjogren's syndrome (pSS) (reviewed in 
(Mackay, et al., 2005). A mechanistic basis for BAFF’s involvement in the 
negative selection of auto-reactive cells stems from the fact that the latter 
require higher BAFF-concentrations for survival than normal naive B cells 
(Lesley, et al., 2004: ; Thien, et al., 2004). Given that the amount of available 
BAFF is limited in a normal physiological context, this differential BAFF-
requirement ensures the exclusion of auto-reactive cells from the stable 
peripheral B cell pool. Conversely, excess BAFF enables the persistence of B 
cells with a self-reactive receptor specificity in the periphery with the potential 
to cause tissue damage. This model fits very well with the observed clinical 
correlation between BAFF titers and autoimmune symptoms in humans and 
mice. Also in line with this model is the observation that ablation of two BAFF-
regulated negative players in B cell survival, namely PKCδ and Bcl-2 
interacting mediator of cell death (Bim), renders B cell survival BAFF-
independent, ablates B cell tolerance and causes autoimmunity (see below).  
The dual B cell pathologies resulting from insufficient as well as excess BAFF-
signaling illustrate that the amount of biologically active BAFF has to be very 
tightly regulated to ensure the maintenance of a physiological peripheral B cell 
pool. BAFF-synthesis has been attributed to radiation-resistant stromal cells in 
the spleen, different myeloid cell types including monocytes, macrophages, 
neutrophils and dendritic cells, as well as activated T cells, follicular dendritic 
cells, astrocytes, osteoclasts and others (Craxton, et al., 2003: ; Gorelik, et al., 
2003: ; Kalled, 2006: ; Litinskiy, et al., 2002: ; Nardelli, et al., 2001: ; Scapini, 
et al., 2005). While stromal cells could be a constitutive source of BAFF which 
is mainly responsible for the maintenance of physiological BAFF serum titers, 
BAFF-production by monocytes, macrophages, dendritic cells or neutrophils is 
externally regulated by other cytokines and could serve the modulation of 
BAFF-concentrations in specialized micro-environments such as inflammatory 
sites. Some instances of BAFF-production have been related to a pathological 
state, such as BAFF-synthesis by fibroblast-like synoviocytes in rheumatic 
joints, by ductal epithelial cells in the salivary gland of Sjogren’s syndrome 
patients and by nurse-like cells in chronic lymphocytic leukemia (CLL) 
(Groom, et al., 2002: ; Ittah, et al., 2006: ; Nishio, et al., 2005: ; Ohata, et al., 
2005). Despite the identification of numerous BAFF-producing cell types, the 
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mechanism accounting for the precise regulation of BAFF levels remains 
unknown.  
In addition to the available amount of BAFF, the level of BAFF-R surface 
expression seems to impact the strength of BAFF-signaling. This is evidenced 
by the intermediate B cell phenotype of heterozygous A/WySnJ mice 
compared to homozygous A/WySnJ mice and the parental A/J strain and 
indicates a gene dosage effect (Harless, et al., 2001: ; Lentz, et al., 1996: ; 
Miller and Hayes, 1991). 
 
1.3.3 The functions of TACI, BCMA and APRIL 
Despite certain structural similarities between the ligands BAFF and APRIL as 
well as the receptors TACI, BCMA and BAFF-R, the biological functions of the 
individual proteins vary dramatically. As described above, mature B cell 
survival is predominantly accomplished by BAFF-binding to BAFF-R whereas 
a similar role for the other proteins is less likely based on the phenotype of the 
respective knock-out mice. Lack of BCMA does not have a discernable effect 
on mature B cell viability (Xu and Lam, 2001). Yet, it plays a role in the 
survival of long-lived plasma cells in the bone marrow (Avery, et al., 2003: ; 
O'Connor, et al., 2004).  
The function of TACI in B cell biology appears to be fairly complex and may 
not be entirely conserved between mice and humans. On the one hand, TACI-
deficiency in mice renders B cells hyper-responsive to mitogenic stimuli and 
leads to an SLE-like disorder, B cell hyperplasia and even spontaneous 
development of lymphoma in a significant fraction of mutant animals 
(Seshasayee, et al., 2003: ; von Bulow, et al., 2001: ; Yan, et al., 2001). 
These symptoms argue for a predominantly inhibitory role for TACI in B cell 
activation in mice. On the other hand, TACI is required for a proper immune 
response to type II T cell-independent antigens and plays a role in class 
switch recombination to IgG1 and IgA, a process which is promoted by both 
BAFF and APRIL through BAFF-R and TACI (Castigli, et al., 2004: ; Castigli, 
et al., 2005: ; Litinskiy, et al., 2002: ; Sakurai, et al., 2006). Furthermore, 
mutations in TACI are associated with an immunodeficiency syndrome in 
humans (Castigli, et al., 2005: ; Salzer, et al., 2005). Interestingly, in addition 
to the ligands BAFF and APRIL, TACI was shown to interact with the heparan 
sulfate moiety of the cell surface protein Syndecan-2 and this interaction 
induced TACI-mediated signaling (Bischof, et al., 2006: ; Sakurai, et al., 
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2006). Collectively, TACI-signaling appears to effect B cell functions both 
negatively and positively. The precise impact may be related to the B cell 
maturation stage, the type of ligand or even the species.  
APRIL-deficiency does not appear to influence the survival of mature B cells, 
but as mentioned above, it can contribute to class-switch recombination by 
signaling through TACI and promotes plasma cell survival through BCMA 
(Avery, et al., 2003: ; O'Connor, et al., 2004). Intriguingly, in addition to 
binding to the TNF-family receptors TACI and BCMA, APRIL displays an 
affinity for the glycosaminoglycan side chains of proteoglycans (Ingold, et al., 
2005). APRIL has also been implicated in the survival of lymphatic 
malignancies including B-cell chronic lymphoid leukemia (B-CLL), multiple 
myeloma and non-Hodgkin's lymphoma (Dillon, et al., 2006).  
In addition to their individual functions, APRIL, TACI and BCMA can have a 
dramatic effect on B cell survival by titrating the available amounts of 
biologically active BAFF and BAFF-R. For example, TACI- or BCMA-fusion 
proteins function as decoy BAFF receptors when injected in mice or 
expressed from a transgene, depleting the peripheral B cell compartment 
(Gross, et al., 2001: ; Pelletier, et al., 2003: ; Schneider, et al., 2001: ; 
Thompson, et al., 2000). Also, chimeric receptor proteins containing the 
intracellular portion of BAFF-R, TACI or BCMA, respectively, elicit partially 
overlapping outcomes in terms of cell survival and molecular responses when 
expressed and triggered in B cell lines (Craxton, et al., 2005). In this 
experimental system, all three proteins boost cell survival while BAFF-R and 
TACI but not BCMA cause Bim-phosphorylation and only BAFF-R induces 
NF-κB processing (see below). In summary, there appears to be an intricate 
web of interactions between the ligands BAFF and APRIL, the receptors 
BAFF-R, TACI and BCMA and possibly also the proteoglycan moieties of cell 
surface molecules such as members of the syndecan family. While individual 
functions have been assigned to specific contacts, the full scope of potential 
cross-communication may continue to unfold. 
 
1.3.4 The molecular consequences of BAFF-signaling 
Considering the enormous interest and the wealth of knowledge on the 
function of BAFF in B cell physiology and disease, the level of insight into its 
signaling mechanism is surprisingly modest. A search for proximal signaling 
factors which directly interact with BAFF-R has so far yielded a single protein, 
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TRAF3. A physical and functional association has been proposed between 
BAFF-R, TRAF3 and the adaptor protein NF-κB activator 1 (Act1) which 
dampens BAFF-induced cellular responses (Qian, et al., 2004: ; Xu and Shu, 
2002). Despite limited knowledge on the direct proximal signaling events upon 
B cell stimulation with BAFF, several molecular changes have been observed 
which likely contribute to its B cell survival effect (figure 6). First, it was 
discovered that BAFF induces activation of the transcription factor NF-κB 
which is known to play a central role in lymphocyte survival. NF-κB in 
mammals comprises a family of five related proteins (p50, p52, p65, RelB and 
c-Rel) which function in transcriptional regulation as hetero- or homodimers 
(Bonizzi and Karin, 2004). p50 and p52 originate from the processing of 
precursor proteins p105 (NF-κB1) and p100 (NF-κB2), respectively. The 
mechanism of NF-κB activation has been well studied for many years and 
relies on the rapid IKK-mediated phosphorylation and subsequent proteolytic 
degradation of IκB proteins which allows for the nuclear translocation of 
transcriptionally active NF-κB dimers. An example for this type of NF-κB 
activation is B cell stimulation through its antigen receptor. By contrast, BAFF 
primarily elicits NF-κB activation through an alternative mechanism in which 
NF-κB2 p100 is processed to mature p52 and subsequently forms 
transcriptionally active dimers with RelB (Claudio, et al., 2002: ; Kayagaki, et 
al., 2002: ; Senftleben, et al., 2001: ; Xiao, et al., 2001). The transcriptional 
targets of BAFF-induced NF-κB activation are not well characterized. 
Upregulated expression of some pro-survival members of the Bcl-2 family has 
been observed in some instances but not in others (Claudio, et al., 2002: ; 
Hatada, et al., 2003: ; Hsu, et al., 2002: ; Lesley, et al., 2004: ; Thomas, et al., 
2005: ; Trescol-Biemont, et al., 2004) and my own unpublished observations). 
In addition to NF-κB activity, BAFF controls the subcellular localization of 
PKCδ. PKCδ is an important negative regulator of B cell viability as evidenced 
by B cell hyperplasia, autoimmunity and lack of B cell tolerance in PKCδ-
deficient mice (Mecklenbrauker, et al., 2002). Furthermore, mature B cell 
survival becomes BAFF-independent in the absence of PKCδ 
(Mecklenbrauker, et al., 2004). The pro-apoptotic function of PKCδ is 
associated with its translocation to the nucleus and capacity for histone 
modification. BAFF promotes the cytoplasmic retention of PKCδ, thus 
containing its pro-apoptotic potential.  
While the BAFF-induced expression of pro-survival Bcl-2 family members 
remains somewhat controversial, the pro-apoptotic Bcl-2 family member Bim 
is an undisputed target of BAFF-mediated regulation (Craxton, et al., 2005). A 
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Figure 6: BAFF-induced changes in cellular signaling. BAFF binding to its receptor 
induces NF-κB activation by enhancing the processing of NF-κB2 p100 to mature p52 
which regulates gene transcription in conjunction with RelB. BAFF-mediated 
cytoplasmic retention of PKCδ is indicated by the symbol and arrow size. Regulation of 
Bim by BAFF involves its phosphorylation and degradation. 
 
key function for Bim in B cell homeostasis is demonstrated by elevated 
numbers of B cells and impaired deletion of auto-reactive cells in Bim-
deficient mice as well as by the extended survival of Bim-deficient B cells in 
vitro (Bouillet, et al., 1999: ; Enders, et al., 2003). As in the case of PKCδ-
deficiency, absence of Bim alleviates the BAFF-dependency of mature B cells 
for survival (Oliver, et al., 2006). BAFF-treatment also has a direct effect on 
Bim expression as a consequence of BCR-cross linking which it is able to 
suppress (Craxton, et al., 2005). This coincides well with the augmentation of 
BCR-induced proliferation and survival upon co-stimulation with BAFF. Also, 
BAFF promotes Erk-mediated phosphorylation of Bim which curbs its pro-
apoptotic function.  
The transcription factor c-Myb has been identified as another regulator of 
BAFF-mediated B cell survival (Thomas, et al., 2005). Lack of c-Myb reduces 
the frequency of mature peripheral B cells in mice and c-Myb-deficient B cells 
are partially refractive to BAFF-mediated responses, possibly due to 
suboptimal BAFF-R expression. Lack of c-Myb impairs BAFF-induced survival 
and cytoplasmic retention of PKCδ but not p100 processing. Impaired BAFF-
mediated B cell survival and defective BAFF-R expression also occur in the 
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absence of the GTPases Rac1 and Rac2, suggesting that these proteins may 
play a role in the regulation of BAFF-signaling (Walmsley, et al., 2003). 
BAFF-mediated effects on NF-κB activation, PKCδ localization and Bim 
expression are observed in a range of 12 to 24 hours after stimulation, raising 
the question, whether they represent direct BAFF-induced signaling events. 
Alternatively, diminished p100 processing, nuclear translocation of PKCδ and 
upregulation of Bim in the absence of BAFF could merely reflect early signs of 
cellular atrophy which are prevented by BAFF’s effect on B cell viability. In 
either scenario, all the described molecular changes are most likely involved 
in enhancing B cell survival in the presence of BAFF. Indeed, artificial 
augmentation of B cell viability by ectopic expression of Bcl-2, Bcl-xL (Bcl2-
like 1) or constitutively active NF-κB as well as removal of PKCδ is sufficient 
to restore peripheral B cell survival in BAFF-R-mutant mice (Amanna, et al., 
2003: ; Gorelik, et al., 2004: ; Mecklenbrauker, et al., 2004: ; Rahman and 
Manser, 2004: ; Sasaki, et al., 2004: ; Sasaki, et al., 2006: ; Tardivel, et al., 
2004). 
 
1.4 Lymphocyte survival through growth factor 
signaling 
1.4.1 The association between the trophic state of a cell and 
its viability 
The supply of nutrients from the extracellular environment is indispensable to 
the viability, growth, division and differentiation of all cell types. At the same 
time, it is imperative for multicellular organisms to regulate these processes 
not only based on nutrient availability, but on additional extracellular cues 
whose concerted action ensures the proper development and function of the 
organism as a whole. Lymphocytes are a prime example for a cell type whose 
survival and expansion is, among others, dependent on extracellular nutrients 
as well as trophic cytokines or growth factors. The latter afford cells the ability 
to not only ingest nutrients, but to optimize nutrient metabolism for cellular 
growth and energy derivation. For example, stimulation with trophic cytokines 
promotes the cell surface expression of glucose and amino acid transporters, 
thus enabling cellular nutrient uptake (Edinger and Thompson, 2002). At the 
same time, it influences nutrient metabolism by regulating the activity of 
enzymes which control rate-limiting steps of glycolysis. Glycolytic glucose 
utilization is promoted through localization of hexokinase at the mitochondrial 
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membrane where access to intramitochondrial ATP enhance the enzyme’s 
kinetics, while the activity of phosphofructokinase is sensitive to growth factor-
dependent phosphorylation (Bertrand, et al., 1999: ; Deprez, et al., 1997: ; 
Marsin, et al., 2000: ; Robey and Hay, 2006). Glycolytic glucose-utilization 
and energy derivation feed back to mitochondrial respiration by supplying 
critical intermediates of the electron transport chain. Cellular deprivation from 
growth factors creates a shortage of electron transport substrates, leading to 
a drop in mitochondrial membrane potential and a subsequent closure of 
voltage-dependent anion channels, preventing the exchange of metabolites 
between mitochondria and the cytoplasm (Plas, et al., 2002: ; Plas and 
Thompson, 2002). Atrophy as a consequence of growth factor withdrawal in 
lymphoid and hematopoietic cells is characterized by impaired nutrient 
transporter expression and nutrient uptake, decreased glycolytic rates and a 
drop in the mitochondrial membrane potential (Barata, et al., 2004: ; Rathmell, 
et al., 2000: ; Vander Heiden, et al., 2001).  
An important consequence of trophic cytokine mediated nutrient uptake is the 
cells’ ability to maintain or increase their size. Cell growth is obviously a 
prerequisite for proliferative expansion and has to precede cell division unless 
daughter cells should become progressively smaller. At the same time, cell 
growth should not proceed beyond a certain checkpoint, unless in preparation 
for subsequent cell division. Demonstrating the trophic function of growth 
factors, cells deprived of nutrients or growth factors will become progressively 
smaller before they collapse (Plas, et al., 2001: ; Rathmell, et al., 2000). While 
constitutive ectopic expression of anti-apoptotic Bcl-2-family proteins prevents 
the death of such cells, it does not restore size maintenance, nutrient uptake 
or energy homeostasis. This indicates that cell survival mediated by Bcl-2-
family proteins or growth factors constitute separate non-redundant 
mechanisms.  
 
1.4.2 Growth factor signaling is transduced by the PI3K-Akt 
pathway 
In contrast to Bcl-2-family members, components of the PI3K pathway are 
able to avert the decline in cellular metabolism as a consequence of growth 
factor deprivation, indicating that this pathway plays a vital role in growth 
factor signaling (Plas, et al., 2001). PI3K can act on lipids as well as proteins, 
but its best characterized and presumably most important function is the 
phosphorylation of inositol phospholipids on the D3-position of the inositol ring 
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to create, depending on the substrate, phosphatidylinositol-3,4-bisphosphate 
(PIP2) and phosphatidylinositol-3,4,5-triphosphate (PIP3) (Fruman, 2004: ; 
Okkenhaug and Vanhaesebroeck, 2003). The most common PI3K isoform in 
B cells belongs to the class IA subgroup and is composed of a catalytic 
subunit p110δ and a regulatory subunit p85α. PI3K-activation occurs by 
binding of the regulatory subunit’s SH2-domain to phosphorylated tyrosine 
residues in upstream regulatory proteins which result from tyrosine kinase 
activation by growth factor stimulation. p85-binding of upstream activators 
induces a conformational change in the protein complex which allows for 
enzymatic activity of the constitutively associated catalytic subunit. PI3K-
mediated PIP3-accumulation at the plasma membrane creates a docking site 
for signaling proteins bearing a PH-domain. In terms of growth factor 
signaling, the most important of these is the oncogenic serine-threonine 
kinase Akt (figure 7).  
 
 
Figure 7: The PI3K-Akt signaling pathway. See text for details. 
 
Akt, sometimes also called protein kinase B (PKB), is known as a master 
regulator of cell survival, growth and cell cycle progression (Massague, 2004: 
; Plas and Thompson, 2005). It directly influences cell viability through down-
regulation of Bcl-2-associated death promoter (Bad), a member of the pro-
apoptotic BH3-only sub-family of Bcl-2 proteins (Datta, et al., 1997: ; del Peso, 
et al., 1997). A major executer of Akt’s effect on cell survival, cell cycle 
progression and metabolism are members of the Forkhead box O (FoxO)-
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family of transcription factors (Burgering and Kops, 2002). In a process which 
is evolutionary conserved from Caenorhabditis elegans through to mammals, 
FoxO transcription factors protect cells from oxidative stress and signal cell 
cycle exit under glucose limiting conditions. Apoptosis and cell cycle exit are 
promoted by FoxO proteins through upregulation of Bim and the cyclin-
dependent kinase (Cdk) inibitors p21 and p27 (Seoane, et al., 2004: ; Stahl, et 
al., 2002). Collectively, FoxO-proteins antagonize growth factor-induced 
cellular responses. Accordingly, direct FoxO-phosphorylation by growth 
factor-activated Akt inhibits FoxO-mediated transcriptional regulation in the 
nucleus by creating a binding site for 14-3-3 proteins and subsequent 
sequestration of FoxO-proteins in the cytosol (Brunet, et al., 1999). In addition 
to this immediate mechanism of FoxO-inactivation, prolonged Akt-activity has 
the potential to permanently modify the cellular transcriptional program by 
targeting FoxO-proteins for proteolytic degradation (Plas and Thompson, 
2003). In mature B cells, mitogenic stimulation leads to FoxO1-
phosphorylation in a PI3K-dependent manner and over-expression of a 
mutant FoxO-protein which is resistant to Akt-mediated inactivation, causes 
cell cycle arrest and apoptosis concomitant with an induction of p27 and Bim 
in activated lymphocytes (Stahl, et al., 2002: ; Yusuf, et al., 2004). 
One of the most important targets of Akt-signaling is the mammalian target of 
rapamycin (mTOR), a kinase of the phosphoinositide-3-kinase-related kinase 
(PIKK) family which also includes ATM (ataxia telangiectasia mutated), DNA-
PK (DNA-dependent protein kinase) and others (Martin and Hall, 2005: ; 
Wullschleger, et al., 2006). Although mTOR has been a subject of close 
investigation for many years, its regulation and function appear to be 
incredibly complex and are still incompletely understood. mTOR exists in 
complex with accessory proteins raptor (mTORC1) or rictor (mTORC2). The 
two complexes serve distinct cellular functions and are further distinguished 
by their differential sensitivity to the immunosuppressant rapamycin (Bhaskar 
and Hay, 2007). While mTORC2 functions in actin-polymerization and is 
indifferent to rapamycin treatment, mTORC1 represents the “classic“ mTOR 
complex which acts in protein synthesis, metabolism and growth in a 
rapamycin-sensitive fashion. The following description of mTOR function and 
regulation will apply to mTORC1 unless otherwise stated. Under growth-
favorable conditions, mTOR has a direct impact on protein synthesis through 
phosphorylation of ribosomal S6 kinase 1 (S6K1) and 4E binding protein 1 
(4E-BP1) (Ruggero and Sonenberg, 2005). S6K1-mediated phosphorylation 
of ribosomal S6 protein is considered a hallmark of active protein synthesis, 
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whereas 4E-BP1 is an inhibitor of translational initiation through its 
sequestration of eukaryotic translation initiation factor 4E (eIF4E). 
Phosphorylation of 4E-BP1 disrupts its association with eIF4E, thus enabling 
the latter’s participation in the translation initiation complex. mTOR-activity 
also contributes to cell growth by promoting ribosome biogenesis as well as 
the expression of many metabolically relevant genes (Martin and Hall, 2005: ; 
Peng, et al., 2002). Furthermore, mTOR negatively impacts protein 
degradation via autophagy (Lum, et al., 2005). Finally, organization of the 
cytoskeleton which is important in growth related events including 
establishment of cell polarity and cell division is regulated by mTORC2 
(Jacinto, et al., 2004: ; Sarbassov, et al., 2004).  
Given that the mTOR-dependent cellular events are overwhelmingly energy-
consuming, it is probably as appropriate as it is necessary that mTOR 
functions as an integrator for a multitude of signaling inputs including growth 
factors, nutrients, energy and stress, all of which can impact mTOR-activity. 
The metabolic function of mTOR is dependent on the small G-protein Rheb 
(Ras homolog enriched in brain) which is subject to inactivation by the 
GTPase activating protein (GAP) Tuberous sclerosis 2 (TSC2) (Tee and 
Blenis, 2005). Mutations in the TSC2 gene are the leading cause for the 
disease Tuberous sclerosis, a hereditary condition characterized by the 
frequent appearance of benign tumors in multiple organs. Very recently, 
PRAS40 (proline-rich Akt substrate 40kD) has been identified as another 
major mTOR inhibitor (Sancak, et al., 2007: ; Vander Haar, et al., 2007). 
Under conditions unfavorable for mTOR-activity and growth, PRAS40 binds to 
mTOR and prevents its activation. One important characteristic of unfavorable 
growth conditions is a low ATP to AMP ratio which is directly sensed by the 
AMP-activated protein kinase (AMPK) (Hardie, 2005). AMPK-activity has a 
dual negative effect on mTOR-signaling: it enhances TSC2’s GAP-activity 
through direct phosphorylation, thus constraining mTOR activity, while at the 
same time inhibiting activation of the mTOR targets 4E-BP1 and S6K. Growth 
factor-induced activation of the PI3K-Akt pathway has a profound effect on 
mTOR activity at multiple levels. First, Akt phosphorylates and inactivates 
TSC2, thus enabling Rheb·GTP-dependent mTOR activity. As has been 
discovered very recently, Akt also alleviates PRAS40-dependent suppression 
of mTOR activity (Kovacina, et al., 2003: ; Sancak, et al., 2007: ; Vander 
Haar, et al., 2007). Through a mechanism reminiscent of Akt-mediated FoxO-
inactivation, phosphorylation of PRAS40 by Akt enhances its binding to 14-3-3 
proteins, thus sequestering it away from mTOR. In addition to these two direct 
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mechanisms, Akt can relieve AMPK-mediated suppression of mTOR-activity 
through its effect on cellular energy homeostasis. Akt promotes the 
localization of hexokinase at the mitochondrial membrane which contributes to 
cellular energy supply as described above. mTOR activity is also sensitive to 
the cellular concentration of amino acids, in particular leucine, although the 
mechanistic basis for this phenomenon is still unresolved (Martin and Hall, 
2005). 
Another well-characterized target of Akt is glycogen synthase kinase 3 (GSK-
3). In addition to its metabolic role in inactivating glycogen synthase, GSK-3 
impacts cell cycle progression by regulating the protein stability of myc and 
cyclins D and E (Diehl, et al., 1998: ; Embi, et al., 1980: ; Sears, et al., 2000: ; 
Welcker, et al., 2003). Furthermore, GSK-3-dependent destabilization of the 
pro-survival Bcl-2 family protein Mcl-1 (myeloid cell leukemia sequence 1) 
compromises mitochondrial integrity, thus creating a direct link between GSK-
3 activity and apoptosis (Maurer, et al., 2006). GSK-3-mediated inhibition of 
the transcription factor NFAT could be of particular importance in lymphocytes 
(Neal and Clipstone, 2001). GSK-3 is inactivated by direct phosphorylation by 
Akt (Cross, et al., 1995). 
Growth factor-mediated Akt-activation occurs in a two-step mechanism. One 
prerequisite already mentioned is the binding of Akt’s PH-domain to PIP3, the 
product of PI3K, at the plasma membrane. Subsequent Akt-phosphorylation 
at T308 and S473 is essential to its catalytic activity. T308 is part of the 
activation loop within the kinase domain and is the target for 3-
phosphoinositide-dependent kinase 1 (PDK1), whereas S473 resides in the 
hydrophobic motif C-terminal of the kinase domain and, most likely, more than 
one kinase mediates its phosphorylation in different contexts or cell types 
(Fayard, et al., 2005: ; Yang, et al., 2004). S473 phosphorylation of Akt 
stabilizes the active conformation and allows it to move from the plasma 
membrane to the cytosol and nucleus following activation at the plasma 
membrane (Andjelkovic, et al., 1999: ; Yang, et al., 2002).  
Three Akt-isoforms exist in mammals whose functions appear to be at least 
partially non-redundant based on the phenotypes of individual knock-out mice. 
Lack of the ubiquitously expressed Akt1 increases neonatal lethality, retards 
embryonic growth and elevates susceptibility to apoptosis in several cell types 
(Chen, et al., 2001: ; Cho, et al., 2001: ; Yang, et al., 2003). While Akt1-
deficiency does not impair glucose homeostasis, absence of Akt2 causes 
insulin resistance and a type-II diabetes like disease in addition to growth 
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retardation (Cho, et al., 2001: ; Garofalo, et al., 2003). This corresponds to the 
elevated expression level of Akt2 in insulin-responsive tissues such as liver 
and muscle. Combined deletion of Akt1 and Akt2 aggravates the neonatal 
lethality and growth retardation in addition to impairing skin, bone and muscle 
development (Peng, et al., 2003). By contrast, Akt3 is predominantly 
expressed in neuronal tissue and is required for normal size and cellularity of 
the brain (Easton, et al., 2005: ; Tschopp, et al., 2005). The phenotype of the 
B cell compartment in the absence of one or more Akt-isoforms has not been 
reported. However, an important role for the PI3K-Akt pathway in B cell 
biology can be inferred from the phenotype of p85α and p110δ-mutant mice 
which display impaired B lymphopoiesis in the bone marrow as well as a 
reduction in splenic B cell numbers (Clayton, et al., 2002: ; Fruman, et al., 
1999: ; Jou, et al., 2002: ; Okkenhaug, et al., 2002: ; Suzuki, et al., 1999)  
 
1.4.3 Association between the PI3K pathway and cell 
transformation 
The cellular response to growth factor stimulation is strikingly reminiscent of 
the signaling and metabolic signature of transformed cells. As noted by Otto 
Warburg more than 80 years ago, glucose utilization in tumor cells leads to an 
increased aerobic glycolysis rate (Warburg, 1956: ; Warburg, et al., 1924) 
similar to the effect of growth factor stimulation on non-transformed cells. In 
fact, a characteristic feature of many malignancies is the ability to strive in the 
absence of growth factors. One way to achieve this growth factor 
independence is the constitutive activation of the PI3K-Akt pathway in the 
absence of an external signal. Indeed, Akt was first identified as a cellular 
proto-oncogene to the viral fusion protein v-Akt which encodes a constitutively 
membrane-targeted and active form (Bellacosa, et al., 1991). Amplification 
and overexpression of PI3K p110 or Akt occur in a subset of human cancers 
(Hennessy, et al., 2005). Moreover, one of the most important tumor 
suppressors, PTEN (phosphatase and tensin homolog deleted from 
chromosome 10), plays a vital role in Akt-regulation. PTEN is a 3-
phosphoinositide phosphatase which antagonizes the function of PI3K 
(Maehama and Dixon, 1998). In this manner, it ensures that the presence of 
PIP3 at the plasma membrane and subsequent Akt-activation is a transient 
event following growth factor stimulation (Stambolic, et al., 1998). Loss of 
PTEN is a very common feature of many human cancers (Sansal and Sellers, 
2004). In mice, PTEN-haploinsufficiency in heterozygotes causes the 
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development of a wide range of tumors, which can be prevented by 
concomitant loss of Akt1 (Chen, et al., 2006: ; Di Cristofano, et al., 1998: ; 
Podsypanina, et al., 1999: ; Suzuki, et al., 1998). With regard to the lymphoid 
compartment, PTEN heterozygous mice develop a fatal autoimmune disorder 
characterized by lymphocyte hyper-proliferation and insensitivity to apoptosis 
(Di Cristofano, et al., 1999). A lethal lymphoproliferative disease also ensues 
from PTEN-inactivation targeted solely to the T cell compartment (Suzuki, et 
al., 2001). 
In addition to the PI3K-Akt pathway, trophic signaling utilizes a second 
oncogenic kinase Pim-2. Expression of Pim-2 is induced by growth factor 
stimulation and, in analogy to constitutively active Akt, ectopic Pim-2 
expression can compensate for growth factor deprivation in terms of cell 
survival and energy homeostasis (Fox, et al., 2003: ; Hammerman, et al., 
2005). One molecular target of Pim-2 activity appears to be 4E-BP1, 
indicating a dual and potentially redundant mechanism of protein synthesis 
stimulation by growth factors.  
 
1.5 The aims of this study 
The broad aim of this study was to elucidate the mechanisms of mature B cell 
survival through two distinct pathways: signaling by the cytokine BAFF and 
tonic BCR signaling with an emphasis on the role of the protein tyrosine 
kinase Syk in this process. The results presented here characterize BAFF as 
a trophic growth factor for mature B cells which boosts B cell viability, growth 
and metabolism through activation of the PI3K-Akt pathway and Pim-2. 
Furthermore, the present study demonstrates an indispensable role for Syk in 
BCR signaling throughout B lymphopoiesis, including an obligatory function in 
tonic BCR survival signaling in mature resting B cells. Within the scope of this 
project, a novel method of Syk protein inactivation was investigated which 
shows potential for inducible kinase inactivation. 
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2 Materials and Methods 
2.1 Materials 
2.1.1 Equipment and consumables 
• Semidry blotters TE 77 and TE 70, Amersham 
• Trans-Blot Cell tank transfer system, BIO-RAD 
• miniVE Vertical Electrophoresis System, Amersham 
• EPS 2A200 Power Supply, Amersham 
• UV Transilluminator, Spectroline 
• DNA-Engine Peltier Thermal Cycler, BIO-RAD 
• Gel-Dryer and Vacuum Pump, BIO-RAD 
• ProBlot Hybridization oven, Labnet 
• BioPhotometer spectrophotometer, Eppendorf 
• Image Master Video Documentation System, Pharmacia 
• UV Stratalinker, Stratagene 
• Bench-top refridgerated centrifuge, Eppendorf 
• Microcentrifuge, Eppendorf 
• Sorvall RC 5C Plus Superspeed centrifuge, Sorvall 
• Optima L-90K Ultracentrifuge, Beckman Coulter 
• UA-6 UV-detector, ISCO 
• FACSCalibur, Becton Dickinson 
• BD LSR flow cytometer 
• BD FACSort flow cytometer 
• ÄktaPrime, Amersham 
• Innova incubator shaker, New Brunswick Scientific 
• Heracell CO2-incubator, Heraeus 
• SterilGARD III Advance Biological Safety Cabinet, The Baker Company 
• EdgeGARD Laminar-Flow Clean Bench, The Baker Company 
• Nikon Eclipse microscope, Nikon 
• Horizontal Electrophoresis System, C.B.S. Scientific 
• Microwave, GE 
• Waterbath, Precision 
• Heat blocks, VWR 
• Kodak X-OMAT 2000A Processor, Kodak 
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• Milli-Q Ultrapure Water Purification System, Millipore 
• Orbitron Rotator II, Boekel Scientific 
• Shaker, IKA Labortechnik 
• Roto-Torque rotator, Cole-Parmer 
• Sonifier 450 sonicator, Branson 
• Vortex Genie 2, Fisher 
• VERSAmax microplate reader, Molecular Devices 
Chemicals were purchased from Sigma, Fisher or Fluka unless otherwise 
stated. 
Plastic ware was purchased from Falcon, Corning or Sarstedt unless 
otherwise stated. 
 
2.1.2 Standard buffers 
10 x phosphate-buffered saline (PBS) 
For 1l, dissolve 80g NaCl, 2g KCl, 11.5g Na2HPO4, 2g KH2PO4; pH to 7.2 for 
1 x PBS 
 
Hanks Balanced Salt Solution (BSS) 
Prepared from 20 x stock solutions: 
20 x BSS Stock 1: 20.0 g/l glucose, 1.2 g/l KH2PO4, 3.8 g/l Na2HPO4, 40ml/l 
0.5% phenol red 
20 x BSS Stock 2: 3.8 g/l CaCl2·2H2O, 4.0 g/l KCl, 80 g/l NaCl, 4 g/l 
MgCl2·6H2O, 1.0 g/l MgSO4 
 
TE 
10 mM Tris-HCl pH 8.0, 1 mM EDTA 
4 x DNA sample buffer for agarose gel electrophoresis 
50% Tris/EDTA pH 8.0, 50% glycerol, orange G 
50 x TAE 
For 1l, dissolve 242g Tris-base, 57 ml glacial acetic acid, 100 ml 0.5 M EDTA 
pH 8.0 
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20 x SSC 
For 1l, dissolve 175.25g NaCl, 88.25g Na Citrate; pH to 7.0 
 
5 x Protein Sample Buffer for SDS-PAGE 
250 mM Tris-HCl pH 6.8, 3.5 M β-mercaptoethanol, 10% SDS, 0.5% 
Bromphenolblue, 50% glycerol 
 
10 x SDS-PAGE Running Buffer 
For 1l, dissolve 30g Tris-base, 144g glycine, 5g SDS 
 
10 x TBS 
For 1l, dissolve 24.2g Tris-base, 80g NaCl; pH to 7.6. 1 x TBS containing 
0.1% Tween-20 (TBS-T) was used for Western blotting. 
 
2.1.3 Oligonucleotides 
Oligonucleotides were purchased lyophilized from commercial vendors 
(Invitrogen or Fisher), reconstituted in ddH2O to a 200 µM concentration and 
stored at -20ºC. 
 
Table 1: Oligonucleotides used for mouse genotyping 
Primer name Sequence 
Syk F 5’ - GCC CGT TCT GTG CCT ACT GG - 3’ 
Syk R 5’ - GCT GGT TCC CTT TTC CTT CC - 3’ 
Syk R2 5’ - TAG CTA ACC AAA CCC ACG GC - 3’ 
Mx Cre F 5’ - CAT GTG TCT TGG TGG GCT GAG - 3’ 
Mx Cre R 5’ - CGC ATA ACC AGT GAA ACA GCA T- 3’
CD19-Cre 1 5’ - AAC CAG TCA ACA CCC TTC C - 3’ 
CD19-Cre 2 5’ - CCA GAC TAG ATA CAG ACC AG- 3’ 





Table 2: PCR-programs used for mouse genotyping (WT = wild-type, fl 







Cycles Expected product size
Syk 1 58°C 60 120 31 WT 1186 bp; fl 1428 bp;
∆ 320 bp 
Syk 2 58°C 30 40 29 WT 234 bp; fl 349 bp; 
∆ no band 




59.5°C 60 120 33 WT 450 bp; Cre 715 bp 
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2.1.4 Antibodies 
Table 3: Staining antibodies for flow cytometry 
Antibody name Company and  
catalogue number 
Dilution 
rat anti-mouse CD21/35-FITC  
clone 7G6 
BD Pharmingen #553818 1:100 
rat anti-mouse CD45R/B220-
cychrome clone RA3-6B2  
BD Pharmingen #553091 1:100 
rat anti-mouse CD45R/B220-biotin  
clone RA3-6B2 
BD Pharmingen #553086 1:100 
rat anti-mouse CD43-FITC  
clone S7 
BD Pharmingen #553270 1:100 
rat anti-mouse CD25-biotin  
clone 7D4  
BD Pharmingen #553070 1:100 
rat anti-mouse CD90.2-PE  
clone 53-2.1  
BD Pharmingen #553006 1:400 
rat anti-mouse CD5-PE  
clone 53-7.3  
BD Pharmingen #553023 1:100 
rat anti-mouse CD19-FITC  
clone 1D3  
BD Pharmingen #553785  1:100 
rat anti-mouse IgD-FITC  
clone 11-26c.2a  
BD Pharmingen #553439 1:100 
Streptavidin-Phycoerythrin-Cy7  BD Pharmingen #557598 1:400 
F(ab')2 fragment goat anti-mouse  
IgM-PE µ chain-specific 
Jackson ImmunoResearch  
#115-116-075 
1:100 
F(ab')2 fragment goat anti-mouse  
IgM-FITC µ chain-specific 
Jackson ImmunoResearch  
#115-097-020  
1:200 






Table 4: Antibodies for Western Blotting; all antibodies were diluted in 
TBS-T containing 3% non-fat dry milk or 5% bovine serum albumin 
(BSA) 
Antibody name Company and  
catalogue number 
Dilution 
rabbit polyclonal anti-phospho-S6  
ribosomal protein (S235/236)  
Cell Signaling #2211 1:1000 
rabbit polyclonal anti-S6 ribosomal protein  Cell Signaling #2212 1:1000 
rabbit polyclonal anti-phospho-eIF4E (S209) Cell Signaling #9741 1:1000 
rabbit polyclonal anti-eIF4E  Cell Signaling #9742 1:1000 
rabbit polyclonal anti-phospho-4E-BP1 (S65) Cell Signaling #9451 1:1000 
rabbit polyclonal anti-4E-BP1  Cell Signaling #9452 1:1000 
rabbit polyclonal anti-phospho-Akt (S473)  Cell Signaling #9271 1:1000 
rabbit monoclonal anti-phospho-Akt (T308)  
clone 244F9  
Cell Signaling #4056 1:1000 
rabbit polyclonal anti-phospho-TSC2 (S1462) Cell Signaling #3611 1:1000 
rabbit polyclonal anti-phospho-FoxO1 (S256) Cell Signaling #9461 1:1000 
rabbit polyclonal anti-FoxO1  Cell Signaling #9462 1:1000 
rabbit polyclonal anti-phospho-GSK-3ß (S9)  Cell Signaling #9336 1:1000 
rabbit polyclonal anti-p44/42 MAP Kinase 
(Erk)  
Cell Signaling #9102 1:1000 
rabbit polyclonal anti-phospho-PTEN (S380) Cell Signaling #9551 1:1000 
rabbit polyclonal anti-PTEN  Cell Signaling #9552 1:1000 
rabbit polyclonal anti-phospho-PDK1 (S241) Cell Signaling #3061 1:1000 
rabbit polyclonal anti-PDK1  Cell Signaling #3062 1:1000 
mouse monoclonal anti-Pim-2 clone 1D12  Santa Cruz #sc-13514 1:200 
goat polyclonal anti-Akt1/2  Santa Cruz #sc-1619 1:1000 
rabbit polyclonal anti-Tuberin (TSC2)  Santa Cruz #sc-893 1:500 
rabbit polyclonal anti-PKCßII  Santa Cruz #sc-210 1:1000 
rabbit polyclonal anti-PKCδ  Santa Cruz #sc-937 1:1000 
goat polyclonal anti-Lamin B  Santa Cruz #sc-6216 1:1000 
rabbit polyclonal anti-cyclin D2  Santa Cruz #sc-593 1:1000 
rabbit polyclonal anti-cyclin E  Santa Cruz #sc-198 1:1000 
rabbit polyclonal anti-Cdk4  Santa Cruz #sc-260 1:1000 
goat polyclonal anti-Mcm3  Santa Cruz #sc-9849 1:1000 
rabbit polyclonal anti-Mcm2  BD Pharmingen #559542 1:1000 
rabbit polyclonal anti-Syk  Santa Cruz #sc-1077 1:1000 
mouse monoclonal anti-phospho-tyrosine  Upstate #05-321 1:1000 
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clone 4G10  
rabbit polyclonal anti-GSK-3ß  Stressgen #KAP-ST002C 1:1000 
rabbit polyclonal anti-p85a  Upstate #06-497 1:1000 
mouse monoclonal anti-p110d clone AW103 Upstate #05-703 1:500 
rabbit polyclonal anti-p52  Upstate #06-413 1:1000 
rabbit polyclonal anti-Mcm2  BD Pharmingen #559542 1:1000 
mouse monoclonal anti-Rb clone XZ55  BD Pharmingen #554144 1:1000 
rat monoclonal anti-Ki67 clone TEC-3  Dako #M7249 1:1000 
rabbit polyclonal anti-survivin  Chemicon #AB3611 1:500 
rat monoclonal anti-Bim clone 14A8  Chemicon #MAB17001 1:500 
mouse monoclonal anti-α-Tubulin clone 
DM1A  
Sigma #T6199 1:2000 
mouse monoclonal anti-FLAG clone M1  Sigma #F3040 1:1000 
rabbit polyclonal anti-Lyn  gift from Cliff Lowell 1:1000 
donkey anti-rabbit IgG HRP-linked  Amersham #NA934 1:10000 
sheep anti-mouse IgG HRP-linked  Amersham #NA931 1:10000 
goat anti-rat IgG HRP-linked  Jackson ImmunoResearch 
#112-035-167 
1:10000 




2.2.1 Molecular Biology 
2.2.1.1 Bacterial transformation 
Heat shock competent Escherichia coli (E. Coli) DH5α were mixed with 
approximately 10 ng of plasmid DNA or 1µl of a ligation reaction, incubated for 
15 min on ice and heat-shocked for 90 sec in a 42ºC water bath. After cooling 
on ice for 2 min and addition of 1 ml LB medium, the transformation reaction 
was incubated for 30 min at 37ºC under agitation and plated on LB agar 
containing appropriate selection antibiotics. Single colonies were picked after 
12 to 16 hrs of incubation at 37ºC. 
 
2.2.1.2 Plasmid DNA purification 
For Mini-Preps, bacteria from a single colony were grown under agitation for 
12 to 16 hrs in 2 ml LB medium containing the appropriate selection antibiotic. 
Larger culture volumes (50 ml to 100 ml) were used for Midi and Maxi-Preps. 
Plasmid DNA was purified using Qiagen Kits according to the manufacturer’s 
protocols. 
 
2.2.1.3 Restriction digests 
DNA was digested with restriction enzymes from New England Biolabs 
according to the manufacturer’s protocols. 
 
2.2.1.4 DNA sequencing 
DNA sequencing was performed by commercial vendors (Genewiz) and the 
DNA sequencing core facility at The Rockefeller University. 
 
2.2.1.5 Agarose gel electrophoresis 
DNA was separated on 0.5% to 2% agarose gels in TAE running buffer. 
 
2.2.1.6 Labeling of hybridization probes 
Gel-purified restriction fragments or PCR-products were radioactively labeled 
using 25 – 50 ng DNA, 50 µCi 32P α-dCTP (Amersham) and Ready-To-Go 
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DNA Labeling beads (-dCTP) (Amersham) and purified using ProbeQuant G-
50 micro columns (Amersham) according to the manufacturer’s instructions. 
 
2.2.1.7 Southern blot 
Approximately 10 µg of genomic DNA was digested for 12 to 16 hrs with the 
appropriate restriction enzyme and resolved on a 0.6% agarose gel. The gel 
was equilibrated in transfer buffer (0.4 M NaOH, 0.6 M NaCl) for 20 min and 
DNA was transferred onto a nitrocellulose membrane (Hybond N+, 
Amersham) by capillary transfer. Following equilibration in neutralization 
buffer (0.5 M Tris-HCl pH 7.0, 1M NaCl), DNA was fixed to the membrane by 
UV cross-linking (UV Stratalinker, Stratagene) and the membrane was 
blocked in hybridization buffer (50 mM Tris-HCl pH 7.5, 1 M NaCl, 1% SDS, 
10% dextran sulfate, 300 µg/ml sonicated salmon sperm DNA) for 4 hrs at 
65ºC. The incubation was continued over night following the addition of the 
radioactively labeled DNA probe. The membrane was washed several times 
in 0.5 – 2 x SSC, 0.1 – 1% SDS and exposed for autoradiography. 
 
2.2.1.8 Genomic DNA purification  
Mouse tail tips were digested over night at 55ºC in 500 µl tail lysis buffer 
containing 10 mM Tris-HCl pH 8.5, 200 mM NaCl, 5 mM EDTA, 0.2% SDS 
and 100 µg/ml Proteinase K (Roche). Debris was removed by centrifugation at 
15,000 x g for 10 min and DNA was precipitated from the supernatant by 
addition of 1 ml 100% EtOH. The precipitate was pelleted through 
centrifugation at 15,000 x g for 1 min, washed in 70% EtOH, air-dried and 
dissolved in 200 µl TE buffer. 
 
2.2.1.9 Polymerase chain reaction (PCR) 
PCR was used routinely for genotyping of mouse mutant strains. 1 µl of 
genomic tail DNA was used as template in a 20 µl PCR reaction containing 2 
µl 10 x Klentherm PCR buffer (670 mM Tris-HCl pH 9.1, 160 mM (NH3)2SO4, 
35 mM MgCl2, 1.5 mg/ml BSA), 0.2 µl 25 mM dNTPs (Amersham), 0.5 µl 20 
µM Primer Mix and 1 U Taq DNA polymerase (Sigma). Primer sequences and 
PCR programs are listed in tables 1 and 2. PCR products were resolved on 1 
– 2% agarose gels. 
For cloning purposes, other DNA polymerase including Pfu (Stratagene) and 
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KOD (Novagen) were used according to the manufacturers’ protocols. 
 
2.2.1.10 RNA isolation 
Total RNA was isolated from 1 x 105 – 106 B cells using Trizol (Gibco) 
according to the manufacturer’s protocol. 
 
2.2.1.11 Reverse transcriptase (RT)-PCR and cloning of the mouse 
Syk cDNA 
First strand cDNA synthesis was performed on 100 ng of total RNA using 
oligo (dT) priming and Superscript II (Invitrogen) according to the 
manufacturer’s instructions. Full-length Syk cDNA was amplified from the first-
strand reaction using the Expand Long Template PCR System (Roche) and 
primers 5’-agaactctgaaggggtgc-3’ (forward) and 5’-cttgggaatccgtggtgt-3’ 
(reverse). The PCR-product was gel-purified (QIAquick Gel Extraction Kit, 
Qiagen) and cloned into the pCR2.1 vector using TA cloning (TA Cloning Kit, 
Invitrogen). Insert-containing colonies were identified by blue-white selection 
and sequenced. Point-mutations were repaired using the QuickChange XL 
Site-directed Mutagenesis Kit (Stratagene) according to the manufacturer’s 
instructions. 
 
2.2.2 Cellular Methods 
2.2.2.1 Preparation of murine lymphocyte suspensions 
Mice were sacrificed on dry ice (CO2). Spleen, thymus and lymph nodes were 
removed and single cell suspensions were made in BSS by pressing 
individual organs through a wire mesh. Bone marrow cells were isolated by 
flushing femur, tibia and ilium of both hind legs with BSS. Peritoneal cavity 
cells were collected by rinsing the peritoneum with 10 ml BSS. Where 
necessary, erythrocytes were lyzed by incubating cells for 1 min in ACK buffer 
(0.15 M NH4Cl, 10 mM KHCO3, 0.1 mM EDTA). Live cells numbers were 




2.2.2.2 Lymphocyte purification by Magnetic Cell Sorting (MACS) 
Mature B lymphocytes were purified from murine spleen and lymph nodes by 
MACS in a two-step protocol. First, non-B cells were depleted using anti-
CD43 antibody coupled magnetic beads. Mature B cells were further purified 
by enrichment of CD62L-positive cells. Cells were kept in BSS throughout the 
purification procedure. Antibody-coupled magnetic beads (Miltenyi) were used 
in a 1 in 10 dilution and MACS LD and LS columns (Miltenyi) were used. 
Purification purity was controlled by cell surface staining and FACS 
(fluorescence-activated cell sorting) analysis and was routinely above 95%. 
 
2.2.2.3 Cell surface staining and flow cytometry 
For surface staining, 5 x 105 to 1 x 106 cells were washed once in PBS/BSA (1 
x PBS, 0.5% BSA, 0.02% NaN3) and resuspended in 10 µl of the appropriate 
antibody dilution in PBS/BSA in a 96-well U-bottom plate. After 20 min of 
incubation at 4 ºC, cells were washed in PBS/BSA and, where necessary, 
stained with secondary antibody. Staining antibodies and dilutions are listed in 
table 3. Cells were analyzed on a flow cytometer (FACSCalibur, BD) using 
CellQuest (BD) software. Dead cells were excluded from the analysis through 
addition of 10 nM TO-PRO-3 (Invitrogen) prior to acquisition and subsequent 
gating on the TO-PRO-3- cell population. 
 
2.2.2.4 Primary B cell culture 
Purified B cells were cultured in RPMI 1640 (Gibco) containing 10% fetal 
bovine serum (FBS, HyClone), 2 mM L-glutamine, 50 µM β-mercaptoethanol 
and 100 U/ml penicillin/streptomycin (all Gibco) at 37ºC in a humidified 7.5% 
CO2-incubator. For analysis of BAFF-induced signaling, cells were pre-
incubated in medium plus the above supplements for 12 hrs to reduce the 
background caused by exposure to endogenous BAFF in vivo prior to the cell 
preparation (after (Claudio, et al., 2002). Cells were stimulated with 25 ng/ml 
recombinant mouse BAFF (R&D Systems), 1.3 µg/ml F(ab’)2 fragment goat 
anti-mouse IgM (Jackson ImmunoResearch Laboratories) and 5 µg/ml 




2.2.2.5 Analysis of B cell proliferation using CFSE labeling 
5- (and 6-) carboxyfluorescein diacetate succinimidyl ester (CFDA-SE, 
Molecular Probes) is a colorless, cell-permeable compound which is 
processed to fluorescent carboxyfluorescein succinimidyl ester (CFSE) inside 
the cell. The latter is highly reactive and forms protein adducts which are 
retained inside the cell and split equally onto daughter cells following division 
such that cell division can be tracked by FACS analysis as a sequential 
decline in fluorescence. For CFSE labeling, purified B cells were washed 
extensively in plain RPMI and incubated with 5 µM CFSE for 10 min at 37ºC 
at a concentration of 1 x 107 cells per 1 ml. Labeling was stopped by addition 
of complete B cell culture medium. Cells were washed twice in complete 
medium and plated with the indicated stimuli for 3 days. At the time of 
analysis, cells were surface-stained for the pan-B cell marker B220 and 
analyzed by flow-cytometry. CFSE-dilution was monitored on live B220+ cells. 
 
2.2.2.6 Analysis of B cell proliferation using bromodeoxyuridine 
(BrdU) labeling 
Purified B lymphocytes were cultured in the presence of 10 µM BrdU (BD 
Biosciences). Cells were fixed and stained using the FITC BrdU Flow Kit (BD 
Biosciences) and analyzed by flow cytometry.  
 
2.2.2.7 Measurement of mitochondrial membrane potential 
Purified B cells were cultured with 100 nM of the potentiometric dye 
tetramethylrhodamine ethyl ester (TMRE, Invitrogen). 50 µM carbonyl cyanide 
m-chlorophenyl hydrazone (CCCP, Sigma-Aldrich) was added simultaneously 
to control samples as an uncoupler of the mitochondrial respiratory chain. 
Following 30 min of incubation at 37 ºC in a CO2-incubator, cells were 
analyzed by flow cytometry. 
 
2.2.2.8 Metabolic labeling of primary B cells 
Purified B cells were cultured in labeling medium composed of methionine- 
and cysteine-free RPMI 1640 (Sigma), 10% FBS (Hyclone, dialyzed over 
night in PBS), 2 mM L-glutamine, 50 µM β-mercaptoethanol, 100 U/ml 
penicillin/streptomycin (all Gibco) and 500 µCi/ml Trans 35S-label (ICN). 
Labeling was continued for 6 hrs at 37ºC in a humidified 7.5% CO2-incubator, 
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after which cells were washed extensively first in normal complete medium 
not containing radioactivity and then in PBS prior to lysis in a buffer containing 
350 mM NaCl, 20 mM HEPES/NaOH pH 7.9, 1 mM MgCl2, 0.2 mM EDTA, 0.1 
mM EGTA, 1% NP-40, 20% glycerol, 10 µM NaF, 2 mM Na3VO4 and protease 
inhibitor cocktail (Sigma). Cell extracts were resolved by SDS-PAGE and 
stained with Coomassie Brilliant Blue. The gel was treated with EN3HANCE 
(PerkinElmer) according to the manufacturer’s instructions, dried and exposed 
for autoradiography. 
 
2.2.2.9 Cell line culture 
DT40 cells were cultured in RPMI 1640 (Gibco) containing 10% FBS 
(HyClone), 2 mM L-glutamine, 50 µM β-mercaptoethanol, 100 U/ml 
penicillin/streptomycin (all Gibco) and 1% chicken serum (Sigma). Wild-type 
and Syk-deficient (Takata, et al., 1994) lines were a kind gift of Ed Clark. 2 
µg/ml of mouse anti-chicken IgM antibody (clone M-4, Southern 
Biotechnology) was used for stimulation. 
293GP cells (Clontech) and HEK 293 (ATCC) were maintained in DMEM 
(Gibco) containing 10% FBS (HyClone), 1 mM sodium pyruvate and 100 U/ml 
penicillin/streptomycin (both Gibco). 
 
2.2.2.10 Calcium-phosphate mediated transient transfection of HEK 
293 cells 
HEK 293 cells were transfected with mammalian expression vectors for 
various Syk-constructs and TEV-protease. All inserts were cloned into 
pcDNA3.1 (Invitrogen) using standard molecular biology procedures. In brief, 
the full-length Syk cDNA was PCR amplified from the original cloning vector 
pCR2.1 (see 2.2.1.11) using primers 5’-cgggatcccagacatggcgggaagtgctgtg-3’ 
(forward) and 5’-cggaattccgttagaggtcttcctcagaaatcaacttctgctcgccggagccgttaac 
cacgtcgtagtag-3’ (reverse) with the reverse primer containing a C-terminal 
Myc-tag. The PCR-product was cloned into pcDNA3.1 using BamHI and 
EcoRI restriction sites. Syk mutants X1 through X6 were generated from the 
wild-type pcDNA3.1-Syk template by site directed mutagenesis using the 
Quickchange XL Site-directed mutagenesis kit (Stratagene) and the following 
mutagenesis primers: 
X1 forward: 5’-gtggctgtgaaaatcctgaagaacgaggccggcagcggcgagaacctgtacttcca 
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gtccgcgggcagcaacgacccggctttgaaggacgagctgctg-3’ 
X1 reverse: 5’-cagcagctcgtccttcaaagccgggtcgttgctgcccgcggactggaagtacaggttc 
tcgccgctgccggcctcgttcttcaggattttcacagccac-3’ 
X2 forward: 5’-tcctggatgctggtgatggagatggcggagggcagcggcgagaacctgtacttccag 
tccgcgggcagcctggggccgctcaacaagtacctgcagcag-3’ 
X2 reverse: 5’-ctgctgcaggtacttgttgagcggccccaggctgcccgcggactggaagtacaggttc 
tcgccgctgccctccgccatctccatcaccagcatccagga-3’ 
X3 forward: 5’-agcgaagtgaccgccatgctggagaaaggaggcagcggcgagaacctgtacttcc 
agtccgcgggcagcgagcggatggggtgccctgcaggatgcccg-3’ 
X3 reverse: 5’-cgggcatcctgcagggcaccccatccgctcgctgcccgcggactggaagtacaggtt 
ctcgccgctgcctcctttctccagcatggcggtcacttcgct-3’ 
X4 forward: 5’-gatttcggtctttccaaagccctgcgtgctggcagcggcgagaacctgtacttccagtc 
cgcgggcagcgatgaaaactactacaaggcccagacccac-3’ 
X4 reverse: 5’-gtgggtctgggccttgtagtagttttcatcgctgcccgcggactggaagtacaggttctc 
gccgctgccagcacgcagggctttggaaagaccgaaatc-3’ 
X5 forward: 5’-gcgttctcctatgggcagaagccctacagaggcagcggcgagaacctgtacttccag 
tccgcgggcagcgggatgaaagggagcgaagtgaccgccatg-3’ 
X5 reverse: 5’-catggcggtcacttcgctccctttcatcccgctgcccgcggactggaagtacaggttctc 
gccgctgcctctgtagggcttctgcccataggagaacgc-3’ 
X6 forward: 5’-ctcaacaagtacctgcagcagaacaggcacggcagcggcgagaacctgtacttcc 
agtccgcgggcagcattaaggataagaacatcatagagctggtt-3’ 
X6 reverse: 5’-aaccagctctatgatgttcttatccttaatgctgcccgcggactggaagtacaggttctcg 
ccgctgccgtgcctgttctgctgcaggtacttgttgag-3’ 
Correct cloning and successful mutagenesis was confirmed by sequencing in 
all cases. 
For the TEV-protease expression construct, TEV was PCR-amplified from the 
TEV-containing vector pGEX2T-27k (kind gift of Michael Ehrmann) using 
primers 5’-cgcggatccctgtttaagggaccacg-3’ (forward) and 5’-
ccggaattccgagtacaccaattcattc-3’ (reverse) and cloned in frame into a 
previously constructed pcDNA3.1 plasmid containing an N-terminal triple 
FLAG-tag using BamHI and EcoRI restriction sites. Correct cloning was 
confirmed by sequencing. 
For transient expression of the above DNA constructs in HEK 293 cells, a 
total of 12 µg DNA in a 150 µl volume was mixed with an equal volume of 0.5 
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M CaCl2 and added drop wise under vortexing to a 2 x HEPES-buffered saline 
solution (HBS) containing 0.28 M NaCl, 0.05 M HEPES and 1.5 mM 
Na2HPO4. The mixture was incubated for 30 min at room temperature and 
spread onto cells plated in a 10 cm dish 24 hrs previously. Cells were 
analyzed 24 hrs to 48 hrs following transfection. 
 
2.2.2.11 Calcium flux analysis 
The calcium-sensitive dye Indo-1 was used to measure BCR-induced 
Calcium-flux in DT40 cells. When excited at 360 nm, Indo-1 emits light at 485 
nm in the Ca2+-free state and at 404 nm in the Ca2+-bound state. Indo-I light 
emission was recorded at 395 nm (violet) and 530 nm (blue) and the 
violet/blue ratio was used as readout for the relative intracellular calcium 
concentration. 5 x 106 DT40 cells were loaded with 1.25 nM Indo-I (Invitrogen) 
at 37ºC for 30 min. Cells were acquired on a BD LSR FACS machine 
equipped with a UV-laser. A baseline of the Ca2+-bound/ Ca2+-free ratio was 
acquired for 20 sec followed by addition of 2 µg/ml anti-chicken IgM antibody 
and further acquisition for 200 sec. 
 
2.2.2.12 Retroviral tranduction of DT40 cells 
The wild-type Syk cDNA and its mutants X1 through X6 were excised from the 
respective pcDNA3.1 plasmids (see 2.2.2.10) using BamHI and EcoRI 
restriction sites and inserted into the pMIG retroviral vector (kind gift of Luk 
Van Parijs) using BglII and EcoRI restriction sites. The packaging cell line 
293GP (Clontech) which stably expresses the gag and pol genes of the 
Moloney murine leukemia virus was co-transfected with the retroviral 
constructs in combination with a packaging plasmid (pVSV-G, Clontech) 
encoding the pantropic envelope protein VSV-G derived from vesicular 
stomatitis virus using Lipofectamine 2000. Viral supernatant was collected 72 
hrs and 96 hrs after transfection, filtered and stored at -80ºC. Wild-type and 
Syk-deficient DT40 cells were infected with viral supernatant diluted 1:2 in 
culture medium and containing 8 µg/ml polybrene. 72 hrs post-infection, single 
GFP-positive cells were sorted into 96-well U-bottom tissue culture plates on 
a FACSort (BD). Clones were grown for 14 days and analyzed for GFP-
expression by FACS and Syk-expression by Western blot. Selected positive 
clones for each construct were expanded and used for further analysis. 
 
 44 
2.2.3 Biochemical Methods 
2.2.3.1 Preparation of cell lysates 
For routine cytoplasmic extracts, cells were washed once in ice-cold PBS and 
lyzed in a buffer containing 150 mM NaCl, 20 mM Tris-HCl pH 7.5, 1 mM 
EDTA, 10% glycerol, 1% NP-40, 10 µM NaF and 2 mM Na3VO4 as 
phosphatase inhibitors and protease inhibitor cocktail (Sigma). After 15 min 
rotation at 4ºC, nuclei were pelleted by centrifugation at 15,000 x g for 10 
minutes. The resulting supernatant was either immediately used for Western 
blot or immunoprecipitation or stored at -80ºC for later use. For whole cell 
lysates, the lysis buffer contained 350 mM NaCl, 20 mM HEPES/NaOH 
pH7.9, 1 mM MgCl2, 0.2 mM EDTA, 0.1 mM EGTA, 1% NP-40, 20% glycerol, 
10 µM NaF, 2 mM Na3VO4 and protease inhibitor cocktail (Sigma). 
 
2.2.3.2 Western blot 
The protein concentration of cellular extracts was measured using the DC 
Protein Assay (BIO-RAD) and a VERSAmax microplate reader (Molecular 
Devices). Equal protein amounts were loaded onto SDS polyacrylamide gels 
after boiling for 5 min in 1 x sample buffer. Commercial protein standard 
mixtures (BIO-RAD) were used as size markers. Proteins were resolved by 
SDS polyacrylamide gel electrophoresis (SDS-PAGE) on 8% to 15% gels and 
transferred onto polyvinylidenediflouride (PVDF) membranes (Immobilon P, 
Millipore) using standard procedures (Sambrook, et al., 1989). Protein transfer 
was routinely confirmed by reversible staining of the membrane with Ponceau 
S solution (Sigma). Membranes were blocked in 1 x TBS, 0.1% Tween (TBS-
T) containing 3% non-fat dry milk (Carnation) and incubated over night at 4ºC 
with primary antibody diluted in blocking buffer or TBS-T containing 5% 
bovine serum albumin (BSA, Roche). Antibodies and dilutions are listed in 
table 4. Membranes were washed 3 times for 5 min in TBS-T and incubated 
for 1 hr with the appropriate horseradish peroxidase-coupled secondary 
antibody diluted in blocking buffer. After repeated washes in TBS-T, proteins 
were detected using chemiluminescent substrates. Depending on the signal 
strength, ECL (Amersham) or more sensitive substrates (SuperSignal West 
Dura Extended Duration Substrate and SuperSignal West Femto Maximum 
Sensitivity Substrate, both from Pierce) were used. Signal quantification was 
done using NIH Image 1.63 software. 
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2.2.3.3 Western blot stripping 
Membranes were agitated in 63 mM Tris-HCl pH 6.7, 2% SDS, 200 mM β-
mercaptoethanol for 30 min in a 50ºC water bath. Complete removal of 
primary antibodies was confirmed by developing membranes after incubation 
with secondary antibody. 
 
2.2.3.4 Immunoprecipitation 
Cell lysates were pre-cleared with non-specific immunoglobulin of the same 
species as the antibody used for immunoprecipitation and protein A or protein 
G sepharose (Amersham) for 1 hr at 4ºC. Protein A was used for rabbit 
antisera, protein G was used for mouse and goat antisera. Pre-cleared lysates 
were incubated with primary antibody over night at 4ºC followed by addition of 
protein A or protein G sepharose for 2 hrs at 4ºC or incubated with primary 
antibody directly coupled to protein A agarose over night. Immunoprecipitates 
were washed 3 – 5 times in lysis buffer. Bound proteins were eluted by boiling 
samples in 1 x SDS sample buffer and subjected to SDS-PAGE. 
 
2.2.3.5 Subcellular fractionation 
Fractionation of primary mouse B cells into cytoplasmic and nuclear extracts 
was done as described (Mecklenbrauker, et al., 2004). Briefly, cells were 
lyzed in a cytoplasmic lysis buffer containing 320 mM sucrose, 10 mM Tris-
HCl pH 8.0, 3 mM CaCl2, 2 mM Mg acetate, 0.1 mM EDTA, 0.5% NP-40 and 
fresh protease and phosphatase inhibitors. Nuclei were pelleted through 
centrifugation at 500 x g for 5 min, washed once in wash buffer (as 
cytoplasmic lysis buffer, but without addition of NP-40) and lyzed in nuclear 
lysis buffer containing 500 mM NaCl, 50 mM Tris-HCl pH 8.0, 1% NP-40, 10% 
glycerol and fresh protease and phosphatase inhibitors. After sonication, 
debris was removed through centrifugation at 13,000 rpm for 15 min. 
Cytosolic and nuclear extracts were stored at -80ºC for Western blot analysis. 
Fractionation purity was assessed by the presence of tubulin as cytoplasmic 
and lamin B as nuclear markers, respectively.  
For preparation of cytoplasmic and membrane extracts, cells were disrupted 
by hypotonic lysis for 15 min on ice in a buffer containing 10 mM HEPES pH 
7.4, 10 mM KCl, 1.5 mM Mg Cl2, 0.1 mM EDTA and fresh protease and 
phosphatase inhibitors. Nuclei were removed by centrifugation at 400 x g for 
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10 min. The supernatant was then centrifuged at 95,000 x g for 1 hr in a 
SW55Ti rotor (Beckman Coulter). The supernatant was removed and saved 
as the cytoplasmic fraction. The pellet containing the membrane fraction was 
resolved in 1 x SDS sample buffer and aliquots of cytoplasmic and membrane 
fractions were subjected to Western blot analysis. Fractionation purity was 
assessed using tubulin as cytoplasmic and Lyn as membrane markers, 
respectively. 
 
2.2.3.6 Lipid raft isolation 
Lipid rafts were isolated as described (Dobenecker, et al., 2005). Briefly, cells 
were lyzed in TNNE buffer containing 10 mM Tris-HCl pH 7.5, 150 mM NaCl, 
5 mM EDTA, 0.1% Triton X-100 and fresh protease and phosphatase 
inhibitors and mixed with iodixanol (Optiprep, Axis-Shield) to a final 
concentration of 40% in TNNE buffer. Samples were overlaid with 30% 
iodixanol and TNNE buffer to create an iodixanol step gradient and were 
centrifuged at 60,000 rpm for 3 hrs in a Sorvall TH-660 rotor. 500 µl fractions 
were collected with lipid rafts localizing to the top fraction. Aliquots of each 
fraction were used for Western blot analysis. The purity of the preparation was 
assessed by the presence of Lyn and the lipid raft marker ganglioside GM1 
which was detected using horseradish peroxidase-coupled cholera toxin B 
subunit (Sigma). 
 
2.2.3.7 Purification of polysomal RNA 
Polysome purification was performed after Stefani et. al. (Stefani, et al., 
2004). All chemicals and reagents were of molecular biology grade purity and 
nuclease-free. B cells were incubated with 100 µg/ml cycloheximide (CHX, 
Sigma) for 15 min, washed three times in PBS containing CHX and lyzed in 
10 mM HEPES-KOH pH 7.4, 150 mM KOH, 5 mM MgCl2, 1% NP-40, 0.5 mM 
DTT, 100 µg/ml CHX, 200 U/ml RNAsin (Promega), 100 U/ml SUPERase 
(Ambion) and EDTA-free protease inhibitor cocktail (Roche). Nuclei were 
removed from the extracts by centrifugation at 2000 x g for 10 min. An aliquot 
of the lysate was saved for preparation of total RNA. The remaining lysate 
was loaded onto a 20% - 50% w/w linear density sucrose gradient in 10 mM 
HEPES-KOH pH 7.4, 150 mM KCl and 5mM MgCl2. Gradients were 
centrifuged for 2 hrs at 40,000 x g at 4ºC in a SW41 rotor (Beckman Coulter). 
Fractions of 0.7 ml volume were collected with continuous monitoring at 254 
 47 
nm using an ISCO UA-6 UV-detector. Polyribosome-containing fractions were 
identified based on the UV-trace and, in trial experiments, on the presence of 
S6 ribosomal protein in the fractions after TCA-precipitation and SDS-PAGE. 
For RNA-isolation, polysome-containing fractions were pooled and RNA was 
isolated from total and polysomal samples using Trizol LS (Invitrogen) 
according to the manufacturer’s protocol. 
 
2.2.3.8 Purification of recombinant TEV-protease 
The plasmid pTPSN (Lucast, et al., 2001) containing TEV S219N fused to a 
C-terminal Hexa-His-tag in the bacterial expression vector pET15b 
(Novagen), was obtained from Jennifer Doudna. The PTD-sequences were 
inserted in frame into an N-terminal NcoI restriction site using the following 
oligonucleotides: 
TAT forward: 5’-catggggtacggtcgcaagaaacgtcgccaacgtcgccgtggcagcggcgc-3’ 
TAT reverse: 5’-catggcgccgctgccacggcgacgttggcgacgtttcttgcgaccgtaccc-3’ 
MTS forward: 5’-catgggggcagccgttcttctcccctgttcttcttgccgcacccggcagcggcgc-3’ 
MTS reverse: 5’-catggcgccgctgccgggtgcggcaagaagaacaggggaagaacggctgccc 
c-3’ 
Pen forward: 5’-catggggcgccagatcaaaatttggttccagaatcgtcgcatgaaatggaagaaag 
gcagcggcgc-3’ 
Pen reverse: 5’-catggcgccgctgcctttcttccatttcatgcgacgattctggaaccaaattttgatctgg 
cgccc-3’. 
Oligonucleotides were annealed, digested with NcoI and cloned into the NcoI 
site of pTPSN. A plasmid containing TAT-NES-TEV was constructed by PCR-
amplification of TEV from pTPSN using the primers 5’-
ataccatggggtacggtcgcaagaaacgtcgccaacgtcgccgtggcagcggcgccttgcagaagaag
ctggaggagctggagcttgacgctgaaagcttgtttaag-3’ (forward) and 5’-
cgggctttgttagcagcc-3’ (reverse). The PCR-product was digested with NcoI and 
BamHI and inserted into the NcoI-BamHI-opened pTPSN vector. All 
constructs were confirmed by DNA-sequencing prior to application. 
TEV-protease was purified in a denaturing preparation following the 
procedure of Lucast et. al. (Lucast, et al., 2001). E. coli BL21 (DE3) cells 
(Novagen) were transformed with plasmid DNA and overnight cultures were 
grown from single colonies in LB medium containing 100 µM ampicillin (LB 
Amp). 2 l LB Amp were inoculated with the overnight culture in a 1 in 10 
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dilution and incubated at 37ºC under constant agitation. At an OD of 1.0, 
protein expression was induced by addition of 400 µM isopropyl-β-D-
thiogalactopyranoside (IPTG, Sigma) and incubation continued for another 5 
hrs. Cells were collected by centrifugation at 4000 rpm for 30 min at 4ºC, 
resuspended in 50 mM Tris-HCl pH 8.0, 300 mM NaCl and protease inhibitor 
cocktail (Roche) and stored at -80ºC. Upon thawing, cells were disrupted by 
addition of 500 µg/ml lysozyme, 200 µg/ml DNase I, 20 mM MgSO4 and 2 mM 
CaCl2, agitation for 30 min at 4ºC followed by addition of 1% Triton X-100. 
Bacterial inclusion bodies were pelleted by centrifugation at 10,000 g for 20 
min at 4ºC and protein was extracted from the pellet by overnight incubation in 
6 M guanidine-HCl, 100 mM NaH2PO4, 10 mM Tris-HCl pH 8.0 at 4ºC under 
gentle agitation. The protein extract was cleared by centrifugation at 17,000 
rpm for 30 min at 4ºC. 
A pre-charged Ni Sepharose column (HisTrap HP affinity column, Amersham) 
was equilibrated in a binding buffer containing 8 M Urea, 100 mM NaH2PO4 
and 10 mM Tris-HCl pH 8.0. The protein extract was loaded onto the column 
and the protein content was monitored by UV-absorption at 280 nm in an Äkta 
Prime (Amersham). Column-bound proteins were eluted using 8 M Urea, 100 
mM NaH2PO4, 10 mM Tris-HCl pH 4.5. Protein-containing fractions confirmed 
by SDS-PAGE and Coomassie-staining were pooled and dialyzed overnight 
against 100 mM Tris-HCl pH 8.5, 500 mM NaCl, 5 mM DTT, 0.5 mM EDTA, 
50% glycerol at 4ºC in dialysis tubing with a 6 – 8000 Dalton MWCO 
(Spectrapor). Refolded protein was cleared by centrifugation at 17,000 rpm for 
30 min at 4ºC and concentrated in Amicon Ultra-15 filters with a 5000 Dalton 
MWCO. The protein was further purified on a HiTrap Desalting column 
(Amersham) pre-equilibrated in 20 mM Tris-HCl pH 8.0, 500 mM NaCl, 20% 
glycerol, 50 mM β-mercaptoethanol. Protein-containing fractions whose purity 
had been confirmed by SDS-PAGE and Coomassie-staining were pooled and 
concentrated as above to a maximum concentration of approximately 2 
mg/ml. Aliquots were stored at -80ºC. 
 
2.2.3.9 Measurement of TEV activity in vitro 
The catalytic activity of the purified PTD-TEVs was measured in an in vitro 
assay using a recombinant substrate protein (kind gift of André Hoelz) which 
contains a TEV target site and whose size changes from 36 to 33 kD upon 
TEV-mediated cleavage. Assays were carried out in a reaction buffer 
containing 500 mM NaCl, 10 mM Tris-HCl pH 8.0, 5 mM DTT, 20 µg substrate 
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protein and 10 µg recombinant TEV for 30 min at room temperature. 
Conversion of the substrate protein was visualized by SDS-PAGE and 
Coomassie-staining. 
 
2.2.3.10 FITC-labeling of recombinant TEV 
Purified TEV or BSA was fluorescently labeled using the EZ-label FITC 
Protein Labeling Kit (Pierce) according to manufacturer’s instructions. Briefly, 
proteins were first dialyzed against PBS and then against a borate buffer 
supplied by the manufacturer to remove Tris from the protein preparation. The 
protein was then incubated with a 24-fold molar access of fluorescein 
isothiocyanate (FITC) for 2 hrs in the dark. Unincorporated FITC was removed 
from the labeling reaction by dialysis against PBS. Labeled proteins were 
stored at 4ºC. 
 
2.2.4 Other Methods 
2.2.4.1 Gene expression analysis 
RNA quality analysis, labeling and hybridization as well as raw data 
processing and normalization were performed by the Genomics Core 
Laboratory at the Memorial Sloan-Kettering Cancer Center.  
Quality of RNA was confirmed before labeling by analyzing 20 - 50 ng of each 
sample using the RNA 6000 NanoAssay and a Bioanalyzer 2100 (Agilent 
Technologies). All samples had a 28S/18S ribosomal peak ratio of 1.8 – 2 and 
were considered suitable for labeling. 2 µg of total RNA was used for cDNA 
synthesis using an oligo(dT)-T7 primer and the SuperScript Double-Stranded 
cDNA Synthesis Kit (Invitrogen). Synthesis, linear amplification and labeling of 
cRNA were accomplished by transcription in vitro using the MessageAmp 
aRNA Kit (Ambion) and biotinylated nucleotides (Enzo Diagnostics). 10 µg of 
labeled and fragmented cRNA were hybridized to the mouse genome 
MOE430 2.0 array (Affymetrix), which interrogates ~39,000 transcripts at 45°C 
for 16 hrs. Automated washing and staining were performed using the Fluidics 
Station 400 (Affymetrix), according to the manufacturer's protocols. Finally, 
chips were scanned with a high numerical aperture and flying objective lens in 
the scanner (GS3000; Affymetrix). Raw expression data were analyzed using 
Microarray Analysis software (version 5.1; Affymetrix). Data were normalized 
to a target intensity of 500 to account for differences in global chip intensity. 
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The complete set of data is available at the GEO public repository and can be 
accessed at http://www.ncbi.nlm.nih.gov/geo under accession no. GSE5985.  
Genes which were differentially expressed between unstimulated and BAFF-
treated cells, were initially identified using GeneChip Operating Software 
(GCOS, Affymetrix). 377 transcripts showed a change of two-fold or more and 
were selected for further analysis. Approximately three quarters of these 
genes were up-regulated upon BAFF stimulation, whereas one quarter was 
down-regulated. For a biological interpretation of the differentially regulated 
genes, the GoMiner gene ontology (GO) tool was used (Zeeberg, et al., 
2003). GO is a genome project that describes gene products in terms of their 
associated biological processes, cellular components, and molecular functions 
(Ashburner, et al., 2000). GO categories are organized in directed acyclic 
graphs, a kind of hierarchy in which one category can have more than one 
"parent". GoMiner identifies GO categories that are over- or underrepresented 
in lists of genes of interest, such as differentially expressed genes from a 
microarray experiment, and calculates statistical significance as the one-sided 
nominal unadjusted p-value from Fisher's exact test. Only those biological 
processes for which the p-value was below <0.001 were included in the 
analysis. 
 
2.2.4.2 Protein identification by mass-spectrometry 
Protein identification by mass-spectrometry was performed by Hediye 
Erdjument-Bromage and Paul Tempst of the Molecular Biology Program at 
the Memorial Sloan-Kettering Cancer Center.  
Gel-resolved proteins were digested with trypsin, batch purified on a reversed-
phase microtip, and resulting peptide pools were individually analyzed by 
matrix-assisted laser desorption/ionization reflectron time-of-flight (MALDI-
reTOF) mass spectrometry (MS; ultraflex TOF/TOF; Bruker Daltronics Inc.) for 
peptide mass fingerprinting (PMF), as previously described (Sebastiaan 
Winkler, et al., 2002). Selected peptide ions (m/z) were taken to search a 
nonredundant (NR) protein database (3,245,378 entries on 28 January 2006; 
National Center for Biotechnology Information) using the PeptideSearch 
algorithm (developed by Matthias Mann, Max-Planck-Institute for 
Biochemistry, Martinsried, Germany; an updated version of this program is 
currently available as PepSea from Applied Biosystems/MDS SCIEX). A 
molecular mass range up to twice the apparent molecular weight (as 
estimated from electrophoretic relative mobility) was covered, with a mass 
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accuracy restriction of <35 ppm and a maximum of one missed cleavage site 
allowed per peptide. To confirm PMF results with scores ≤40, mass 
spectrometric sequencing of selected peptides was done by MALDI-TOF/TOF 
(MS/MS) analysis on the same prepared samples using the ultraflex 
instrument in "LIFT" mode. Fragment ion spectra were taken to search the NR 
protein database using the Mascot MS/MS ion search program (version 2.0.04 
for Microsoft Windows; Matrix Science Ltd.) (Perkins, et al., 1999). Any 
tentative confirmation (Mascot score ≥30) of a PMF result thus obtained was 
verified by comparing the computer-generated fragment ion series of the 
predicted tryptic peptide with the experimental MS/MS data. 
 
2.2.5 Mice 
Mice were housed in the Laboratory Animal Research Center at the 
Rockefeller University under specific pathogen-free conditions and were 
analyzed at an age between 8 and 12 weeks. Animal protocols were 
approved by the Institutional Animal Care and Use Committee at the 
Rockefeller University. 
Conditional Syk knockout mice were generated and kindly provided by 
Christian Schmedt (Saijo, et al., 2003). Cre-recombinase-bearing strains 
CMV-Cre (Schwenk, et al., 1995), CD19-Cre (Rickert, et al., 1997) and Mx-
Cre (Kuhn, et al., 1995) were used for inactivation of the floxed Syk-allele in 
mice. All Syk mice from these crosses were on a mixed genetic background. 
PKCβ-deficient mice were generated by Michael Leitges (Leitges, et al., 1996) 
and used on a C57BL/6 background (Saijo, et al., 2002). MyD88-mutant 
(Kawai, et al., 1999) and ROSA-GFP mice (Mao, et al., 2001) have been 
described. C57BL/6 mice were obtained from commercial vendors (Charles 
River Laboratories, Taconic, The Jackson Laboratory) and used as a source 
of wild-type B cells. 
 52 
3 Results 
3.1 Part 1: BAFF acts as a survival and growth factor on 
B cells 
3.1.1 BAFF promotes B cell growth and metabolic fitness 
To test whether BAFF promotes cellular responses which are characteristic 
for growth factors besides survival, I measured B cell size, mitochondrial 
membrane potential and protein synthesis in naive versus BAFF-stimulated B 
cells. To this end, B cells were cultured in the presence of BAFF for up to 72 
hrs and B cell viability and size was measured by FACS analysis at selected 
time points. BAFF-treatment enhances the survival of B cells as expected and 
this is accompanied by an increase in the cells’ size (figure 8A and B). This 
cell growth is not caused by a potential contamination of the BAFF-
preparation with endotoxin as evidenced by the identical response of MyD88-
deficient B cells which are resistant to LPS stimulation (Kawai, et al., 1999) 
and figure 8C). The electrostatic potential across the inner mitochondrial 
membrane (∆Ψm) reflects the efficiency of electron transport along the 
respiratory chain and can be used as an indicator of the cellular metabolic 
rate. Mitochondrial membrane potential was measured in naive and BAFF-
treated cells by flow-cytometry following incubation with the potentiometric 
fluorescent dye TMRE which incorporates into mitochondria in a ∆Ψm-
dependent manner (Edinger and Thompson, 2002). BAFF-stimulated cells 
have an elevated mitochondrial membrane potential compared to non-treated 
cells, whereas the ∆Ψm base-line, determined by co-incubation with the 
respiratory uncoupler CCCP, is identical in both types of cells (figure 8D). 
Together, these results show that BAFF promotes both cell growth and 
energy homeostasis in B cells in addition to its survival effect. 
BAFF-induced cell growth corresponds to a raise in the cellular protein 
content and heightened protein synthesis, as judged from the quantification of 
protein concentrations in B cell lysates prepared from naive and BAFF-treated 
B cells as well as from the increased incorporation of 35S-labeled amino acids 
into BAFF-stimulated B cells (figure 8E and F). This is reflected on a 
molecular level by the phosphorylation state of key translational regulatory 
proteins. First, BAFF-treatment leads to phosphorylation of S6 ribosomal 
protein, an indicator of active protein synthesis (figure 8G). Furthermore, 
BAFF facilitates the initiation of translation by activating eIF4E in a dual 
fashion. BAFF-stimulation induces phosphorylation of eIF4E itself, but also of  
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Figure 8: BAFF acts as a growth factor on B cells. A. Mature B cells were incubated in 
culture medium in the absence (squares) or presence (diamonds) of BAFF for three 
days. Cell viability based on exclusion of TOPRO-3 was quantified by FACS at selected 
time points. B. Mature B cells were incubated in culture medium in the presence of 
BAFF and the cell size was measured by FACS analysis of the forward scatter (FSC). 
Error bars represent the standard deviation based on three independent experiments. 
C. Mature B cells from MyD88 +/+ and MyD88 -/- mice were incubated in culture 
medium (filled gray area) or in the presence of BAFF (thick black line) or LPS (thin grey 
line). Cell size was measured by FACS analysis of the forward scatter (FSC) after 72 
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hours of culture. D. Mitochondrial membrane potential (∆Ψm) was measured by TMRE 
labeling. Histograms show TMRE fluorescence of B cells incubated in the absence 
(filled area, thin lines) or presence of BAFF (clear area, thick line). In control samples 
(dashed lines), the membrane potential was dissipated by addition of the uncoupling 
agent CCCP. E. Protein amount per million B cells. Error bars represent the standard 
deviation based on three independent experiments. F. Protein synthesis was measured 
by metabolic labeling of mature B cells using 35S-methionine and -cysteine. 
Radioactivity incorporation was visualized by autoradiography (right) of cellular 
protein extracts stained with Coomassie Brilliant Blue (left). Numbers represent the 
relative signal intensity after quantification of individual lanes. G. BAFF activates 
components of the translational machinery. Purified B cells were incubated with BAFF 
for the indicated time and phosphorylation of proteins that control translation was 
measured by Western blot analysis of S6 (pS235/236), eIF4E (pS209) and 4E-BP1 
(pS65). Membranes were stripped and re-probed with non-phospho-specific antibodies 
against the respective proteins. Numbers represent the fold change of the phospho-
specific signal normalized to the non-phospho-specific signal. 
 
its inhibitor 4E-BP1 which frees eIF4E to participate in the translation initiation 
complex. Collectively, BAFF induces changes to B cell morphology, energy 
homeostasis and protein synthesis which are characteristic features of 
canonical growth factor signaling. In addition to looking for specific growth 
factor-induced events, BAFF-mediated cellular changes were characterized 
using an unbiased approach in which the gene expression profile was 
compared between BAFF-treated and naive B cells. In an attempt to more 
specifically identify those genes whose protein expression correlates with 
BAFF stimulation, polyribosomes, whose associated RNA represents the 
fraction of actively translated transcripts within the cell, were isolated from cell 
lysates prior to RNA isolation. Hybridization of the reverse-transcribed 
samples to Affymetrix arrays which allow for probing of 34,000 well 
characterized mouse genes, yielded 377 transcripts which were differentially 
regulated by at least two-fold in BAFF-treated cells. Of those, approximately 
three quarters were upregulated while one quarter was downregulated. The 
complete set of data is available at the GEO public repository and can be 
accessed at http://www.ncbi.nlm.nih.gov/geo under accession no. GSE5985. 
In order to assess how these transcriptional changes would impact cellular 
physiology, we determined the biological processes in which the differentially 
regulated genes are involved. This was accomplished in an unbiased fashion 
using annotations from the Gene Ontology (GO) Consortium  
 55 
 
Figure 9: BAFF induces selective changes in gene transcription. The expression 
pattern and levels of polysome-associated mRNAs in unstimulated and BAFF-treated B 
cells were determined by Affymetrix microarray analysis. The biological significance of 
BAFF-induced changes in gene expression was then analyzed using the Gene 
Ontology tool GOminer. GO categories representing biological processes are 
displayed as a directed acyclic graph and those over-represented in BAFF-stimulated 
cells are marked. Colors indicate a statistical significance of p<0.001 (light red) or 
p<0.0001 (dark red) A. Two prominent clusters of over-represented GO categories are 
framed and displayed in B and C. Labeling represents GO “Biological Process” 
category names. Gene identities for the displayed GO categories are listed in table 5 
(see Appendix). 
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(Ashburner, et al., 2000). GO represents an extensive pool of databases 
which aim to describe gene products in terms of, among others, the biological 
processes which they are involved in. The relationship between individual 
processes is illustrated by a directed acyclic graph which, similar to a 
hierarchy, organizes processes from broad and less specific to very 
specialized. To determine which biological processes were induced in BAFF-
stimulated B cells, the GO tool GOMiner was used (Zeeberg, et al., 2003). 
This program identifies GO biological processes which are over- or 
underrepresented in a statistically significant manner in lists of genes of 
interest, in this case, genes differentially regulated by BAFF in B cells. In this 
way, 33 biological processes were found to be stimulated in BAFF-treated B 
cells (figure 9A). Approximately two thirds of those fell into either one of two 
clusters which center around the biological processes glycolysis and cell 
cycle, respectively (figure 9B and C). The individual genes which belong to 
these clusters are listed in table 5 (see Appendix).Both of these BAFF-
regulated clusters are classic targets of growth factor regulation. BAFF-
induced upregulation of glycolytic enzymes in combination with its previously 
observed effect on mitochondrial respiration argue for a complex function of 
BAFF in the maintenance of cellular energy homeostasis. The profound effect 
of BAFF on cell cycle regulation is again a typical feature of growth factor 
signaling. However, it is surprising in a sense that BAFF by itself is known not 
to elicit B cell division (Schneider, et al., 1999). Indeed, BAFF fails to induce 
DNA-replication, judging from a lack of BrdU-incorporation and B cell 
proliferation as measured by CFSE-dilution (figure 10 A and B). However, on 
a molecular level, the levels of a plethora of cell cycle regulatory proteins, 
including cyclin D2, cyclin E, cyclin-dependent kinase (Cdk) 4, 
minichromosome maintenance deficient (Mcm) 2 and 3, Survivin and the 
commonly used proliferation marker Ki67 are increased by BAFF-stimulation 
(figure 10C). In accordance with the increased expression of Cdk4 and cyclin 
D, BAFF enhances phosphorylation of the Cdk4 target retinoblastoma (Rb), a 
prerequisite for the expression of E2F-regulated genes and S-phase entry. 
This profile of cell cycle regulatory protein changes is indicative of cell cycle 
progression from G1 to S phase, but does not match the cellular physiological 
effect of BAFF. One way to explain this discrepancy is a potential BAFF-
independent regulation of Cdk-activity by the inhibitor proteins p27 and p18 
(Huang, et al., 2004). Overall, BAFF appears to promote B cell exit from the 
resting state G0 into G1, but stops short of inducing cell cycle progression 
beyond the G1 to S checkpoint. This effect of BAFF positions B cells in a state  
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Figure 10: BAFF induces up-regulation of cell cycle-controlling proteins, but not cell 
division. A. B cell entry into S-phase in vitro was measured by BrdU-incorporation. 
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Frequencies of BrdU+ B cells incubated in medium alone (diamonds) or in the presence 
of BAFF (filled triangles), of anti-IgM (filled squares), of BAFF and anti-IgM (open 
triangles) or after pre-incubation with BAFF for 24 hrs followed by anti-IgM treatment 
for the indicated time (open squares) are shown. B. Mature B cells were labeled with 
CFSE, incubated for 3 days in medium alone or in the presence of BAFF or anti-IgM 
and the fluorescence of live B220+ B cells was measured by FACS. A reduction in 
CFSE fluorescence is proportional to the number of cell divisions. The position of the 
medium peak (dashed line) is included in BAFF and anti-IgM plots. C. Purified B cells 
were incubated with BAFF for the indicated time and the expression levels of cell cycle 
regulatory proteins cyclin D2, cyclin E, Cdk4, Mcm2, Mcm3, Ki67, Survivin and Rb 
following BAFF-stimulation were measured by Western blotting. Protein loading was 
controlled by tubulin expression level analysis. Numbers represent the fold induction 
normalized to the tubulin signal. Hyper-phosphorylated Rb (pRb) is identified by a 
migratory shift. 
 
were they remain resting but highly responsive to a mitogenic signal and 
prepares them for an immediate proliferative response in the event of antigen 
encounter. This is in line with the observed co-stimulatory effect of BAFF in 
conjunction with mitogenic stimulation (Schneider, et al., 1999). In further 
support of this model, incubation of B cells with BAFF prior to their challenge 
with anti-IgM accelerates their entry into S phase (figure 10A, open 
squares).In summary, a BAFF-mediated effect on B cell cell growth, protein 
synthesis, cellular energy derivation and cell cycle progression is evident both 
from selectively testing the sensitivity of these processes to BAFF as well as 
from analyzing the gene expression profile of BAFF-treated B cells in an 
unbiased fashion, demonstrating that the effect of BAFF on B cells exceeds 
mere survival. 
 
3.1.2 BAFF activates the PI3K-Akt signaling pathway 
Having established that the effect of BAFF on B cells mirrors many growth 
factor-induced responses, it was plausible to look for potential activation of 
canonical growth factor induced signaling pathways by BAFF. As explained in 
detail in the previous section, cell survival, growth, energy homeostasis, 
metabolism and cell cycle progression are all subject to regulation by the 
PI3K-Akt pathway.  
Activation of Akt can be inferred from its phosphorylation state at S473 and  
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Figure 11: BAFF activates the Akt signal transduction pathway. A. BAFF-induced Akt 
phosphorylation on S473 and T308 was measured by immunoblot analysis using the 
respective phospho-specific antibody (top panel). Akt expression was controlled by 
reprobing with a non-phospho-specific Akt antibody. Numbers represent the fold 
change of the phospho-specific signal normalized to the non-phospho-specific signal. 
B. Akt-phosphorylation at S473 in response to BAFF (right) or control agent (left) was 
measured and quantified as in A. C. BAFF-induced phosphorylation of TSC2 at T1462, 
of GSK-3β at S9 and of FoxO1 at S256 were measured by sequential immunoblot 
analysis. The amount of tested proteins was measured by re-probing of immunoblots 
with non-phospho-specific antibodies against the respective proteins. Quantification 
was done as in A. Erk expression is provided as a protein loading control. 
 
T308 and both residues are phosphorylated in B cells upon stimulation with 
BAFF. Akt-activity reaches a first peak early on at approximately 10 minutes 
of BAFF-treatment and, after a temporary decline, reaches a maximum at 24 
hours (figure 11A). Mock stimulation of cells with medium not containing the 
stimulating agent results in weak Akt-phosphorylation after 10 minutes, 
indicating that a fraction of the BAFF-induced signal at this time point is of 
unspecific nature (figure 11B).Akt exerts its effect on cell growth, protein 
synthesis, metabolism, survival and cell cycle progression through direct 
inactivation of the downstream targets TSC2, GSK-3 and FoxO transcription 
factors. As expected, BAFF leads to phosphorylation of TSC2, GSK-3β and 
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FoxO1 at their respective Akt target sites (figure 11C). Furthermore, 
prolonged BAFF-treatment diminishes FoxO1 protein levels, which is a 
characteristic consequence of prolonged Akt-activity.  
Akt-activation is a multi-step process initiated by its binding to PIP3 at the 
plasma membrane, which mediates a conformational change in the protein 
and allows for its phosphorylation (figure 12A). This sequence of events is 
suggested by the fact that inhibition of PI3K activity using the specific 
pharmacological inhibitor LY294002 abrogates Akt-phosphorylation 
(Vanhaesebroeck and Alessi, 2000) and figure 12B). 
 
 
Figure 12: Multi-step mechanism of Akt-activation. A. Inactive Akt is recruited from the 
cytoplasm to the plasma membrane through binding to the PI3K-product PIP3. A 
conformational change allows for PDK1-mediated phosphorylation of T308 within the 
kinase domain as well as for phosphorylation of S473 within the C-terminal 
hydrophobic motif (HM) by an as yet not conclusively defined kinase X. B. 
Pharmacological PI3K-inhibition abrogates Akt-phosphorylation. Mature B cells were 
stimulated with BAFF in the absence or presence of LY294002 and Akt-
phosphorylation was analyzed as in figure 11. 
 
The PIP3 content within the plasma membrane is reversibly regulated through 
its generation by PI3K and its break-down by PTEN. In order to clarify the 
mechanism of BAFF-induced Akt-activation, the potential activation of PI3K or 
inactivation of PTEN were analyzed. In B cells, the main isoform of PI3K 
consists of the regulatory subunit p85α and the catalytic subunit p110δ. 
Immunoprecipitation of p85α from untreated and BAFF-stimulated B cells 
reveals co-precipitation of an approximately 110 kD protein which was 
inducibly tyrosine-phosphorylated (figure 13A). A protein band which co-
migrated with phospho-p110 was subjected to mass-spectrometric analysis  
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Figure 13: PI3K controls BAFF-induced Akt-activation and B cell survival. A. BAFF 
induces phosphorylation of p110. The p85 subunit was immunoprecipitated from 
extracts of BAFF treated cells and tyrosine phosphorylated proteins in 
immunoprecipitates were analyzed by Western blotting using anti-phosphotyrosine 
antibody. The amounts of p85 and p110 in the immunoprecipitates were measured by 
Western blot analysis. B. p85-immunoprecipitates from BAFF-treated and control B 
cells were resolved by SDS-PAGE and visualized by Coomassie Brilliant Blue staining 
(right). A protein band corresponding in size to phospho-p110 (*) was subjected to 
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mass-spectrometric analysis and identified as PI3K p110δ. The peptides used for 
protein identification are listed. Aliquots of the immunoprecipitates were resolved on a 
parallel gel and examined for p110 phosphorylation as in A (left). C. BAFF does not 
induce changes in PTEN-phosphorylation. Phosphorylation of PTEN in extracts of 
BAFF-treated cells was measured by immunoblotting with phospho-Ser380 PTEN 
antibody. The immunoblot was re-probed with a non-phospho-specific PTEN antibody. 
D. PI3K inhibition suppresses BAFF-induced Akt-, GSK-3β- and FoxO1-
phsophorylation. B cells were stimulated with BAFF in the absence or presence of 
LY294002 and protein phosphorylation was measured as described in figure 11. E. 
Inhibition of PI3K reduces the survival of BAFF-treated cells. B cells were cultured in 
medium alone (circles) or in the presence of BAFF (squares), LY294002 (triangles) or 
BAFF together with LY294002 (diamonds). The frequencies of viable B cells were 
determined by FACS analysis. F. BAFF induces expression of Pim-2. The positions of 
three different Pim-2 isoforms are indicated. n.s. denotes non-specific. Erk expression 
is provided as a protein loading control in D and F. 
 
and found to represent p110δ (figure 13B), suggesting that BAFF promotes 
tyrosine phosphorylation of the PI3K catalytic subunit. A similar phenomenon 
has previously been observed in B cell lines in response to stimulation 
through the BCR where it was interpreted as a sign of PI3K activation 
(Craxton, et al., 1999: ; Kuwahara, et al., 1996). It therefore seems that BAFF 
promotes PI3K-activity which is likely to account for its stimulatory effect on 
Akt. Alternatively, BAFF could impact the activity of the phosphoinositide 
phosphatase and Akt-inhibitor PTEN. However, PTEN activity, as judged by 
the phosphorylation state of the inhibitory residue serine 380 (Birle, et al., 
2002), does not appear to be altered by BAFF (figure 13C). In further support 
of BAFF-mediated Akt-regulation through PI3K activation, the phosphorylation 
of Akt-target proteins GSK-3β and FoxO1 is abrogated by suppression of 
PI3K-activity using the pharmacological inhibitor LY294002 (figure 13D). 
Under the same conditions, BAFF-mediated B cell survival is severely 
impaired (figure 13E), illustrating the importance of the PI3K-Akt pathway for 
BAFF-mediated B cell survival.  
In summary, BAFF elicits molecular changes to B cell signaling proteins which 
mirror growth factor-mediated activation of the PI3K-Akt pathway. In addition 
to this pathway, a second oncogenic kinase, Pim-2, has a role in trophic 
signal transduction and exerts partially overlapping functions with Akt. BAFF 
not only activates the PI3K pathway, but also induces expression of Pim-2 
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(figure 13F). Both Akt- and Pim-2 can contribute to 4E-BP1-phosphorylation 
and thus exert translational control. 
 
3.1.3 PKCβ controls BAFF-mediated Akt-activation 
Akt-binding to the PI3K-product PIP3 at the plasma membrane is merely the 
first, albeit indispensable, step towards its full activation. Membrane 
translocation allows for Akt-phosphorylation at two essential sites, T308 and 
S473. In all models studied to date, PDK1 conducts Akt T308 phosphorylation 
(Vanhaesebroeck and Alessi, 2000). PDK1 itself is targeted to the plasma 
membrane in a similar fashion as Akt through its PH-domain, although it 
appears to have constitutive enzymatic activity. Therefore, Akt-
phosphorylation by PDK1 is likely regulated by differential accessibility of 
T308 through Akt-membrane recruitment and conformational change. In 
support of this model, PDK1 activity, as judged by phosphorylation of the 
activating residue S241 is constitutive and not altered in response to BAFF 
(figure 14A). 
In contrast to PDK1-mediated T308 phosphorylation, the kinase responsible 
for the phosphorylation of S473 has eluded conclusive identification despite 
substantial efforts. Among the kinase implicated in Akt S473-phosphorylation 
in different contexts and cell types are Akt itself, PDK1, integrin-linked kinase 
1 (ILK1), mitogen activated protein kinase activated protein kinase 2 
(MAPKAP-K2), PKCβ, DNA-PK, ATM and mTORC2 (Alessi, et al., 1996: ; 
Balendran, et al., 1999: ; Feng, et al., 2004: ; Kawakami, et al., 2004: ; 
Persad, et al., 2001: ; Sarbassov, et al., 2005: ; Toker and Newton, 2000: ; 
Viniegra, et al., 2005). In search for the enzyme which regulates BAFF-
induced Akt S473-phosphorylation, PKCβ seemed a good candidate for 
several reasons. First, PKCβ is capable of phosphorylating Akt at S473 but 
not T308 in vitro (Kawakami, et al., 2004). Second, a wealth of information 
demonstrates an important function for PKCβ in B cell biology. Lack of PKCβ 
in mice results in an Xid-like immunodeficiency syndrome and reduces the 
frequency of splenic B cells (Leitges, et al., 1996). Furthermore, PKCβ-
deficient B cells have prominent defects in survival and antigen-induced 
proliferation which has been at least partially attributed to defective BCR-
induced NF-κB activation (Saijo, et al., 2002: ; Su, et al., 2002). In order to 
assess, whether PKCβ could play a potential role in BAFF-dependent Akt-
phosphorylation, we investigated the effect of BAFF on PKCβ-activity. PKCβ 
belongs to the subfamily of conventional PKCs whose activation requires both 
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Figure 14: BAFF controls PKCβ-activity and association with Akt. A. BAFF does not 
induce changes in PDK1-phosphorylation. Phosphorylation of PDK1 in extracts of 
BAFF treated cells was measured by immunoblotting with phospho-Ser241 PDK1 
antibody. The immunoblot was re-probed with a non-phospho-specific PDK1 antibody. 
B. BAFF induces membrane translocation of PKCβ. B cells were stimulated with BAFF 
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followed by the preparation of cytoplasmic and membrane protein extracts. PKCβ and 
Akt content in the extracts was measured by Western blotting. Fraction purity and 
protein loading was controlled by Western blotting using antibodies against tubulin 
and Lyn. Numbers represent the fold change of PKCβ and Akt contents in the 
membrane fractions normalized to the amount of Lyn. C. BAFF does not induce the 
translocation of PKCβ, Akt and PDK1 into lipid rafts. Extracts prepared from BAFF-
stimulated B cells were subjected to high-speed centrifugation for purification of lipid 
rafts. Gradient fractions were collected and subjected to Western blot analysis using 
antibodies against PKCβ, Akt, PDK1 and Lyn. Expression of the lipid raft marker GM1 
was detected using horseradish-peroxidase-coupled Cholera Toxin B subunit. D. BAFF 
induces PKCβ-Akt association. B cells were stimulated with BAFF and protein extracts 
were treated with Akt antibody or control serum. The amounts of PKCβ or Akt in 
immunoprecipitates (IP) or whole cell lysates (WCL) were measured by Western blot 
analysis. Amounts of PKCβ in Akt-IPs were quantified as fold change over the 
corresponding Akt signal. 
 
Calcium-ions and DAG. The latter is a plasma membrane-resident product of 
PLC-activity and membrane recruitment of DAG-sensitive PKC-isoforms 
including PKCβ is typically used as an indicator of their activation (Newton, 
2001: ; Parker and Murray-Rust, 2004). In naive B cells, PKCβ resides 
predominantly in the cytoplasm, while a small proportion is associated with 
the  plasma membrane (figure 14B). BAFF-treatment increases the fraction of 
membrane-localized PKCβ, indicating BAFF-dependent activation of PKCβ. At 
the same time, Akt is enriched in the membrane fraction to a similar 
extend.Translocation of PKCβ into lipid rafts, a specialized ganglioside-rich 
plasma membrane subcompartment, is a critical event in BCR-induced NF-κB 
activation in B cells (Su, et al., 2002). Although a role of lipid rafts in BAFF 
signaling has not been reported, their reputation as important signaling 
platforms (Pierce, 2002) in combination with BAFF-induced enrichment of 
PKCβ at the plasma membrane prompted further investigation into a potential 
BAFF-dependent raft-association of PKCβ. However, an inducible recruitment 
of PKCβ into lipid rafts of BAFF-stimulated B cells is not observed (figure 
14C). Supporting a raft-independent mechanism of BAFF-induced signaling, 
no association between rafts and Akt or PDK1 can be detected.  
Concomitant BAFF-mediated activation of Akt and PKCβ as well as PKCβ- 
dependent Akt-phosphorylation in vitro suggest a functional correlation of the 
two proteins in BAFF-signaling. In further support of this hypothesis, BAFF-
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treatment increases the physical association of Akt with PKCβ as judged from 
co-immunoprecipitation of PKCβ with anti-Akt serum (figure 14D).  
In order to demonstrate the functional significance of these correlative 
observations, the phosphorylation state of Akt was determined in BAFF-
treated B cells from PKCβ-deficient mice. BAFF-induced Akt-phosphorylation 
at S473, but not T308, is diminished compared to wild-type cells in the 
absence of PKCβ (figure 15A). This result, in conjunction with the 
phosphorylation of S473 but not T308 of Akt by PKCβ in vitro (Kawakami, et 
al., 2004), strongly suggests that PKCβ contributes to BAFF-induced Akt-
activation through direct phosphorylation of the S473 residue. Because the 
previous results had indicated the contribution of a non-stimulus-specific  
 
 
Figure 15: PKCβ controls BAFF-induced Akt phosphorylation. A. Akt phosphorylation 
levels in protein extracts derived from unstimulated and BAFF-treated B cells of PKCβ 
+/+ and PKCβ-deficient mice were measured and quantified as described in figure 11. 
B. Mature B cells from PKCβ-sufficient (right) and -deficient (left) mice were stimulated 
with BAFF or control medium and Akt-phosphorylation at S473 was analyzed and 
quantified as in A. C. B cells from PKCβ +/+ and PKCβ-deficient B cells were stimulated 
with BAFF or anti-IgM antibody as indicated. Akt phosphorylation at S473 was 
measured and quantified as in A. 
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component to BAFF-induced Akt-phosphorylation after 10 minutes, it was 
tested whether this could be the origin of the residual Akt-phosphorylation in 
PKCβ-deficient B cells. Mock-stimulation induces unspecific Akt-
phosphorylation to the same extend in PKCβ-sufficient and -deficient cells 
(figure 15B). BAFF-treatment enhances this signal dramatically in wild- type 
cells and to a much lesser extend in PKCβ-null cells, suggesting that 
alternative kinases are in principle capable of Akt S473-phosphorylation 
following stimulation with BAFF. Akt-activation in PKCβ-deficient B cells has 
initially been described as normal (Kawakami, et al., 2004), prompting a 
differential analysis of Akt-activation in BAFF- versus BCR-stimulated B cells. 
Whereas lack of PKCβ has a strong impact on BAFF induced Akt-
phosphorylation, the response to stimulation with anti-IgM is not impaired 
(figure 15C). This result illustrates the complexity of distinct Akt-activation 
mechanisms in which cell type and context appear to be the key 
determinants. It also highlights the specificity of the mechanism responsible 
for BAFF-mediated Akt phosphorylation.  
 
3.1.4 Other BAFF-induced signaling events are PKCβ-
independent 
Given the significance of PKCβ in BAFF-induced Akt-activation, it is 
conceivable that PKCβ plays a universal role in BAFF signaling or that PKCβ 
acts specifically in Akt-activation. To test for a general function of PKCβ in 
BAFF-mediated responses, known molecular targets of BAFF signaling were 
examined in PKCβ-deficient B cells. Support for a potential role of PKCβ in 
BAFF-dependent NF-κB activity comes from the fact that it is known to play a 
critical role in NF-κB activation in BCR-stimulated B cells (Saijo, et al., 2002: ; 
Su, et al., 2002). However, as explained in detail in the previous section, NF-
κB activation in response to antigenic or BAFF-stimulation occurs through 
distinct mechanisms. The canonical pathway downstream of BCR cross-
linking relies on the IKK-mediated degradation of IκB-proteins, whereas BAFF 
promotes the processing of the NF-κB2 protein p100 to mature p52, 
increasing the fraction of transcriptionally competent p52/RelB dimers in the 
nucleus. Possibly due to these very different mechanisms, lack of PKCβ does 
not appear to have a discernable effect on BAFF-induced p100 processing to 
p52 (figure 16A). 
Another BAFF-mediated survival mechanism concerns the subcellular 
localization of PKCδ. Unlike PKCβ, PKCδ is a member of the novel subfamily  
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Figure 16: A. Unaltered BAFF-induced NF-κB2/p100 processing in the absence of 
PKCβ. The presence of p100 and p52 was determined by Western blot analysis using 
an antibody against NF-κB2. Protein loading was controlled by Erk (p44/p42) 
expression. B. Unaltered BAFF-induced cytoplasmic retention of PKCδ in the absence 
of PKCβ. Cytoplasmic and nuclear extracts were prepared from PKCβ +/+ and PKCβ-
deficient B cells at time zero (0) and after 24 hrs of incubation in the absence (-) or 
presence (+) of BAFF. PKCδ expression was assessed by Western blotting. Fraction 
purity and protein loading were controlled by Western blotting using antibodies 
against tubulin and lamin B. C. Protein extracts were prepared from cells at time zero 
(0) or after 24 hrs of incubation in medium (-), with BAFF (B), with anti-IgM (I) or with 
BAFF and anti-IgM combined (B+I) and subjected to Western blot analysis using an 
antibody against Bim. Protein loading was controlled using anti-tubulin antibody. 
 
of PKCs whose activity is sensitive to DAG but independent of Calcium ions. 
PKCδ also plays an important role in the regulation of B cell survival, but, 
where PKCβ- deficiency facilitates B cell death, lack of PKCδ is associated 
with exaggerated B cell survival (Mecklenbrauker, et al., 2002). The pro-
apoptotic function of PKCδ in B cells is linked to its translocation to the 
nucleus where it causes histone 2B phosphorylation on serine 14, an early 
marker of apoptosis (Ajiro, 2000: ; Cheung, et al., 2003: ; Mecklenbrauker, et 
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al., 2004). In fresh ex vivo isolated B cells, PKCδ is exclusively cytoplasmic, 
but the fraction of nuclear PKCδ increases upon their in vitro culture 
concomitant with a decline in cell viability (Mecklenbrauker, et al., 2002). 
BAFF is able to contain the pro-apoptotic function of PKCδ by suppressing its 
nuclear accumulation. Lack of PKCβ does not alter the cytoplasmic retention 
of PKCδ in BAFF-treated B cells (figure 16B), indicating that this process 
occurs PKCβ-independently. 
Finally, BAFF has been shown to influence the expression of Bim (Craxton, et 
al., 2005). As a member of the BH3-only subfamily of Bcl-2-proteins, Bim is 
pro-apoptotic and is strongly induced by anti-IgM stimulation in the absence of 
additional survival stimuli. In this context, co-stimulation with BAFF promotes 
Bim-phosphorylation which is a step towards its subsequent degradation. 
Remarkably, under conditions which normally induce Bim-expression in B 
cells, PKCβ-deficient B cells do not appear to upregulate Bim (figure 16C). 
This is surprising since a higher rather than lower content of pro-apoptotic Bim 
would be expected in cells harboring a survival defect. However, mutant B cell 
death is particularly rapid under conditions which provoke Bim-expression in a 
normal context. Thus, when cell extracts were prepared for the experiment 
shown in figure 16C, only 7% of PKCβ-deficient cells were alive 24 hours after 
anti-IgM stimulation, compared to 42% wild-type cells. The combined 
presence of BAFF improves the survival only moderately (19% live cells in 
PKCβ null cells versus 66% in wild-type). The exaggerated cell death and 
resulting drop in protein content may therefore in fact prevent Bim-detection. 
This precludes a conclusive analysis of whether BAFF-mediated Bim 
regulation requires PKCβ. Yet, it seems clear that elevated Bim-expression 
does not account for the diminished viability of PKCβ-deficient B cells in the 
absence or presence of BAFF. 
In summary, it appears that PKCβ-deficiency specifically impairs Akt-
activation in response to BAFF while other BAFF-induced signaling events 
proceed unperturbed or are not applicable in this particular cellular context. 
 
3.1.5 PKCβ-deficiency impairs BAFF-induced cellular responses 
and causes a defect in peripheral B cell maturation 
Given the requirement of PKCβ for certain but not all aspects of BAFF-
induced signaling, the question arises, if and how BAFF-mediated cellular 
responses are affected by PKCβ-deficiency. To address this matter, wild-type 
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and PKCβ-null B cells were cultured in the absence or presence of BAFF and 
cell survival and growth were monitored over a period of four days (figure 
17A). As expected from previous analysis (Saijo, et al., 2002), PKCβ-deficient 
B cells die more rapidly than wild-type cells in the absence of stimuli. Addition 
of BAFF significantly enhances the viability of both types of B cell, but does 
not fully restore the survival of PKCβ-deficient cells. Especially at later time 
points, the proportion of live PKCβ-null cells is significantly lower than in wild-
type cultures. In addition to a partial defect in BAFF-mediated survival, PKCβ-
deficient B cells are largely refractive to BAFF-induced cell growth (figure 
17B). Neither growth nor viability of PKCβ-deficient cells is restored to wild-
type levels using up to ten-fold higher BAFF concentrations (figure 17A and 
B). The survival defect of PKCβ-deficient cells therefore appears to differ 
mechanistically from that of auto-reactive cells whose susceptibility to cell 
death can be overcome by a higher BAFF-dose (Lesley, et al., 2004: ; Thien, 
et al., 2004). Along the same lines, flow-cytometric analysis of splenic B cells 
reveals that surface expression of BAFF-R is indistinguishable between 
PKCβ-sufficient and -deficient cells (figure 17C). In summary, these results 
support the notion that PKCβ-deficient cells harbor an intrinsic defect in 
BAFF-induced signaling. 
Given the partial refractiveness of PKCβ-deficient B cells to BAFF-mediated 
signaling in vitro, it is important to establish whether this has an impact on the 
B cell compartment in vivo. As detailed previously, lack of BAFF-signaling in 
mice is characterized by a severe reduction in peripheral B cell numbers, with 
the remaining cells belonging for the most part to the IgMhi CD21/35lo T1 
stage and poor maturation to the IgMhi CD21/35hi T2 and IgMint CD21/35hi 
mature stage. While alteration of the B cell compartment in the absence of 
PKCβ is less dramatic, it display characteristic features indicative of a 
suboptimal BAFF-function. First, splenic B cell numbers in PKCβ knockout 
mice are reduced to approximately 70% of wild-type figures (Leitges, et al., 
1996) compared to 10 - 20% in the absence of BAFF survival signaling 
(Lentz, et al., 1996: ; Sasaki, et al., 2004: ; Schiemann, et al., 2001: ; Shulga-
Morskaya, et al., 2004). Second, flow-cytometric analysis of splenocytes 
reveals that the ratio between immature and mature B cells is shifted in 
PKCβ-deficient mice such that there is an enrichment of IgMhi IgDlo cells with 
a concomitant reduction in IgMlo IgDhi cells (figure 17D). Closer inspection of 
transitional B cell stages using the maturation marker CD21/35 shows that 
this coincides with a higher frequency of T1 cells over a reduction in T2 and 
mature cells. Collectively, the phenotype of the B cell compartment in PKCβ- 
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Figure 17: BAFF-induced survival of PKCβ-deficient B cells is impaired in vitro and in 
vivo. A. B cells from PKCβ +/+ (squares) and PKCβ-deficient (triangles) B cells were 
cultured in medium alone (white symbols) or in the presence of 25 ng/ml (light grey 
symbols), 100 ng/ml (dark grey symbols) or 250 ng/ml (black symbols) of BAFF and the 
frequencies of viable B cells were measured by FACS analysis. B. The cell size of live 
BAFF-treated PKCβ +/+ (squares) and PKCβ-deficient (triangles) B cells was measured 
by FACS-analysis of the forward scatter (FSC). Colors represent BAFF-concentrations 
as in A. C. BAFF-R expression on splenic B220+ cells from PKCβ +/+ (solid black line) 
and PKCβ-deficient (dashed black line) was measured by FACS. Thin grey lines 
represent staining with an isotype control antibody. D. Maturity of splenic B cells from 
PKCβ +/+ (left) and PKCβ-deficient (right) mice was assessed by expression of the 
surface markers IgD versus IgM (upper panel) and CD21/35 versus IgM (lower panel). 
Only live lymphocytes are shown and the lower panel is gated on B220+ cells. Numbers 
in the upper panel represent frequencies of cells in the respective quadrants. Gates in 
the lower panel and numbers correspond to B cell developmental stages T1 (IgMhi 
CD21/35lo), T2 (IgMhi CD21/35hi) and mature (M, IgMint CD21/35int). 
deficient mice is indicative of a partially compromised ability to utilize BAFF-
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mediated survival signals and this correlates well with the responses of PKCβ-
null B cells to BAFF-stimulation in vitro. It also illustrates the physiological 
importance of BAFF-mediated Akt-activation to mature B cell homeostasis 
and suggests that this mechanism acts in concert with other BAFF-induced 
signaling events including NF-κB-activation, control of PKCδ subcellular 
localization and Bim-expression to regulate BAFF-dependent B cell 
responses. 
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3.2 Part 2: The role of Syk in B cell survival 
3.2.1 Arrested B cell development in Syk-deficient mice 
In previously published reports, Syk inactivation in mice through conventional 
gene targeting had resulted in perinatal lethality. Chimeric mice, generated by 
adoptive transfer of mutant fetal liver cells into immunodeficient hosts, had 
revealed a requirement for Syk during early B cell development at the 
transition from the pro B to the pre B stage. This has precluded an 
assessment of the role of Syk in mature B cells. In order to overcome this 
problem, a conditional Syk knockout was generated in which Cre-mediated 
recombination results in gene inactivation. A brief overview of the gene 
targeting procedure, conducted by Christian Schmedt, has been given 
previously. More detailed information is published elsewhere (Saijo, et al., 
2003). 
In order to create a Syk null allele (Syk ∆), mice with floxed Syk loci (Syk fl/fl) 
were bred to a CMV-Cre strain which mediates deletion in the germ line 
(Schwenk, et al., 1995). Surprisingly, intercrosses of Syk fl/∆ mice 
occasionally gave rise to viable Syk-deficient mice (Syk ∆/∆), albeit at a very 
low frequency. Such mice generally have a reduced live span and profound 
internal hemorrhaging (data not shown), as expected from the deficits in 
vascular development in Syk-deficient embryos (Abtahian, et al., 2003). Yet, 
those mice surviving to adulthood allowed for an assessment of the B cell 
compartment in Syk null mice. Lymphocyte subpopulations were analyzed by 
surface staining of single cell suspensions from lymphoid organs including 
bone marrow, spleen and peritoneum. Flow-cytometric analysis of B 
lymphopoiesis in the bone marrow reveals an enrichment of B220+ CD43+ 
CD25- pro B cells, concomitant with a severe reduction of B220+ CD43- 
CD25+ pre B, B220+ IgMlo immature B and B220+ IgMhi recirculating B cells in 
Syk null mice (figure 18A). Consequently, B cells, as defined by the pan-B cell 
marker B220, are essentially absent from the spleens, lymph nodes and 
peripheral blood of mutant mice (figure 18B and data not shown). 
Furthermore, the peritoneal cavity of Syk-null mice is devoid of B cells from 
either the B-1 or the conventional B-2 lineage and this applies to both B-1a 
and B-1b cells, two B-1 cells subsets distinguished by the surface marker 
CD5 (figure 18C). 
Collectively, Syk appears to be indispensable during development of both B-1 
and B-2 lineage B cells. The latter is specifically affected early on at the 
transition from the pro to the pre B stage. By and large, the B cell  
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Figure 18: B cell development in Syk-deficient mice. A. Bone marrow cells were 
isolated from Syk-deficient (right) and control (left) mice and analyzed for surface 
expression of B220, CD43, CD25 and IgM by flow cytometry. B. The frequency of B220+ 
B cells and CD90+ T cells in splenocytes from Syk-deficient (right) and control (left) 
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mice. C. The frequency of B-1a (IgM+, CD5+) and B-1b/B-2 (IgM+, CD5-) lineage cells in 
the peritoneal cavity of Syk-deficient (right) and control (left) mice. Numbers in A, B 
and C represent the frequency of cells within the indicated gates which correspond to 
the different cell populations outlined in the diagrams. Only live lymphocytes are 
shown and plots in A are gated on IgM- (top) and B220+ IgM- (middle) cells. 
 
compartment in Syk ∆/∆ mice concurs with the phenotype reported for Syk-
mutant fetal liver chimeras (Cheng, et al., 1995: ; Turner, et al., 1995). 
 
3.2.2 Aberrant B cell development in the absence of Syk is a B 
cell intrinsic phenomenon 
To address whether arrested B cell development in Syk-deficient mice is 
caused by a B cell intrinsic defect or whether Syk-deficiency in other cell types 
contributes to the phenotype, Syk floxed mice were crossed to CD19-Cre 
mice (Rickert, et al., 1997). In this strain, the Cre-recombinase coding 
sequence is inserted into the CD19 locus and is expressed under the control 
of the CD19 promoter in place of the CD19 gene. In order to prevent any 
potential phenotypic effects due to CD19-deficiency, all mice used in the 
subsequent experiments retained at least one wild-type CD19 allele (CD19 
+/+ or CD19 +/Cre) and CD19 +/Cre mice are referred to as CD19-Cre 
positive. CD19 is a B cell specific marker whose expression begins at the late 
pro B stage. B lineage specific Cre-mediated recombination in CD19-Cre mice 
sets in at the pro B stage and its efficiency increases up to the mature B cell 
stage (Schwenk, et al., 1997). Analysis of the B cell compartment in different 
lymphoid organs by surface staining and flow-cytometric analysis of single cell 
suspensions reveals a reduction in the frequency of pre B, immature B and 
recirculating B cells in the bone marrow of Syk fl/∆ CD19-Cre mice compared 
to Syk wild-type (Syk +/fl) and heterozygous (Syk +/fl CD19-Cre, Syk fl/∆) 
mice (figure 19A). Peripheral B cells in the spleen of Syk fl/∆ CD19-Cre mice 
are reduced to approximately a third of wild-type frequencies (figure 19B), 
consistent with a decline in total splenic B cell numbers to a similar extend 
(figure 19C). This phenotype is reminiscent albeit significantly milder than that 
of Syk-deficient mice. Two reasons could potentially account for the 
discrepancy: Lack of Syk in non-B cells could indeed be responsible for the 
aggravated B cell phenotype of Syk null mice or, more trivially, Cre-
recombinase expression under control of the CD19 promoter might be  
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Figure 19: B cell development upon conditional Syk-inactivation in response to CD19-
expression. Cells were isolated from Syk +/fl and Syk fl/∆ mice harboring two wild-type 
CD19-alleles or one wild-type and one CD19-Cre allele. A. B cell development in the 
bone marrow was analyzed as in figure 18 based on surface expression of B220, CD43 
and IgM. B. Splenocytes were analyzed by flow cytometry for surface expression of 
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CD90, CD19, IgM and IgD. C. Absolute numbers of CD19+ cells in the spleen. Error bars 
represent the standard deviation based on two independent experiments. D. Efficiency 
of CD19-Cre-mediated Syk-deletion. Syk-deletion was measured by Southern blot 
analysis of purified B cells isolated from bone marrow (top) and spleen (bottom). The 
positions of the wild-type (+), floxed (fl) and deleted (∆) alleles are indicated. Numbers 
represent the relative signal intensity as a fraction of 1.0 for each lane. Numbers in A 
and B represent the frequency of cells within the indicated gates which correspond to 
the different cell populations outlined in the diagrams. Only live lymphocytes are 
shown and the top panel in A is gated on IgM- cells. 
 
insufficient to ensure complete Syk-inactivation. In the latter case, the majority 
of B cells present in Syk fl/∆ CD19-Cre mice would retain the floxed Syk allele 
and therefore essentially be wild-type cells. This scenario is not unlikely given 
that escape from Syk-deletion would afford the respective cells an enormous 
advantage in the chance for further developmental progression and survival, 
whereas Syk-deletion would be expected to cause their demise. The 
possibility of incomplete CD19-Cre mediated Syk-deletion was assessed by 
genotyping of purified B cells derived from bone marrow and spleen using a 
Southern blot strategy, which distinguishes between the wild-type (+), the 
floxed (fl) and the deleted (∆) Syk allele. CD19-Cre mediated Syk-deletion 
works well in principle as evidenced by the near complete conversion of the 
floxed to the deleted Syk allele in those cells which retain the Cre-insensitive 
wild-type allele (figure 19D, compare lanes 1 and 2). In contrast, the floxed 
allele of Syk fl/∆ CD19-Cre mice is only marginally altered by CD19-Cre-
mediated recombination (figure 19D, compare lanes 3 and 4). The latter 
observation is more pronounced in B cells isolated from the spleen (figure 
19D bottom) than from the bone marrow (figure 19D top), indicating that the 
latter contains a higher frequency of Syk-deleted cells. The most likely 
explanation for incomplete Syk-deletion in splenic B cells from Syk fl/∆ CD19-
Cre mice is that CD19-Cre-mediated Syk deletion does not work 100% 
effectively and that Syk-deleted cells disappear rapidly and thus cannot be 
detected by flow-cytometry, resulting in a gross enrichment of the fraction of 
cells which escape CD19-Cre-mediated recombination. In summary, Syk-
inactivation beginning at the late pro B stage effects B cell development in a 
similar manner as complete absence of Syk in mice. The considerable 
phenotypic difference between Syk null and Syk fl/∆ CD19-Cre mice results 
from incomplete CD19-Cre mediated Syk inactivation and counter-selection of 
Syk-deleted cells such that the sizable B cell population of Syk fl/∆ CD19-Cre 
 78 
mice essentially consists of wild-type cells. This experiment demonstrates that 
the requirement for Syk during early B lymphopoiesis is indeed a B cell 
intrinsic phenomenon. Furthermore, it shows that Syk-expression is 
indispensable for development and survival beyond the late pro B cell stage. 
 
3.2.3 Syk is indispensable for mature B cell survival 
While some informative conclusions could be made from CD19-Cre mediated 
Syk-inactivation, it turned out not to be suitable for determining the function of 
Syk in mature B cells, since it did not rescue the developmental block at the 
pro to pre B transition caused by Syk-deficiency. To overcome this drawback, 
a different Cre-strain was used in which Cre-recombinase is expressed 
transgenically under control of the Mx-promoter (Kuhn, et al., 1995). The Mx-
protein is part of the cellular antiviral response and, as such, its expression is 
strongly induced by type I interferons (IFNs) α and β. Exogenous 
administration of type I interferons or the double-stranded RNA analogue 
polyinosinic acid - polycytidylic acid (poly(I)-poly(C)) which is a potent 
interferon inducing agent, can be used to induce transient expression of Cre-
recombinase in mice harboring the Mx-Cre transgene. This system offers the 
advantage of external manipulation of Cre-expression at any desired time 
point. However, Mx-controlled Cre-expression will not discriminate between 
different cell types such that Cre-mediated gene inactivation will in principle 
occur ubiquitously. This method has previously been used successfully to 
inducibly ablate surface BCR-expression and has demonstrated the 
dependency of mature resting B cells on tonic BCR-signaling (Lam, et al., 
1997), suggesting Mx-Cre as a suitable system to assess the requirement for 
Syk in peripheral B cells. One important technical difference between the two 
cases, however, is the intracellular localization of Syk-protein in contrast to 
the surface-expressed BCR. This precludes a convenient detection of deleted 
cells by flow-cytometry. Yet, from the previous experience with CD19-Cre 
mice, it is evident that the distinction between Syk-retaining and Syk-deleted 
cells is vital for the appropriate interpretation of any data. To allow for 
straightforward detection of Syk-inactivation on a single cell level by flow-
cytometry, the ROSA-GFP allele was introduced into Syk Mx-Cre mice by 
interbreeding. In the ROSA-GFP strain, a novel gene-cassette is inserted into 
the ROSA26 locus, a ubiquitously expressed genomic region of unknown 
function (Mao, et al., 2001). The novel sequence is composed of the green 
fluorescent protein (GFP) coding region, which is preceded by a loxP-flanked 
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stop-cassette, such that Cre-mediated recombination in ROSA-GFP mice will 
result in GFP-expression. Assuming that Cre-mediated deletion at the Syk- 
and the ROSA26-locus occurs with equal efficiency, Syk-deficient cells can be 
identified as GFP-positive by flow-cytometry in mice harboring the correct 
combination of alleles. 
Trial experiments were conducted to optimize the time between the induction 
of Cre-mediated recombination and analysis. Assuming a function of Syk in 
tonic BCR survival signaling, the expectation would be that B cells collapse 
upon loss of Syk. In order to maximize the chances of detecting Syk-deficient 
cells in vivo, it would be desirable to analyze B cell populations immediately 
after the induction of deletion. However, administration of the inducing agent 
interferon or poly(I)-poly(C) by itself elicits an immune response which 
transiently perturbs the B cell compartment. Based on the results of trial 
experiments, mice were analyzed on the seventh day after receiving a single 
dose of 300 µg poly(I)-poly(C) by intraperitoneal (i.p.) injection. Flow-
cytometric analysis reveals that the B220+ B cell compartment in the bone 
marrow is overwhelmingly GFP+ in both Syk +/fl ROSA-GFP and Syk fl/∆ 
ROSA-GFP mice expressing Mx-Cre compared to those not carrying the Mx-
Cre transgene (figure 20A, bottom row). In accordance, analysis of the bone 
marrow-resident B cell subpopulations shows a familiar pattern of changes 
associated with loss of Syk in Syk fl/∆ Mx-Cre ROSA-GFP mice, including 
enrichment of the pro B fraction versus decline in the populations of pre, 
immature and recirculating B cells (figure 20A, top and middle rows). 
Together, these observations argue for efficient Cre-mediated recombination 
at both the Syk- and the ROSA26-locus in the bone marrow upon induction of 
Cre-expression. Analysis of GFP-expression in Syk +/fl Mx-Cre ROSA-GFP 
mice reveals that Mx-Cre-mediated recombination is less efficient in the 
spleen than in the bone marrow, with only approximately 20% of splenic B 
cells becoming GFP+ (figure 20B, bottom row). Despite the modest extend of 
Mx-Cre-mediated recombination in the spleen, it is important to note the 
difference in the frequency of GFP+ B cells in the presence or absence of a 
wild-type Cre-insensitive Syk allele. In contrast to Syk +/fl Mx-Cre ROSA-GFP 
mice, a GFP+ B cell population is largely absent in the spleen of Syk fl/∆ Mx-
Cre ROSA-GFP mice. This is not due to differences in deletion efficiency 
between individual mice, as the frequency of GFP+ non-B cells is not 
negatively affected by the absence of a wild-type Syk allele. This result 
indicates that B cells are unable to sustain survival upon loss of Syk and is in 
line with the lower frequency of B220+ B cells in spleens of Syk fl/∆ Mx-Cre 
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ROSA-GFP mice (figure 20B, top row).  
 
Figure 20: B cell development upon induction of Mx-Cre mediated recombination in 
mice harboring Cre-sensitive Syk and GFP-alleles as described in the text. A. B cell 
development in the bone marrow was analyzed as in figure 18 based on surface 
expression of B220, CD43 and IgM (top two panels). The efficiency of Syk-deletion is 
proportional to the fraction of GFP+ cells (lower panel). B. The frequency of B cells was 
measured in splenocytes by expression analysis of the surface markers B220 and IgM 
(top panel). The efficiency of Syk-deletion is proportional to the fraction of GFP+ cells 
(lower panel). Numbers in A and B represent the frequency of cells within the indicated 
gates or quadrants which correspond to the different cell populations outlined in the 
diagrams. Only live lymphocytes are shown. 
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In conclusion, Syk-deficiency appears to be incompatible with mature B cell 
survival supporting the hypothesis that Syk is a critical mediator of the tonic 
BCR survival signal. 
 
3.2.4 Development of an experimental system for inducible 
Syk-ablation in vitro 
The hypothesis that Syk is a mediator of the tonic survival signal initiating 
from the BCR-complex, traditionally originates from its function in B cell 
development and the activation of its kinase activity upon BCR-ligation. The 
result of the previous experiment additionally demonstrates its indispensability 
for mature resting B cell survival. Yet, none of the above observations offer 
any potential mechanistic explanation as to how Syk exerts its survival 
function during tonic BCR signaling. In quiescent B cells, Syk is either 
catalytically inactive or its activity is below the detection limit, complicating the 
search for potential downstream targets of Syk which translate the tonic signal 
to the actual executers of cell survival (Hutchcroft, et al., 1991: ; Law, et al., 
1994: ; Yamada, et al., 1993). One way to possibly identify such factors could 
be to closely follow the course of cellular and molecular changes immediately 
following Syk-ablation. The feasibility of this approach, however, is hampered 
by technical limitations, which are unavoidable features of the standard 
procedure for gene inactivation based on Cre-recombinase. First, the above 
experiments in which Syk was inactivated by Cre-expression in mice, have 
demonstrated that the generation of Syk-deficient B cells in vivo is not a 
feasible approach as peripheral B cells either disappear or escape deletion. 
Second, for the purpose of examining the early stages of the cellular response 
to Syk removal, it would be necessary to induce Syk deletion in vitro. In the 
past, two different strategies have been employed to deliver Cre-recombinase 
into live cells in vitro, namely infection with a Cre-recombinase-expressing 
virus or cell transduction with a membrane-permeable Cre-protein. In 
lymphocytes, retroviral transduction is most commonly used to achieve Cre-
mediated deletion of floxed alleles. However, this method works only on 
dividing cells which precludes an application on resting B cells. More recently, 
the ability of lentiviruses which constitute a subfamily within the retroviridae, to 
integrate into the genome of non-dividing cells has been exploited to deliver 
Cre-recombinase into cell and tissue types which had previously been 
unsusceptible to retroviral transduction (Naldini, et al., 1996). However, 
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successful use of this technology in lymphocytes has not been widely 
reported and an effort to establish this procedure for the purpose of Syk-
deletion yielded good results in cell lines and stimulated, proliferating but not 
quiescent ex vivo isolated B cells (data not shown). An alternative to viral 
infection is the use of a Cre-recombinase fusion protein which contains a 
signal peptide that enables its translocation from the extracellular medium into 
live cells. This peptide is derived from the TAT protein of HIV, hence the name 
TAT-Cre denoting the fusion protein. TAT-Cre has been successfully 
employed for conditional gene inactivation in embryonic stem cells, fibroblasts 
and splenocytes (Peitz, et al., 2002). Yet, no application on resting B cells has 
been reported to date. In trial experiments using B cells isolated from ROSA-
GFP mice, TAT-Cre-mediated recombination turned out to be highly 
ineffective as judged by GFP-expression in B cells unless stimulated with a 
mitogen (data not shown). Collectively, these standard Cre-based approaches 
did not appear suited to achieve rapid Syk-inactivation in resting B cells. 
Another concern associated with Cre-mediated recombination in B cells in 
vitro is the time frame. Unless cultured in the presence of some form of 
stimulus, B cell viability rapidly declines over the course of only a few days. 
On the other hand, the Cre-based methods of gene inactivation described 
above usually take 24 hours or more to show an effect on the DNA level and 
possibly even longer on the protein level, depending on the stability of the 
target. This lengthy time frame would interfere with B cell viability in vitro in 
general and especially with the objective of examining early cellular changes 
specifically related to Syk-removal. Prompted by these restrictions, I sought to 
develop a different system for rapid inducible Syk inactivation. In the strategy I 
followed, the goal is to abruptly disrupt Syk function through its cleavage by a 
target-specific protease. One protease with a highly conserved target 
sequence is the NIa-protease derived from Tobacco Etch Virus (TEV). TEV-
protease specifically recognizes the target sequence ENLYFQS with cleavage 
occurring between the glutamine and the serine (Carrington and Dougherty, 
1988: ; Dougherty, et al., 1989). Database searching using BLAST did not 
detect this sequence as a natural component of the mouse proteome (data 
not shown). TEV-protease has a long-standing history in biochemistry, where 
it is commonly used to remove affinity tags from recombinant proteins (Lucast, 
et al., 2001). Beyond its in vitro application, TEV-protease has already been 
ectopically expressed in eukaryotic cells where it is active without showing 
obvious signs of cytotoxicity (Uhlmann, et al., 2000). All these factors made 
TEV my protease of choice for inducible Syk inactivation. The aim was to 
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create a modified version of Syk which contains the TEV-protease target site, 
but otherwise behaves like the wild-type protein. Introduction of TEV-protease 
should lead to Syk cleavage and its instant inactivation (figure 21A). 
The first step towards the development of such a system was to clone the full-
length Syk cDNA from a B cell RNA library. Details of this procedure are given 
in the methods section. Subsequently, a 39 base pair insertion was introduced 
at strategic sites within the Syk coding sequence through site-directed 
mutagenesis. The insertion encodes the seven amino acid TEV target 
sequence flanked by a three amino acid linker on either side (figure 21B). All 
insertion sites were located within the kinase domain with the intention that 
TEV-mediated cleavage should instantly abolish Syk catalytic activity. While 
the molecular structure of Syk has yet to be determined, crystal structures 
from several different kinase domains are available. Sequence alignments of 
these kinase domains with that of Syk revealed that the EGFR kinase domain 
shares the highest sequence homology to Syk’s (41% identity, for 
comparison: the kinase domain of the closely related ZAP-70 shares 63% 
identity to Syk (data not shown). Given this large extend of homology as well 
as the generally high degree of structural conservation between the kinase 
domains of different proteins in the active state (Huse and Kuriyan, 2002), Syk 
insertion sites were chosen based on the EGFR-structure (Stamos, et al., 
2002). Sites were selected for easy accessibility to the protease while 
avoiding critical catalytic features like the activation loop (figure 21C). Based 
on these criteria, six different Syk-mutants (X1 through 6) were generated 
which contain the TEV-target sequence at different positions within the Syk 
kinase domain (figure 21B). 
To confirm whether the modified kinases were susceptible to TEV-mediated 
cleavage as anticipated, both the different Syk versions as well as TEV-
protease were each cloned into a mammalian expression vector and 
transiently expressed in HEK 293 cells. Gross phenotypic examination did not 
reveal any discernable effect of TEV-expression on cell viability. Cell lysates 
were analyzed by SDS-PAGE and Western blotting using an N-terminal anti-
Syk serum and anti-FLAG-tag antibody to detect FLAG-TEV (figure 21D). 
Full-length wild-type as well as modified Syk migrates at approximately 72 kD 
in the absence of TEV. Faster migrating fragments appear upon co-
expression of the Syk-mutants, but not the wild-type protein, with TEV-
protease. The size of the fragments corresponds to the calculated size of the 
respective N-terminal Syk cleavage products. To exclude the possibility that 
TEV-mediated Syk-cleavage could occur in cell extracts following cell 
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disruption, iodoacetamide was added to the lysis buffer at concentrations  
 
Figure 21: Development of an experimental system for rapid inducible ablation of Syk 
in mature B cells. A. Strategy for rapid inducible Syk inactivation through its 
proteolytic cleavage inside the cell. See text for details. B. The Syk domain structure 
indicating sites X1 through X6 and the inserted sequence including the TEV target site. 
Amino acid residues essential for TEV proteolytic activity are underlined and the slash 
indicates the site of cleavage between the conserved glutamine and serine. N-terminal 
Syk products resulting from TEV-mediated cleavage at sites X1 through X6 are 
depicted together with their expected size. C. Model of the Syk kinase domain shown in 
coil representation, generated using Modeller (Fiser and Sali, 2003) and the atomic 
coordinates of the EGFR kinase domain (PDB accession code 1M14, Stamos et. al., 
2002). The activation loop and its flanking boundaries are colored in purple and red, 
respectively. Residues corresponding to the cleavage sites X1 through X6 are 
highlighted in yellow ball-and-stick representation. D. TEV-mediated cleavage of Syk 
X1 through X6 in vivo. HEK 293 cells were transiently transfected with the indicated 
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Syk-constructs in the absence or presence of FLAG-TEV. Cell lysates were subjected 
to immunoblot analysis using an N-terminal anti-Syk antiserum (top panel) and anti-
FLAG antibody (lower panel). The sizes of full-length Syk and its N-terminal cleavage 
products are indicated. 
 
under which TEV-activity is irreversibly inhibited (Ehrmann, et al., 1997). This 
result implies that TEV is indeed proteolytically active within live cells. TEV-
protease appears as a double band in Western blotting with the lower band 
representing a catalytically inactive auto-cleavage product (Parks, et al., 
1995). 
The next aim was to determine, whether the modified Syk-versions were still 
capable of their normal functions to the same extend as the wild-type protein. 
This is a considerable concern given that the insertion of thirteen amino acids 
into the catalytically sensitive region of an enzyme may well not be tolerated. 
To assess whether insertion of the TEV target site was compatible with 
normal Syk-function, I made use of a Syk-deficient variant of the chicken B 
cell line DT40 (Takata, et al., 1994). DT40 cells are a popular model for 
studying BCR-induced signaling events. This is partially due to their high 
susceptibility to gene targeting, enabling the relatively easy deletion of 
individual signaling proteins (Buerstedde and Takeda, 1991). Furthermore, 
DT40 cells respond to BCR-ligation by inducing global tyrosine 
phosphorylation and Ca2+-flux. Importantly, both of these responses are 
abrogated in Syk-null DT40 cells and can thus serve as a readout of Syk 
functionality upon reconstitution of Syk-deficient cells with the mutant Syk-
versions in question. Wild-type and mutant Syk constructs were introduced 
into Syk-deficient DT40 cells by infection with a pantropic retro-virus in which 
the transgene precedes an IRES-GFP. Details regarding virus production and 
infection are given in the methods section. Infected cells were identified based 
on GFP-expression and positive clones were isolated by single cell sorting. 
Syk-expression was confirmed by Western blot in selected single clones 
which were used in subsequent experiments. To examine BCR-induced 
global tyrosine phosphorylation, cells were stimulated for two and five minutes 
with the anti-chicken IgM antibody M-4 and cell lysates were analyzed by 
Western blot using anti-phosphotyrosine antibody (figure 22A). BCR-ligation 
induces an increase in total tyrosine phosphorylation in Syk-sufficient but not -
deficient cells and reconstitution of the latter with wild-type Syk restores the 
response as expected. Importantly, of the Syk-variants containing the TEV 
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target site, both X1 and X6 are capable of transducing the BCR-mediated  
 
Figure 22: Functionality of the Syk mutants X1 through X6. DT40 cell clones expressing 
the indicated Syk constructs or empty vector were generated as described in the text. 
A. The indicated DT40 clones were stimulated with anti-chicken IgM antibody M-4 for 2 
and 5 minutes. Cell lysates were subjected to immunoblot analysis using anti-
phosphotyrosine (pY) antibody (top panel) and anti-Syk serum (bottom panel). B. The 
indicated DT40 clones were loaded with Indo-I, stimulated with anti-chicken IgM 
antibody M-4 and the ratio of Ca2+-bound to Ca2+-free dye was recorded for 200 
seconds in a BD LSR flow-cytometer equipped with a UV laser. 
 
signal while the mutants X2 through X5 remain insensitive to IgM-stimulation. 
Essentially very similar results were obtained when cells, loaded with a 
Calcium-sensitive fluorescent dye, were stimulated with anti-IgM and the ratio 
of Calcium-bound to Calcium-free dye was followed by flow cytometry (figure 
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22B). BCR cross-linking induces Calcium flux in wild-type cells as well as in 
reconstituted clones expressing either wild-type Syk or the variants X1 or X6, 
while Syk null cells and those expressing Syk X2 through X5 fail to respond to 
the stimulus. Identical responses were observed for several clones from each 
group expressing the same construct; at least two clones from the 
unresponsive and five clones from the responsive groups (figure 22B and 
data not shown). In summary, the Syk variants X1 and X6 are functional in 
transducing BCR-mediated responses to a degree roughly similar to the wild-
type protein despite their carrying the TEV-target site. 
Having generated Syk variants which are functional in BCR-mediated signal 
transduction as well as susceptible to cleavage by TEV-protease, the next aim 
was to test for TEV-mediated Syk-inactivation. In order to achieve acute Syk-
cleavage in cultured cells, several methods were considered of which the 
administration of an active cell-permeable TEV-protein was chosen for the 
following reasons: direct application of the active enzyme to the target 
represents the most straight forward and least invasive way of directly 
regulating Syk activity in vitro in a dose-dependent manner. It avoids 
extensive cell manipulation which would be required for transgenic TEV-
expression by viral infection. A potential alternative in the form of a mouse 
model harboring an inducible TEV-transgene would create an additional set of 
challenges. First, one would have to find a reliable system for inducible gene 
expression in B cells in mice which is by no means a trivial task. Second, for 
the purpose of acute TEV-mediated Syk cleavage, inducible TEV gene 
expression harbors the disadvantage that accumulation of the active enzyme 
increases over time from the onset of TEV gene transcription whereas 
transduction of cell-permeable TEV-protease would allow for the delivery of a 
controlled of amount of active enzyme at a specific time point. Due to the 
common use of TEV for biochemical applications, established protocols for 
the purification of high amounts of the recombinant active protease exist 
(Lucast, et al., 2001: ; Parks, et al., 1995). Importantly, a variety of peptide-
sequences have recently been identified whose attachment to a cargo 
enables the transduction of the entire fusion protein into live cells (figure 23A). 
Such peptides, collectively termed protein transduction domains (PTDs), have 
been derived from the TAT-protein of HIV (Nagahara, et al., 1998), the Kaposi 
fibroblast growth factor (Rojas, et al., 1998) and the Drosophila melanogaster 
transcription factor antennapedia (Derossi, et al., 1998).  
Based on these considerations, I chose to prepare an array of recombinant 
fusion proteins composed of TEV and a PTD, with the expectation that such 
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proteins should mediate intracellular Syk-cleavage upon their transduction 
 
Figure 23: Generation of cell-permeable TEV-protease. A. Protein transduction 
sequences (PTDs) used in this study are listed. See text for details. B. Schematic 
representation of the recombinant proteins. Constructs and their abbreviations are 
listed on the left. C. Representative elution profile (left) of one PTD-TEV following 
affinity chromatography on a HisTrap Ni2+-Sepharose column. Numbers at the bottom 
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correspond to the fractions whose protein content was further analyzed by SDS-PAGE 
and Coomassie-staining (right). The underlined fractions were pooled and purified 
further. D. Representative elution profile (left) of one PTD-TEV following purification 
over a HiTrap size exclusion column. Numbers at the bottom correspond to the 
fractions whose protein content was further analyzed by SDS-PAGE and Coomassie-
staining (right). The underlined fractions were pooled and represent purified PTD-TEV. 
E. Purity and in vitro activity of all five recombinant TEV-proteins. Right: a recombinant 
substrate protein containing a TEV cleavage site (lane 6: 36 kD before cleavage, lane 7: 
33 kD after cleavage) was incubated with the indicated TEV-proteins in vitro. Reactions 
were resolved by SDS-PAGE and stained with Coomassie Brilliant Blue. The size of the 
full-length and the cleaved substrate is indicated together with the size of the different 
TEV-proteins. Recombinant TEV-proteins without substrate are shown on the left. 
 
into cells. Bacterial expression constructs were designed and cloned using 
standard molecular biology techniques. The fusion proteins consist of an N-
terminal PTD, followed by the TEV coding region and a C-terminal hexa-
histidine-tag to facilitate affinity purification (figure 23B). The PTDs used 
correspond to the above mentioned (figure 23A) with one exception. Because 
TAT is believed to mediate intranuclear localization as opposed to the 
predominantly cytoplasmic localization of Syk, a nuclear export signal (NES) 
derived from mitogen-activated protein kinase kinase (MAPKK, (Fukuda, et 
al., 1996) was included in one construct with the intention to facilitate co-
localization of the enzyme and its target. In all constructs, the TEV cDNA 
contains a serine to asparagine mutation at position 219 which renders it 
resistant to inactivation by auto-cleavage (Lucast, et al., 2001). The PTD-TEV 
fusion proteins were expressed in E. coli BL21 (DE3) cells and purified as 
outlined in the methods section. Briefly, recombinant protein contained in 
bacterial inclusion bodies was solubilized using denaturing reagents and 
affinity-purified using the hexa-histidine-tag over a Ni2+-charged sepharose 
column (figure 23C). Protein-containing fractions were pooled and dialyzed 
against a salt buffer containing 50% glycerol for protein re-folding. 
Concentrated, refolded protein was further purified on a size exclusion column 
(figure 23D). Final protein containing fractions were concentrated to a 
maximum of approximately 2 mg/ml and stored at -80ºC. This purification 
procedure resulted in the preparations of recombinant fusion proteins with 
little degree of contamination (figure 23E left). The protease activity of all 
TEV-preparations was tested in an in vitro assay through digestion of a 
substrate protein containing a TEV-cleavage site. In this assay, protease 
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activity is visualized by conversion of a 36 kD substrate to a 33 kD product. All 
TEV-preparations displayed high proteolytic activity on the substrate in vitro, 
demonstrating that the presence of the PTD does not interfere with TEV 
catalytic activity (figure 23E right).  
The next aim was to determine whether the PTD-TEVs were capable of 
mediating intracellular Syk-cleavage. To this end, DT40 clones expressing 
TEV-sensitive Syk X1 or X6 were incubated with increasing amounts of 
recombinant protein for one hour. Cells were analyzed two hours after 
treatment with the protease by SDS-PAGE. Under these conditions, very little 
to no cleavage of Syk could be detected using any of the recombinant PTD-
TEVs (figure 24A and data not shown). TEV-mediated Syk-cleavage was not 
improved by variations in the experimental protocol concerning the 
concentration of recombinant TEV (between 1 µM and 16.5 µM), the 
incubation time (between 1 and 36 hours), the time between incubation and 
cell lysis or the cell type (data not shown). PTD-TEV-mediated Syk cleavage 
was also not enhanced by addition of a peptide which is believed to facilitate 
 
 
Figure 24: PTD-TEV activity in vivo. A. DT40 Syk X1 cells were incubated with buffer or 
with 3.3 µM and 16.5 µM of the indicated PTD-TEVs for 1 hr. Cell lysates were analyzed 
by immunoblot using an N-terminal anti-Syk antibody. The sizes of uncleaved and 
cleaved Syk X1 and a non-specific band are indicated. B. Jurkat cells were incubated 
for 20 and 60 min with medium (thick black line) or 100 nM FITC-BSA (thin dotted line), 
FITC-WT-TEV (thin dashed line) or FITC-TAT-TEV (thin black line) and analyzed by flow-
cytometry under pH 6.5 buffer conditions. 
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release of a PTD-protein following its translocation into the cell (Wadia, et al., 
2004) and data not shown). 
In order to assess, whether the lack of PTD-TEV-mediated Syk-cleavage was 
due to a failure of PTD-TEV to translocate into cells or to a problem with PTD-
TEV activity inside the cells, the recombinant protease was labeled with the 
fluorescent dye FITC and the cellular uptake of fluorescently-labeled TEV was 
measured by flow-cytometry. Jurkat cells were incubated with FITC-labeled 
TAT-TEV, wild-type TEV not containing a PTD or BSA for 20 or 60 minutes, 
washed extensively and resuspended in a pH 6.5 buffer prior to flow-
cytometric analysis. The low pH was used as FITC-fluorescence is quenched 
with increasing acidity, such that any fluorescence detected should stem 
exclusively from the intracellular FITC-labeled protein pool and not from any 
labeled protein potentially attached to the cell surface (Veldhoen, et al., 2005). 
Cells incubated with FITC-TAT-TEV showed strong FITC-staining in a time-
dependent manner (figure 24B), suggesting intracellular uptake of the protein. 
However, cell treatment with a control protein composed of TEV only without 
any PTD yielded a virtually identical result. Furthermore, weaker but 
significant fluorescent staining was also observed with mere FITC-conjugated 
BSA. The significance of this result in judging the capacity of the recombinant 
PTD-TEV to translocate into cells therefore remains questionable. Similar 
observations were obtained by microscopic inspection of cells incubated with 
FITC-labeled TEV, PTD-TEV or BSA (data not shown). In summary, Syk-
cleavage through direct application of cell-permeable PTD-TEV turned out not 
to be a feasible approach to achieve instant Syk-inactivation. 
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4 Discussion and future perspective 
Within the B cell compartment, the life-span of individual cells varies 
dramatically depending on the developmental stage of the cell and the 
extracellular environment. During early B lymphopoiesis in the bone marrow, 
life versus death decisions are made at every transitional step of 
developmental progression (Rolink, et al., 2001). It is estimated that, in the 
mouse, every day 20 million cells manage to survive this rigorous selection 
process and are released from the bone marrow into the periphery (Osmond, 
1993). The size of the peripheral B cell pool is constant at approximately 100 
million cells and the vast majority of these have a life-expectancy of several 
weeks to month (Forster and Rajewsky, 1990). This is in stark contrast to the 
newly emigrated B cells from the bone marrow, 95% of which are believed to 
die within a few days. This massive cell death is a consequence of the 
necessity to compete with the mature long-lived B cell pool for extracellular 
survival cues whose availability is limited in the peripheral lymphoid organs. 
This mechanism of B cell homeostasis serves at once to (1) sustain the 
survival of a mature naive B cell pool with a constant size of approximately 
100 million cells, (2) maintain a diverse repertoire of antigen receptor 
specificities corresponding to the number of B cells, (3) prevent inappropriate 
expansion of the peripheral B cell pool with potentially adverse side effects to 
the organism, (4) mediate a low level of dynamic exchange to the composition 
of the long-lived peripheral B cell pool and (5) enable very efficient 
repopulation of a lymphopenic peripheral environment in a very short time 
frame. Within the scope of this study, the focus has been on the mechanisms 
which enable the longevity of the mature naive B cell pool. It is worth 
mentioning, however, that a different set of regulatory mechanisms come into 
play in the event of a B cell’s encounter with antigen. The immunogenic 
differentiation program of activated B cells creates both extremely short and 
long-lived cell types. For example, cell death is a frequent outcome of affinity 
maturation during the course of the germinal center reaction, but this 
contrasts with the extreme longevity of memory B cells and a subset of 
plasma cells which is the basis for an organisms lasting immunity to 
previously encountered pathogens (Janeway, et al., 2001).  
The aim of this study was to illuminate the survival of mature naive B cells in 
the periphery which is achieved through two distinct mechanisms: an internal 
signal originating from the BCR and the external pro-survival cytokine BAFF. 
During the course of this work, significant advances were made in 
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characterizing the effect of BAFF on B cell physiology as well as towards 
deciphering its signaling mechanisms. Furthermore, the protein tyrosine 
kinase Syk was identified as an integral component of the tonic BCR survival 
signal. 
 
4.1 BAFF-mediated effects on B cell physiology 
The viability of many cell types is closely associated with their trophic state 
(Hammerman, et al., 2004: ; Khaled and Durum, 2002). This concept is well 
established for the effect of nerve growth factor on neurons, for IL-3, IL-5 and 
granulocyte-macrophage colony stimulating factor (GM-CSF) on various 
hematopoietic precursors and for IL-7 and IL-4 on primary T and B 
lymphocytes (Deckwerth and Johnson, 1993: ; Rathmell, et al., 2001: ; Vander 
Heiden, et al., 2001). While cell survival is one important function of growth 
factor signaling, their impact on cellular physiology is more complex and 
extends to the regulation of energy homeostasis, protein synthesis, growth 
and cell cycle progression. Despite the striking effect of BAFF on B 
lymphocyte viability, its potential to act as a growth factor on B cells in 
analogy to the previous examples had not been investigated. In an attempt to 
close this gap in knowledge, I found that, indeed, the BAFF-imposed effects 
on B cells exceeded mere survival. Rather, it caused significant changes to B 
cell physiology which impacted energy homeostasis, protein synthesis, cell 
growth and cell cycle progression.  
One of the most striking observations was that BAFF literally acts as a growth 
factor in increasing B cell size. Cell growth is tightly linked to nutrient 
availability, protein synthesis and survival through an ancient mechanism 
which is essentially conserved in all eukaryotes and centers around mTOR 
(Wullschleger, et al., 2006). The principle function and regulation of mTOR 
have been detailed in a previous section. Several lines of evidence suggest 
regulation of mTOR activity by BAFF in B cells. First, the BAFF-induced 
increases in cell size and protein synthesis are key cellular outcomes of 
mTOR-signaling. On a molecular level, enhanced protein synthesis was 
reflected by BAFF-mediated phosphorylation of TSC2, 4E-BP1 and ribosomal 
S6 protein. In light of the recent discovery of Akt-mediated mTOR regulation 
via PRAS40, it would also be of interest to determine whether BAFF 
enhances PRAS40-phosphorylation and weakens its interaction with mTOR. 
Of note, although 4E-BP1 can be phosphorylated by mTOR, the same 
function can be performed by the oncogenic kinase Pim-2. BAFF had a 
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profound effect on Pim-2 expression at the RNA and protein level (data 
presented herein and (Lesley, et al., 2004: ; Xu, et al., 2002). It is therefore 
conceivable, that BAFF’s impact on protein synthesis is mediated by two 
independent mechanisms, namely mTOR and Pim-2. One possibility of 
experimentally distinguishing these pathways and assessing the individual 
importance of either one for protein synthesis and growth could make use of 
the immunosuppressant rapamycin which selectively inhibits mTOR. 
The potential of BAFF to influence cellular energy homeostasis was 
evidenced both by an elevation of the inner mitochondrial membrane potential 
as well as by the transcriptional upregulation of glycolytic enzymes. This 
observation is not necessarily contradictory, but rather suggests that BAFF 
enhances the cellular uptake of glucose which is used for glycolytic energy 
derivation. This metabolic pathway can feed back into mitochondrial 
respiration by providing essential intermediates of the electron transport chain 
and the citric acid cycle. Glycolytic energy derivation and that via 
mitochondrial respiration are intimately linked by the subcellular location of 
hexokinase. This important enzyme is required for glucose-phosphorylation at 
the 6-position, a rate-limiting event for glycolysis which requires ATP. 
Hexokinase localization at the mitochondrial membrane enhances the 
efficiency of this process, by facilitating ATP-supply and thus altering the 
enzyme’s kinetics in favor of glucose-phosphorylation (Robey and Hay, 2006). 
Of note, the subcellular localization of hexokinase is influenced by Akt-activity 
(Gottlob, et al., 2001: ; Majewski, et al., 2004). In view of BAFF’s effect on 
glucose metabolism and Akt-activity (see below), a similar function in 
enhancing mitochondrial hexokinase association could be anticipated. 
In contrast to the BAFF-dependent regulation of cellular growth and energy 
homeostasis, its potential to promote cell cycle progression came somewhat 
as a surprise. Although cell cycle entry is a common consequence of growth 
factor stimulation, no such effect had been observed in BAFF-treated B cells. 
Quite the contrary, ever since its first characterization, BAFF has been 
described to exclusively promote B cell viability without inducing cell division 
(Schneider, et al., 1999). While it does enhance B cell proliferation in 
response to different mitogens, this phenomenon is due to heightened cell 
survival. Yet, compelling evidence presented herein suggests that BAFF 
alters the profile of cell cycle regulating molecules in a manner which is 
indicative of cell division. In a simplified model of the cell cycle, entry into the 
G1-phase is initiated by activation of Cdk4 by D-type cyclins which results in 
phosphorylation of Rb, alleviating the latter’s inhibitory effect on the 
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transcription factor E2F. Expression of E2F-controlled genes including cyclin 
E activates Cdk2 which further inhibits Rb and results in entry into S-phase 
(Sherr and Roberts, 2004). The second cell cycle checkpoint at the transition 
from G2- into M-phase is controlled by activation of the phosphatase Cdc25C 
which results in activation of the Cdk1/cyclin B complex. Cdc25C activity is 
controlled by multiple input signals including the Polo-related kinase (Plk) and 
Cdk1 itself (Myer, et al., 2005).  
Based on BAFF-induced upregulation of Cdk4, cyclins D and E as well as Rb-
phosphorylation, one would expect B cell entry into S-phase. This assumption 
is further supported by enhanced expression of Mcm2 and 3 as well as Ki67, 
as these proteins function in DNA-replication and Ki67 is in fact commonly 
used as a proliferation marker (Gerdes, 1990). Yet, in agreement with 
previous reports, I found that BAFF-treatment alone elicited neither DNA-
replication nor cell division. A possible explanation to reconcile these 
contradictory observations centers on the regulation of Cdk-activity by Cdk-
inhibitors whose degradation is an integral part of productive cell cycle 
progression (Sherr and Roberts, 1999). p16 and p18 are members of the 
INK4-family of proteins which inhibit Cdk4/cyclin D complexes, while p27 and 
p21 are well characterized negative regulators of the Cdk2/cyclin E complex. 
It is conceivable, that in contrast to mitogens such as anti-IgM or LPS, BAFF 
fails to inactivate such Cdk-inhibitors which would prevent Cdk-activity despite 
the presence of Cdk4/cyclin D and Cdk2/cyclin E complexes. BAFF-mediated 
phosphorylation of Rb and expression of cyclin E indicate enzymatic activity of 
the Cdk4/cyclin D complex and thus a potential for BAFF to negate the action 
of INK4-inhibitors. In contrast, there is no functional evidence for activity of the 
Cdk2/cyclin E complex, suggesting that BAFF may be unable to inactivate 
p27 or p21. This model could be tested by directly measuring the enzymatic 
activities of the respective Cdk-complexes isolated from BAFF-treated B cells. 
Resting and anti-IgM stimulated B cells could serve as negative and positive 
controls, respectively. Using a different approach, an independent study found 
that BAFF-treatment induced S-phase entry in a significant fraction of B cells 
which contained elevated levels of cyclin E and lacked p27 (Huang, et al., 
2004). Together, the results argue in favor of a model in which BAFF elicits B 
cell exit from the resting state G0 and into the G1-phase including activation 
of Cdk4/cyclin D complexes, Rb-phosphorylation, transcription of E2F-target 
genes and expression of proteins involved in DNA-replication. However, 
BAFF-mediated cell cycle progression just stops short of passing the final G1- 
to S-phase checkpoint, possibly due to a failure of inducing Cdk2/cyclin E 
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activity. In a physiological context, this molecular signature translates to a 
situation in which BAFF would keep B cells constantly on the verge of cell 
division, but still in need of an additional final trigger. Considering the primary 
function of B cells in the detection of and fight against foreign antigens, this 
effect of BAFF appears very well suited to enable the most effective 
immunogenic response, both by positioning cells on the verge of S-phase 
entry and by establishing a cellular pool of proteins which will be essential at 
later stages of cell cycle progression. This pool includes the proteins required 
for DNA-replication mentioned above, but apparently also a multitude of 
proteins required for mitosis. From the latter group of proteins, we only 
confirmed the expression of survivin on the protein level, but the results from 
the global gene expression analysis indicate BAFF-mediated upregulation of 
numerous factors involved in chromosome condensation, kinetochore 
formation, cohesion and assembly of the spindle apparatus. A BAFF-
mediated preparation for cell cycle progression upon B cell triggering was 
supported by the observation that cellular pre-treatment with BAFF prior to 
mitogenic stimulation shortened the response time between cell triggering and 
DNA-replication. The suggested hypothesis could also be of use in explaining 
the synergistic effect of BAFF on B cell expansion in response to mitogens as 
well as help explain the strikingly short doubling time of some B cell subsets. 
For example, cycling B cells at the height of the germinal center response 
replicate within seven hours (MacLennan, 1994). 
 
4.2 A novel BAFF-induced signaling mechanism 
The physiological changes that were observed in B cells in response to BAFF, 
including cell survival, growth, regulation of energy homeostasis, protein 
synthesis and cell cycle progression, are all processes which are known to be 
regulated by the PI3K-Akt pathway in other cellular contexts (Massague, 
2004), prompting an examination of the potential sensitivity of this pathway to 
BAFF in B cells. The experimental evidence presented herein, including 
BAFF-mediated activation of PI3K as well as PI3K-dependent activation of Akt 
and several of its target proteins, supports this hypothesis. Furthermore, 
inactivation of TSC2, FoxO1 and GSK-3β in response to BAFF provides a 
mechanistic link to the before mentioned cellular outcomes. 
BAFF-stimulation enhanced Akt-phosphorylation at both of its catalytically 
relevant residues in a biphasic manner with a rapid initial peak at 
approximately 10 minutes and a delayed maximum at circa 24 hours. This 
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pattern of Akt-activity is not unusual and has been observed in other contexts, 
although the time frame may vary depending on the individual circumstances. 
Biphasic PI3K- or Akt-activation at early and late time points has been 
observed in platelets stimulated through the thrombin receptor (Banfic, et al., 
1998), in TNFα-primed neutrophils treated with N-formyl-methionyl-leucyl-
phenylalanine (fMLP) (Condliffe, et al., 2005: ; Guillou, et al., 2007), in 
estradiol-treated hepatoma cells (Marino, et al., 2003), in fibroblasts in 
response to zinc (Kim, et al., 2000), in mesangial cells in response to 
mechanical strain (Krepinsky, et al., 2005), in Kaposi sarcoma cells in 
response to TAT (Deregibus, et al., 2002) and in various cell types upon viral 
infection (Ehrhardt, et al., 2006: ; Flaherty, et al., 2004). In the experimental 
setup used in the present study, mock treatment of cells with control medium 
rather than BAFF caused a modest but discernable increase in early Akt-
phosphorylation, indicating that a fraction of the phospho-Akt signal in 
response to short-term BAFF-treatment is of unspecific nature. For future 
studies, an effort should be made to optimize the experimental conditions 
towards minimal background Akt-phosphorylation. 
With regard to the mechanism of BAFF-mediated Akt-activation, both its 
dependency on PI3K-activity and its phosphorylation of the catalytical 
threonine 308 by PDK1 are parts of a generic mechanism which are 
essentially invariant in all cases studied to date. The main question to resolve 
concerned the mechanism by which Akt’s C-terminal serine 473 was 
phosphorylated following BAFF-treatment, as there appears to be significant 
heterogeneity to this process. Depending on the cellular context and stimulus, 
the panel of implicated S473-kinases include PDK1, ILK1, MAPKAP-K2, DNA-
PK, ATM, mTORC2 and PKCβ (reviewed in (Fayard, et al., 2005). The results 
presented in this study and elsewhere suggest that PKCβ phosphorylates Akt 
at S473 in B cells in response to BAFF. This conclusion is based on the ability 
of PKCβ to phosphorylate Akt at S473 in vitro (Kawakami, et al., 2004) and 
the specific lack of this modification in BAFF-treated PKCβ-deficient B cells 
while Akt T308 phosphorylation remains intact. Residual Akt-phosphorylation 
which was observed in the absence of PKCβ could represent the non-specific 
component of the signal mentioned earlier or indicate a certain amount of 
flexibility in the mechanism of BAFF-induced Akt S473-phosphorylation. The 
latter scenario does not seem unlikely given the large number of previously 
identified Akt S473 kinases, some of which may be able to partially 
compensate for a lack of PKCβ. PKCβ-independent Akt-activation following 
BCR-ligation further suggests a context-specific function of PKCβ in BAFF-
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mediated induction of the PI3K-Akt pathway. In support of this model, BAFF 
appeared to activate PKCβ, as judged by its translocation to the plasma 
membrane, and enhanced its physical association with Akt. However, other 
BAFF-dependent signaling mechanisms besides Akt-activation appeared to 
be unperturbed in the absence of PKCβ, arguing against a universal role of 
this kinase in BAFF-mediated signaling.  
Previous experimental evidence had suggested the existence of BAFF-
mediated survival signaling mechanisms in addition to NF-κB-activation. A 
comparison between the signaling capacities of the three BAFF receptor 
proteins’ intracellular domains had shown that BAFF-R, TACI and BCMA are 
all capable of conferring a survival effect on B cell lines, while at the same 
time differing in the molecular responses which they elicit (Craxton, et al., 
2005). In this experimental system, BAFF-R had an impact on NF-κB 
activation and Bim-phosphorylation, whereas TACI only affected Bim and 
BCMA did not elicit any of these responses. With the expanded knowledge of 
BAFF-induced signaling events since the publication of this report, it would be 
of great interest to assess the sensitivity of PKCδ and Akt to the individual 
receptor proteins in this system. In any case, this interesting study implies that 
the three BAFF receptors are at least partially unique in their signaling 
capacity. The fact that all three proteins positively affected cell survival 
despite the inability of some to regulate NF-κB and Bim suggests the 
existence of additional BAFF-induced survival mechanisms. A similar 
conclusion was reached by Bender and colleagues based on the response of 
c-Myb deficient B cells to BAFF (Thomas, et al., 2005). In this study, the 
authors documented normal BAFF-dependent NF-κB activation, but impaired 
regulation of PKCδ subcellular localization which correlates with a reduction in 
BAFF-R expression and partial refractiveness of c-Myb-deficient B cells to 
BAFF-mediated survival. The discovery of BAFF-mediated activation of the 
PI3K-Akt pathway in the present study suggests that this could be part of the 
previously proposed but as yet undefined mechanism which contributes to 
BAFF-mediated B cell survival in addition to the regulation of NF-κB, PKCδ 
and Bim.  
The dependency of BAFF-induced Akt-activation on PKCβ combined with the 
apparent lack of PKCβ-involvement in other BAFF-induced signaling 
pathways provided an opportunity to test this hypothesis. While a lack of 
PKCβ affected B cell viability in vitro, this was not restricted to BAFF-mediated 
B cell survival. This result was not entirely unexpected given the previously 
described function of PKCβ in BCR-mediated NF-κB activation (Saijo, et al., 
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2002: ; Su, et al., 2002) and suggests that PKCβ may have a dual role in the 
regulation of B cell survival via tonic BCR-signaling and BAFF. In vivo, 
reduced B cell numbers and alteration of the splenic B cell compartment 
towards a more immature phenotype were consistent with a defect in BAFF-
mediated survival signaling. The relative mildness of the phenotype compared 
with that of BAFF-deficient mice argued that PKCβ-dependent Akt-activation 
contributes to BAFF-mediated B cell survival without being its sole regulator. 
Judging the physiological importance of BAFF-mediated Akt-activation on the 
responses of PKCβ-deficient B cells may be misleading to some extend since 
residual Akt-S473 phosphorylation in the absence of PKCβ could indicate a 
certain amount of flexibility and thus compensation for this function. One way 
to further confirm the conclusions made in this study would be to characterize 
BAFF-dependent responses in B cells which lack the individual Akt-isoforms 
1, 2 and 3 or a combination of those. This type of analysis could be hampered 
by potential redundancy of the different Akt proteins, but could also point out 
isoform-specific functions, particularly in light of Akt-regulation by PHLPPs 
(see below). Alternatively, B cells deficient for the regulatory or catalytic 
subunit of PI3K could be tested for their response to BAFF. However, lack of 
p85α or p110δ compromises B lymphopoiesis (Okkenhaug and 
Vanhaesebroeck, 2003) and it might be problematic to obtain sufficient 
amounts of cells which match the maturation stage of wild-type follicular B 
cells. If such technical difficulties can be overcome, the characterization of 
BAFF-mediated responses in B cells devoid of components of the PI3K-Akt 
pathway could help clarify the importance of this signaling chain for B cell 
survival, growth or cell cycle entry. 
As mentioned previously, one central conclusion of the present study is that 
BAFF-mediated effects on B cells are not restricted to mere survival but 
include the regulation of energy homeostasis, protein synthesis, cell growth 
and cell cycle progression. This diversity of BAFF-mediated cellular 
responses raises the possibility that certain BAFF-dependent molecular 
changes could act as general regulators of BAFF-signaling and affect the 
various cellular outcomes equally or, alternatively, that individual B cell 
physiological changes might be dependent on a specific signaling pathway. 
Our analysis of the responses of PKCβ-deficient B cells to BAFF in vitro 
suggest that Akt-activation plays a prominent role in B cell growth in response 
to BAFF and this hypothesis could be investigated further by analyzing BAFF-
mediated regulation of translational initiation in the absence of PKCβ.  
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Within the scope of this study, I found evidence for an involvement of PI3K 
and PKCβ in BAFF-mediated activation of Akt. Yet, several aspects of this 
pathway continue to be unclear. Most notably, the proximal signaling events 
which lead from BAFF-treatment to the activation of PI3K and PKCβ remain to 
be investigated. The first question in this respect concerns the binding of 
BAFF to its receptor protein on the B cell surface. As mentioned earlier, three 
proteins have been identified to date, which are capable of BAFF-binding, 
BAFF-R, TACI and BCMA. Judging by the consequences which result from 
genetic inactivation of the individual receptors, the survival effect of BAFF on 
B cells appears to occur primarily through BAFF-R, making it the prime 
candidate for mediating BAFF-induced activation of the PI3K-Akt pathway. By 
contrast, the previously mentioned study comparing the individual receptor 
proteins’ survival and signaling capacity supports the notion that all three 
proteins can in principle enhance cell viability (Craxton, et al., 2005). 
Differential expression of BAFF receptor proteins on various B cell subsets, 
the second potential ligand APRIL and potential interaction with proteoglycans 
could all be factors which would have to be considered in a complete picture 
of B cell survival through this protein family. 
In addition to establishing which BAFF receptor protein accounts for Akt-
activation, it would be of great interest to identify the missing components of 
the molecular signaling chain which link the receptor to PI3K and PKCβ. Very 
little is currently known about the molecules associated with the intracellular 
portions of the BAFF receptor proteins and which would be expected to be the 
primary acceptor and transducer of the activating signal. The specific 
interaction of BAFF-R with TRAF3 could serve as a starting point for further 
analysis (Xu and Shu, 2002), although, to date, TRAF3 has not been 
implicated in the regulation of the PI3K-Akt pathway. It is therefore equally 
conceivable that as yet unidentified receptor-associated proteins might be 
critical mediators in BAFF-mediated activation of this pathway. A promising 
strategy in the search for such factors could focus on binding partners of the 
very C-terminal eight residues of BAFF-R which are altered in the A/WySnJ 
mutant, as B cell lymphopenia in these mice has been attributed to a 
dramatically impaired BAFF-R signaling capacity (Thompson, et al., 2001: ; 
Yan, et al., 2001). The significance of the identification of BAFF-responsive 
proximal signaling factors is heightened by the fact that they could provide 
insights not only into the activation of the PI3K-Akt pathway, but also the 
remainder of the BAFF-induced molecular responses. To date, the 
mechanism by which the BAFF-signal is relayed to NF-κB2 p100-processing, 
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PKCδ regulation and Erk-mediated phosphorylation of Bim is largely elusive. 
The search for novel BAFF receptor associated signaling factors could thus 
be potentially daunting but very rewarding.  
An alternative approach in illuminating the BAFF-mediated activation of the 
PI3K-Akt-pathway could focus on those factors which have been identified as 
key regulators of this pathway in other cellular contexts. As this is a 
tremendously complex field, not all potential candidates can be discussed 
here, but several recent novel insights definitely deserve closer inspection. 
One very interesting family of Akt-regulators are the recently discovered PH 
domain leucine-rich repeat phosphatases (PHLPPs) 1 and 2 (Brognard, et al., 
2007: ; Gao, et al., 2005). Like PTEN, PHLPP 1 and 2 are phosphatases 
which negatively regulate Akt-activity, but where PTEN functions in the 
breakdown of the essential Akt co-activator PIP3, the PHLPPs act directly on 
Akt by dephosphorylating the C-terminal hydrophobic motif residue serine 
473. The importance of S473-phosphorylation to Akt’s catalytic activity is 
related to its stabilizing effect on the active protein confirmation and this has 
long been believed to be an integral aspect of the enzyme’s activity. Only 
recently has it emerged that S473-phosphorylation may in fact be dispensable 
in the regulation of a subset of Akt targets under certain conditions (Guertin, 
et al., 2006: ; Jacinto, et al., 2006: ; Shiota, et al., 2006: ; Yang, et al., 2006). 
Nevertheless, PHLPP-mediated Akt S473-dephosphorylation plays a role in 
the regulation of cell survival and cell cycle progression (Mendoza and Blenis, 
2007). Since both of these cellular responses are subject to control by BAFF 
in B cells, it could well be worthwhile to explore a potential regulation of 
PHLPPs by BAFF. Another very interesting aspect of the PHLPPs is that they 
appear to at least partially distinguish between the different Akt-isoforms 1, 2 
and 3 as substrates for S473-dephosphorylation. While PHLPP1 preferentially 
acts on Akt 2 and 3, PHLPP2 favors Akt 1 and 3. This differential pattern of 
substrates coincides with a partially unique profile of activity of the Akt-targets. 
While TSC2, FoxO1 and Gsk3β are apparently sensitive to both PHLPPs and 
all three Akts, the CDK-inhibitor p27 seems to be exclusively regulated by Akt 
3 and PHLPP2. This latter finding is of pivotal interest in light of the fact that a 
lack of p27-inactivation could account for BAFF’s failure to surpass the G1 to 
S phase checkpoint of the cell cycle. While it would have to be confirmed 
whether this exact mechanism of p27-regulation by Akt and PHLPP is 
conserved in B cells, the differential regulation of certain Akt-targets by 
specific isoforms of Akt and/or PHLPP represents an intriguing mechanism by 
which the generic outcomes of the PI3K-Akt pathway could be modulated to 
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reflect the particular effects of BAFF on B cells. Within the scope of the 
present study, I did not distinguish between the different Akt isoforms, but the 
very recent findings in connection with the discovery of the PHLPPs suggest 
this to be an undertaking well worthwhile.  
Another very interesting group of Akt regulatory proteins is the proto-
oncogene family TCL1 (T cell leukemia), which comprises the proteins TCL1, 
MTCP1 and TCL1b (reviewed in (Noguchi, et al., 2007). The TCL1 proteins 
interact with the PH-domain of Akt and function as a co-activator of its 
catalytic activity. Curiously, although TCL1 expression in mice is almost 
exclusively restricted to embryogenesis, it is expressed in some lymphoid 
lineages including mature B cells, suggesting that it may play an important 
role in the regulation of peripheral B cell survival. In support of this hypothesis, 
overexpression of TCL1 is a common feature of many B and T cell 
malignancies and transgenic TCL1 family member expression in mice results 
in the development of lymphatic neoplasias (Gritti, et al., 1998: ; Hoyer, et al., 
2002: ; Virgilio, et al., 1998). Conversely, loss of TCL1 in mice reduces the 
cellularity of the B cell compartment in both spleen and bone marrow (Kang, 
et al., 2005). The lack of manifestation of a more dramatic phenotype is most 
likely owing to a compensatory effect of other members of the TCL1 family. 
Given the expression pattern and the in vivo evidence for involvement of 
TCL1-family members in regulation of the B cell compartment, it would be of 
great interest to investigate, whether BAFF has the capacity to alter the 
protein content of individual TCL1-proteins in B cells or modify their 
association with Akt upon BAFF-treatment. 
Of note, an independent study has investigated the potential of BAFF to act 
as a growth factor on B cells (Woodland, et al., 2006). In line with the results 
presented here, the investigators observe BAFF-mediated B cell growth, 
activation of the pro-survival kinases Pim-2 and Akt as well as 
phosphorylation of effector proteins including FoxO transcription factors, 
mTOR and 4E-BP1. In addition, the authors report increased glucose 
metabolism and nutrient uptake in response to BAFF which represents further 
proof for the growth factor function of BAFF.  
A meticulous understanding of the signaling mechanisms which mediate 
BAFF-dependent survival of mature B cells constitutes not only an intellectual 
exercise, but has the potential to offer new alternatives for the treatment of B 
cell-related pathologies. As mentioned in a previous section, excess amounts 
of BAFF promote the persistence of self-reactive B cells and systemic 
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autoimmune disease is a common consequence of misregulation of factors 
whose activity is BAFF-controlled. In this sense, BAFF and the survival 
signaling mechanisms induced by it are an attractive therapeutic target and 
clinical efforts are underway to reduce BAFF-titers in patients through 
administration of soluble BAFF receptor proteins (Martin and Chan, 2006). 
Components of the PI3K-Akt pathway have long been the subjects of 
pharmacological interest owing to their association with neoplastic disease 
(Hennessy, et al., 2005). The results obtained as part of the present study 
could expand the application of potential drugs targeting the PI3K-Akt 
pathway for the treatment of autoimmune diseases such as SLE, rheumatoid 
arthritis or Sjogren’s syndrome. In addition to the striking association of BAFF 
to autoimmunity, there is increasing evidence that BAFF and its relative 
APRIL may play a role in several B cell malignancies including mature B cell-
derived non-Hodgkin’s lymphoma (NHL) and chronic lymphocytic leukemia 
(B-CLL) as well as plasma cell-derived multiple myeloma (Tangye, et al., 
2006). This is based on the observation that BAFF and APRIL promote the 
survival and proliferation of neoplastic cells as well as on higher serum titers 
of BAFF and APRIL in NHL and B-CLL patients. Furthermore, the malignant B 
cells themselves were found to synthesize BAFF and APRIL, suggesting the 
existence of an autocrine loop which promotes the expansion of tumor cells. 
Given the extensive connection of the PI3K-Akt signaling pathway to 
tumorigenesis, it is interesting to speculate that BAFF-induced activation of 
this pathway may at least in part account for its effect on malignant B cells. In 
support of this hypothesis, Akt-activation has been observed in BAFF- and 
APRIL-treated multiple myeloma cell lines (Moreaux, et al., 2004). 
 
4.3 The role of Syk in mature B cell survival 
In the present study, the role of Syk in the survival of mature resting B cells 
was investigated using a mouse model in which Syk-expression was inducibly 
ablated by Cre-recombinase. Surprisingly, Syk-deficient mice turned out to be 
viable in rare cases despite the profound defect in vascular development 
which caused severe hemorrhaging in such animals (Abtahian, et al., 2003). 
Of note, Syk-null mice only resulted from crosses of parents with a mixed 
genetic background and ceased to appear on a pure C57Bl/6 background. It 
is possible that the mixed background confers a somewhat greater robustness 
such that the severe vascular defect caused by lack of Syk penetrates to a 
lesser extend and can in some instances be compatible with an animal’s 
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survival. Apart from this surprising finding, the phenotypic properties of the B 
cell compartment in the absence of Syk overlapped very well with those 
derived from fetal liver chimeras (Cheng, et al., 1995: ; Turner, et al., 1995) 
and can essentially be summarized as a complete absence of B lymphocytes 
with the exception of bone marrow resident pro B cells.  
Regulated ablation of the Syk allele according to the expression pattern of the 
B cell-specific marker CD19, showed that the arrest in B cell development is 
caused by a defect which is an intrinsic property of the affected cell type. This 
excludes the possibility that aberrant B lymphopoiesis could be related to a 
Syk-dependent function in bone marrow resident stromal cells or other cell 
types which create the environment necessary for B cell development. The 
onset of CD19-Cre mediated Syk-deletion at the late pro B stage also showed 
that the inability to progress through B cell development is not a consequence 
of Syk-deficiency in stem cells, but rather, that Syk is specifically required at 
the pro to pre B transition following the onset of CD19-expression. In addition 
to these conclusions, the use of this experimental system exposed the 
potential problems which arise from inefficient Cre-mediated deletion in 
conditional knock-outs and which can dramatically affect the phenotypic 
appearance at first glance. When using Cre-mediated gene inactivation, it is 
therefore always essential to control for the efficiency of this process and, if 
required, an effort has to be made to distinguish mutant from wild-type cells to 
allow for correct interpretation of the phenotype. Such considerations are of 
particular importance when ablation of the target gene is detrimental to the 
viability of the cell type of interest, as this could evoke a substantial counter-
selection pressure. For these reasons, a genetic system was used in the 
subsequent experiment in which the event of successful Cre-mediated 
recombination is marked by the acquisition of a fluorescent signal. This 
enabled the flow-cytometric identification of Syk-deleted cells upon induction 
of Cre-expression in mice transgenic for the Mx-Cre gene.  
This system revealed significant differences in the efficiency of Cre-mediated 
recombination between different lymphoid organs. While hematopoietic cells 
in the bone marrow overwhelmingly lost Syk and showed characteristic 
alterations indicative of Syk-deficiency, Cre-mediated recombination occurred 
to a much lesser degree in splenocytes. This was not primarily due to a 
potential disadvantage of Syk-null cells, as deletion efficiency did not reach 
beyond 20% percent even when the cells retained a functional, Cre-
insensitive Syk-allele. While it could be possible to improve peripheral deletion 
efficiency to some extend by repeated induction of Cre-expression, this option 
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would have interfered with the primary purpose of the experiment, namely to 
monitor the fate of mature naïve B cells immediately following Syk-removal. 
Despite the comparatively modest extend of Cre-mediated recombination in 
splenocytes, a significant difference in the size of the recombination-positive B 
cell compartment was apparent between mice who retained a wild-type Syk 
allele and those which were rendered Syk-deficient. While the former 
constituted approximately a quarter of splenic B cells following induction of 
Cre-expression, the latter were virtually absent. No such difference occurred 
in splenic non-B cells whose viability is expected to be unaffected by lack of 
Syk.  
Together, these observations lead to the conclusion that the constitutive 
presence of Syk is indispensable for the maintenance of the mature resting B 
cell compartment and Syk-loss is incompatible with B cell persistence in the 
periphery and triggers B cell demise. This result strongly argues that Syk is a 
critical mediator of the tonic BCR-signal which ensures the survival of the 
mature B cell repertoire. In view of the homeostatic equilibrium model 
proposed to explain tonic BCR signaling (Monroe, 2006), the results 
presented herein support the notion that Syk mediates transient 
phosphorylation of ITAMs in the BCR complex or that its transient activation 
transduces a low level of signaling to downstream targets such as PLCγ or 
BLNK. The mechanistic details of the role of Syk in tonic BCR signaling 
remain an important topic for future studies. 
 
4.4 Development of a novel protein knockout system 
for Syk inactivation in B cells 
While the present work established a function of Syk in tonic BCR survival 
signaling, the precise action of Syk during this process remained unknown. 
My aim was to create an experimental system by which it would be possible to 
study how tonic BCR-induced Syk-activity is translated into precise cellular 
events responsible for B cell viability. This task was not brought to a satisfying 
conclusion within the scope of this study. While the development of a 
functional Syk-kinase which is susceptible to proteolytic cleavage was 
successful, the main technical problem that remained concerned the efficient 
delivery of the protease to its target inside the cell. While considerable effort 
was invested in the generation of an active cell-permeable protease, the 
complete range of possibilities which could potentially improve the method 
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has not been fully exploited.  
One possible option could be the use of a different peptide sequence to 
mediate protein transduction. The three different peptides which were used 
during the course of this work had previously been described as highly 
efficient and were selected on that basis. Judging from the published 
literature, the most commonly used peptide for protein transduction appeared 
to be TAT. The capacity of full-length HIV TAT protein to translocate into cells 
has been known for some time (Frankel and Pabo, 1988: ; Green and 
Loewenstein, 1988). Chemical cross linking of a 36 residue TAT-domain to 
cargo proteins as well as the preparation of fusion proteins composed of an 
11 amino acid TAT-peptide and a cargo protein have been successfully used 
to achieve transport of a diverse collection of proteins across the plasma 
membrane (Fawell, et al., 1994: ; Vocero-Akbani, et al., 2000). The fusion 
proteins range in size from 15 to 115 kD and include β-galactosidase, Gst, 
Cre, ovalbumin, Cdk inhibitors p16 and p27, HPV-E7, GFP, cdc42 and cyclins 
D3 and E (Ezhevsky, et al., 1997: ; Hsia, et al., 2002: ; Huang, et al., 2004: ; 
Kim, et al., 1997: ; Lissy, et al., 1998: ; Nagahara, et al., 1998: ; Peitz, et al., 
2002: ; Schwarze, et al., 1999: ; Su, et al., 2005: ; Tyagi, et al., 2001: ; 
Vocero-Akbani, et al., 2000). In virtually all cell and tissue types tested, 
protein transduction proved to be very efficient. This includes various murine 
and human cell lines such as NIH3T3, HEK 293, HeLa and CHO in vitro as 
well as whole mouse organs including liver, kidney, heart and brain in vivo. Of 
particular importance for my purpose, TAT-mediated protein transduction 
seems to work very efficiently in the lymphoid compartment as judged by 
results on Jurkat T and BJAB B cell lines, human and murine peripheral blood 
lymphocytes, splenocytes as well as purified T and B cells (Hsia, et al., 2002: 
; Huang, et al., 2004: ; Krautwald, et al., 2004: ; Peitz, et al., 2002: ; 
Schwarze, et al., 1999: ; Su, et al., 2005: ; Veldhoen, et al., 2005: ; Vocero-
Akbani, et al., 2000). While functional read-outs in all the studies mentioned 
above indicate correct protein function upon transduction, direct enzymatic 
activity has been observed for catalytically active proteins such as β-
galactosidase, cdc42 and Cre, justifying the expectation that a PTD-TEV-
protease should retain its proteolytic activity upon intracellular translocation. 
Although ample evidence exists on the efficiency of the TAT-peptide in protein 
transduction, the repertoire of PTDs used within the scope of this study was 
expanded to include additional peptides to which the capacity for protein 
transduction has been ascribed. One such sequence is derived from the 
Drosophila melanogaster homeodomain protein antennapedia and has been 
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termed Penetratin. It has mainly been used for the intracellular delivery of 
peptide cargos (Derossi, et al., 1998: ; Horng, et al., 2001). The MTS-peptide 
derived from Kaposi fibroblast growth factor has been shown to mediate 
transmembrane transport of both oligo- and polypeptides including Gst and 
Cre, although a later report has questioned the effectiveness of this sequence 
in protein transduction (Derossi, et al., 1996: ; Jo, et al., 2001: ; Peitz, et al., 
2002: ; Rojas, et al., 1998). Another sequence to which protein transduction 
capacity has been ascribed is derived from the Herpes simplex virus-type 1 
tegument protein VP22 (Elliott and O'Hare, 1997). Beyond mere translocation 
from the extracellular environment into the cellular interior, VP22 has actually 
been shown to mediate transcellular protein migration. Later studies have 
questioned the protein transduction potential of VP22, although there are 
conflicting reports which strengthen the original claim (Bennett, et al., 2002: ; 
Lundberg and Johansson, 2001). Due to the ongoing controversy, this 
particular PTD was not included in the present study, but it may still be 
worthwhile testing this sequence for the purpose of intracellular protease 
delivery. Very recently, a novel cell-permeable peptide has been derived from 
the human transcription factor Hph-1 (Choi, et al., 2006) which shows an 
impressive capacity to mediate protein translocation into Jurkat T cells and 
various other cell lines as well as mouse organs in vivo, making it another 
candidate for PTD-TEV translocation. 
The mechanism by which PTD-linked proteins are able to cross the cell 
membrane from the extracellular environment to the cells’ interior has not 
been conclusively settled. Originally, it had been suggested that PTD-proteins 
could directly cross the lipid bilayer in an unfolded state and refold once inside 
the cell (Schwarze, et al., 2000). However, such a scenario is somewhat 
difficult to picture mechanistically and, at present, a different hypothesis is 
considered more likely. With the exception of the MTS-sequence whose 
functionality has been questioned independently, one feature that all the 
PTDs mentioned here have in common is their high content of positively-
charged amino acids. In fact, a repeat of nine to eleven arginines confers 
translocation capacity to attached cargo proteins with at least equal efficiency 
to TAT (Futaki, et al., 2001: ; Matsui, et al., 2003: ; Wender, et al., 2000). The 
polybasic PTD-peptide is believed to mediate cargo-protein attachment to 
negatively charged heparan sulfate proteoglycans which coat the extracellular 
cell surface, such that proteins can enter cells through an endocytotic 
mechanism (Belting, 2003: ; Tyagi, et al., 2001). Although the further 
intracellular processing of the transduced proteins and their potential release 
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from endosomes are unknown, several observations support this model. Most 
importantly, cells genetically incapable of synthesizing fully sulfated heparan 
sulfate proteoglycans are refractive to the translocation of TAT fusion proteins 
(Tyagi, et al., 2001). This model could also help explain the phenomenon of 
cell membrane translocation of histones considering their high basic charge 
(Hariton-Gazal, et al., 2003). Based on this model, it has been suggested that 
a peptide derived from the haemagglutinin (HA) protein of influenza virus 
could enhance protein transduction efficiency by facilitating the exit of 
transduced proteins trapped inside endosome vesicles (Wadia, et al., 2004). I 
tested the effect of this HA-peptide on protein transduction efficiency of TAT-
TEV, but was unable to detect any improvement in Syk-cleavage (data not 
shown). While this observation does by no means prove or disprove the 
current model, it would certainly be desirable to gain a better understanding of 
the exact mechanism of protein transduction, and, with this in mind, make 
strategic amendments to improve the efficiency of the procedure. 
Based on the wealth of published information on the successful intracellular 
transduction and activity of PTD-fusion proteins, the expectation that 
recombinant PTD-TEV would translocate into cells and be capable of Syk-
cleavage appeared reasonable. Unfortunately, this was not the case under 
the conditions used in the present work. However, given the widespread use 
of this technology especially in lymphocytes, the present results may still be 
improved by using slightly modified strategies. As evident from the extensive 
description of PTDs above, the full repertoire of possible peptide sequences 
has not been exploited within the scope of this study. Promising PTD-
candidates could be VP22, Hph-1 or poly-arginine which could be fused to 
TEV-protease in a similar manner to the ones described in this study. 
Alternatively, TEV-protease, despite its high catalytic activity and lack of 
cytotoxicity may not be the ideal protease of choice for this purpose. One 
problem encountered with this enzyme during the course of this study was 
that the recombinant protein could only be concentrated to a maximum of 2 
mg/ml and that its buffer composition proved to be toxic to cells. From this 
ensues a limitation on the maximum concentration of PTD-TEV which can be 
used for cellular incubation. If it were possible to prepare a more concentrated 
protease stock solution, the amount of enzyme that could be applied to cells 
would proportionally increase, which may positively effect the protein 
transduction efficiency. In addition, proteases other than TEV may be soluble 
in a buffer whose composition is less toxic to cells. One candidate for a 
potentially superior enzyme could be PreScission protease (Cordingley, et al., 
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1990). Similar to TEV, this protease is derived from a virus (human 
rhinovirus), has a very high specificity for its target sequence and is commonly 
used for biochemical purposes. To my knowledge, potential cytotoxicity of the 
enzyme has not been tested in eukaryotic cells, but it seems rather unlikely 
given its high degree of target sequence specificity. For these reasons, it may 
be worthwhile testing the capacity of PreScission protease for the purpose of 
inducible protein inactivation. 
 
4.5 Other potential methods for rapid inducible Syk 
inactivation 
Lastly, the approach used herein for inducible Syk inactivation may be 
internally flawed to some extend as it may be difficult to achieve one hundred 
percent of target cleavage depending on the abundance of Syk, the maximal 
amount of protease transduction and the ability of the protease to find its 
target inside the cell. Yet, complete protein inactivation is a priority when 
addressing the function of Syk in tonic BCR survival signaling as, most likely, 
even residual amounts of Syk would be capable of mediating this presumably 
weak signal. In this sense, other ways of inducible protein inactivation may be 
better suited for this particular purpose. 
One very attractive system called chromophore-activated light inactivation 
(CALI) exploits the property of some fluorochromes to generate reactive 
oxygen species (ROS) in response to high-intensity illumination. Attachment 
of a suitable fluorochrome to the target protein either via a dye-conjugated 
antibody or genetically makes the target protein susceptible to ROS-mediated 
inactivation upon illumination (Jay, 1988: ; Jay and Sakurai, 1999). This 
technique has been described as highly efficient and offers an ideal means of 
spatiotemporal regulation as target inactivation can be induced under any 
conventional fluorescent microscope. The use of genetically encoded 
fluorochromes is particularly intriguing as it avoids the need to deliver an 
exogenous protein into the cells’ interior, the step which impeded the present 
approach. Genetically encoded dyes suited for CALI include GFP, although 
this is not particularly efficient (Rajfur, et al., 2002). In an alternative 
technique, a short tetracysteine-tag is genetically attached to the target 
protein which renders it sensitive to the binding of non-fluorescent membrane-
permeable biarsenic compounds FlAsH or ReAsH (Marek and Davis, 2002: ; 
Tour, et al., 2003). FlAsH and ReAsH emit green or red light, respectively, 
upon binding to the tetracysteine moiety and both function in CALI with the 
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efficiency of ReAsH being somewhat greater. One drawback of this elegant 
system is that it may cause damage not only to the target, but also to other 
proteins in a close enough vicinity to be affected by the fluorochrome-
generated ROS. Also, the biarsenic dyes may not only bind to the 
tetracysteine tag of the target protein, but show some affinity for endogenous 
cysteine-containing proteins, thus creating some background staining 
(Stroffekova, et al., 2001). Non-specific cytotoxicity may be reduced by further 
optimization of the tetracysteine-motif’s dye-affinity (Tour, et al., 2003) or by 
using multi-photon over single-photon excitation which is associated with less 
phototoxicity (Tanabe, et al., 2005). In another modified and less cytotoxic 
approach, the target protein is fused to a FKBP12 homologue which displays 
high affinity to a synthetic, cell-permeable fluorescein-coupled ligand (Marks, 
et al., 2004). Very recently, a new GFP homologue termed “KillerRed” has 
also been shown to by highly effective for CALI (Bulina, et al., 2006). In 
principle, KillerRed could be an attractive CALI-fluorochrome since it is 
entirely genetically encoded and does not require any type of invasive cell 
manipulation. However, its application is currently restricted by its obligate 
dimerization. In summary, although certain details may have to be optimized, 
CALI in principle is likely to be a good approach for the purpose of rapidly 
inducible Syk-inactivation in cells in vitro. 
Another elegant approach for targeted protein inactivation has been 
demonstrated for tyrosine and serine/threonine kinases. The method relies on 
the sensitization of the target enzyme, but not any other kinases, to a modified 
inhibitor. This is achieved by the modification of a single conserved amino 
acid termed the gatekeeper, thus expanding the kinase’s ATP-binding site by 
an additional pocket. At the same time, a bulky group is added to a general 
protein kinase inhibitor, thus preventing its binding to any native kinases. 
However, due to its enlarged ATP-binding site, the target kinase is susceptible 
to inhibition by the modified inhibitor (Bishop, et al., 2000: ; Liu, et al., 1998). 
Strategies as this are termed chemical genetics and offer several advantages 
(Knight and Shokat, 2007). For one, the kinase inhibitors are readily cell-
permeable, which ablates the main problem I encountered with the present 
strategy. Second, direct administration of the inhibitor to cultured cells without 
the need for any additional equipment would be expected to cause 
instantaneous kinase-inactivation in a dose-dependent manner. Importantly, 
in contrast to conventional pharmacological inhibitors, this strategy confers 
absolute specificity for the selected target kinase. For these reasons, 
chemical genetics represent a highly attractive method for targeted Syk 
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inactivation. While the strategy has to be optimized for every individual kinase, 
it has been successfully employed on Src-kinases as well as EGFR, the 
latter’s kinase domain sharing a high degree of homology to Syk’s (see 
above). It therefore seems plausible that the genetic sensitization of Syk to a 
modified inhibitor should be fairly straight forward. Very recently, the chemical 
genetics approach has been extended by modification of an additional residue 
in the ATP-binding pocket which serves as the anchor point for covalent 
binding of a modified inhibitor and thus irreversible kinase inactivation (Blair, 
et al., 2007). Furthermore, addition of a fluorochrome to the irreversible 
inhibitor creates a means to specifically label the portion among the total pool 
of target kinase molecules which are activated in response to a certain 
stimulus. Such a measurement would be of enormous interest regarding the 
role of Syk and other kinases in tonic versus immunogenic BCR signaling.  
While the alternative tactics discussed above may offer some considerable 
advantages for the purpose of rapid inactivation of Syk in cultured B cells, the 
approach attempted herein may still be of significant interest for other 
applications. For one, the information on the structural flexibility of Syk’s 
kinase domain may be exploited in a scenario where the addition of ectopic 
loops to the kinase domain core may be desired. This could for example be 
with regard to creating novel binding sites which would mediate synthetic 
interaction with other cellular proteins or exogenous pharmacological 
compounds. Quite remarkably, the insertion of at least thirteen residues at at 
least two different positions within the kinase domain appears to be 
compatible with kinase activity, suggesting that significant additions can be 
made to this catalytic module at certain sites. Such alterations might also be 
suited to regulate the degree of enzymatic activity. In addition, kinase 
inactivation through proteolytic cleavage could be of use under conditions 
which involve a cell-free context, ablating the problem of intracellular protease 
delivery. 
 
4.6 B cell survival mechanisms which could represent 
targets of the Syk-mediated tonic BCR signal 
Should it be possible to surmount the technical challenges involved in rapid 
inducible Syk-inactivation, this system could be used to investigate the 
sensitivity of molecular cell survival signatures to loss of the Syk-mediated 
tonic BCR signaling. While not all potential targets of this pathway can be 
thoroughly discussed here, some important mechanisms which deserve 
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mentioning include the Bcl-2 protein family, members of the transcription 
factor NF-κB as well as the B cells’ capacity to respond to BAFF-induced 
survival signals. 
One family of proteins whose members have been briefly mentioned 
throughout this work was originally defined by its founding member Bcl-2 
(reviewed in (Chao and Korsmeyer, 1998). The family encompasses both 
anti- and pro-apoptotic members, the former being multi-domain proteins 
consisting of several Bcl-2 homology domains (BH1 to 4). Pro-apoptotic family 
members include the multi-domain proteins Bax (Bcl2-associated X protein) 
and Bak (BCL2-antagonist/killer) as well as the so-called BH3-only proteins 
comprised of Bad, Bid (BH3 interacting domain death agonist), Bim and 
others. In recent years, significant advances have been made in 
understanding the mechanism how this family of proteins regulates cell 
survival (Willis and Adams, 2005). Briefly, in viable cells, Bax and Bak are 
believed to exist as monomers in the cytoplasm or at the outer mitochondrial 
membrane. A pro-apoptotic signal induces homo-oligomerization of Bax and 
Bak within the outer mitochondrial membrane, causing its permeabilization 
and release of intermembrane-resident proteins including cytochrome C. BH3-
only proteins are mediators whose expression and activity is controlled by 
diverse apoptosis-regulating signals and who in turn assist in the activation of 
Bax and Bak. Their pro-apoptotic potential is believed to be contained by the 
pro-survival Bcl-2 family members through their sequestration away from Bax 
and Bak. This general scheme is likely to be a simplification to some extend 
and, in addition, defined regulatory functions probably exist for the individual 
proteins.  
In the B cell compartment, anti-apoptotic family members Bcl-2, Bcl-xL, A1 
(BCL2-related protein A1) and Mcl-1 are expressed at different stages 
throughout development. In mature peripheral B cells, Bcl-2 and A1 are highly 
expressed, whereas Bcl-xL seems to play a more dominant role at earlier B 
cell stages (Grillot, et al., 1996: ; Merino, et al., 1994: ; Tomayko and Cancro, 
1998). Mcl-1 expression appears to be very dynamic as judged by its high 
protein turnover, its induction by cytokine-treatment and its decline in cells 
undergoing atrophy and death (Lomo, et al., 1996). Lymphocyte development 
in the absence of Bcl-2 is initially normal, but lymphocyte populations 
dramatically collapse later on due to massive apoptosis in the lymphoid 
organs (Veis, et al., 1993). Lack of Bcl-xL impairs the survival of immature 
lymphocytes, but their mature descendents appear to be less affected, 
whereas ablation of Mcl-1 blocks B lymphopoiesis at a very early stage 
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(Motoyama, et al., 1995: ; Opferman, et al., 2003). Conversely, inactivation of 
Bim causes B cell hyperplasia and impairs the negative selection of auto-
reactive B cells (Bouillet, et al., 1999: ; Enders, et al., 2003: ; Oliver, et al., 
2006). Combined inactivation of Bak and Bax also causes lymphoid 
hyperplasia and resistance to death by neglect (Lindsten, et al., 2000).  
It is attractive to speculate that the tonic BCR-signal influences the 
composition of Bcl-2 family proteins in resting B cells, ensuring sufficient 
expression of Bcl-2, A1 and Mcl-1 while keeping at bay the upregulation of 
Bak, Bax and BH3-only proteins. As mentioned before, the distinct outcomes 
of tonic versus immunogenic BCR-signaling are unknown. However, antigenic 
BCR-stimulation effects the expression of several Bcl-2 family proteins which 
tends to coincide with their developmental fate of survival versus death 
(Enders, et al., 2003). In this context, it is interesting to note that ectopic 
overexpression of Bcl-2 prolongs the presence of receptorless B cells in the 
periphery, but fails to prevent their eventual demise (Lam, et al., 1997). In this 
sense, it is conceivable that tonic BCR-mediated survival is partially, although 
not completely, accomplished by regulation of Bcl-2 family proteins.  
One protein family which has simultaneously been implicated in the regulation 
of Bcl-2 proteins as well as lymphocyte survival is the transcription factor NF-
κB. NF-κB comprises a group of five mammalian proteins and ablation of 
individual members as well as proteins which function in NF-κB activation 
affect B cell survival. Loss of individual NF-κB proteins negatively infuences B 
cell viability under various conditions (reviewed in (Siebenlist, et al., 2005). 
More severely, combined ablation of both NF-κB1 and NF-κB2 or of c-Rel and 
p65 diminishes the mature peripheral B cell compartment (Franzoso, et al., 
1997: ; Grossmann, et al., 1999: ; Grossmann, et al., 2000). This coincides 
with decreased expression of A1 and Bcl-2 in B cells while exogenously 
expressed Bcl-2 largely restores peripheral B cell maturation and survival in c-
Rel/p65 double mutant mice (Claudio, et al., 2002: ; Grossmann, et al., 2000). 
As mentioned previously, two modes of NF-κB activation exist which are 
activated by different signals. BCR-engagement triggers the canonical 
pathway of NF-κB activation dependent on PKCβ, the adaptor complex 
CARMA1/BCL-10/MALT1 as well as IKKβ and γ which results in the formation 
of transcriptionally active p50/p65 heterodimers. On the other hand, 
alternative NF-κB activation for example in response to BAFF, involves NIK 
and IKKα and leads to the generation of p52/RelB heterodimers (Siebenlist, et 
al., 2005). Disruptions of either the canonical or the alternative pathway of NF-
κB-activation affect the B cell compartment. Thus, inactivation mutations of 
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either CARMA1/BCL-10/MALT1, IKKβ and IKKγ or NIK and IKKα reduce the 
frequency of mature peripheral B cells (Thome, 2004). Overall, there is ample 
evidence for a tight correlation between NF-κB activity and B cell survival. 
Anti-apoptotic NF-κB target genes include Bcl-2, Bcl-xL and A1 (Dutta, et al., 
2006), suggesting that NF-κB-dependent activation of Bcl-2 family gene 
expression could constitute an outcome of the tonic BCR signal which 
mediates B cell survival.  
The discovery of BAFF as a second essential factor for mature resting B cell 
survival has expanded the possible mechanisms by which the tonic BCR 
signal could mediate B cell viability. It is an attractive hypothesis that at least 
part of the tonic BCR signal is somehow involved in the regulation of BAFF-
mediated survival signaling. In its simplest form, tonic BCR-signaling could 
affect the expression of BAFF receptors, thus sensitizing B cells to the BAFF-
mediated survival function. No such direct correlation has yet been reported. 
However, BAFF-R expression is affected by the small G-proteins Rac1/2 and 
the transcription factor c-Myb, both of which could themselves be targets of 
BCR-signaling (Thomas, et al., 2005: ; Walmsley, et al., 2003). It would also 
be very interesting to follow BAFF-R expression in B cells devoid of Syk or 
surface BCR prior to their complete demise, but such data have yet to be 
reported. Alternatively, it would be conceivable that tonic BCR-signaling 
impacts downstream factors such that they become susceptible to the BAFF-
mediated signal or that the two pathways operate synergistically. For 
example, both NF-κB and Akt are responsive to activating signals from both 
BAFF and the BCR. The proximal signaling events appear to be at least 
partially distinct based on the canonical versus alternative mechanism of NF-
κB activation and the differential requirement for PKCβ in Akt-activation. Yet, it 
is noteworthy, that both pathways appear to intersect at the level of the 
generic survival hallmarks NF-κB and Akt and it is conceivable that there 
might be a synergistic rather than mere additive effect to this mode of 
regulation. Similarly, PKCβ plays a role downstream of both BCR- and BAFF-
mediated signaling in the activation of NF-κB and Akt, respectively. One more 
interesting aspect which has not been investigated to date is the potential 




The persistence of a large pool of mature naive B cells with a broad B cell 
receptor (BCR) repertoire is the basis for an appropriate immunological 
response to antigenic challenge in mice and humans. The longevity of mature 
peripheral B cells in the order of several weeks or month in a resting state is 
dependent on at least two survival cues, a tonic signal originating from the 
BCR and the cytokine B cell activating factor of the TNF family (BAFF).  
The protein tyrosine kinase Syk has been implicated in signaling from the 
BCR during early B cell developmental stages and upon cross-linking of the 
BCR-complex by antigen. Using a mouse model in which Syk was inducibly 
ablated in the B cell lineage or in response to an exogenous trigger, an 
indispensable function for Syk in the survival of mature peripheral B cells was 
shown. The results of this study strongly suggest that Syk is a critical mediator 
of the tonic BCR survival signal. 
Investigation of the effect of BAFF on B cells had so far been restricted to its 
survival function. The present study has uncovered a novel role for BAFF in 
ensuring the functional efficiency of mature peripheral B cells. BAFF was 
found to influence B cell growth, metabolism, energy homeostasis and entry 
into the cell cycle. These cellular changes are mediated by at least two BAFF-
induced mechanisms: upregulation of the oncogenic kinase Pim-2 and 
activation of a signaling transduction pathway which centers around 
phosphoinositide-3-kinase (PI3K) and Akt. The latter controls the activity of 
key effector proteins, including transcription factors of the forkhead box O 
family and the master regulator of cellular metabolism mammalian target of 
rapamycin, whose activation state is sensitive to B cell stimulation with BAFF. 
Protein kinase C (PKC) β, a member of the classic family of PKCs, was found 
to mediate the activation of Akt in response to BAFF-treatment and PKCβ-
deficient mice show signs of partial refractiveness of the B cell compartment 
to BAFF. Misregulated BAFF-signaling has been implicated in a variety of B 
cell pathologies, ranging from lymphopenia to hyperplasia and auto-immunity 
in mice and humans. Involvement of the PI3K-Akt pathway in BAFF-mediated 
B cell signaling may propose novel ways of interfering with pathological BAFF 
signaling in disease states. 
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6 Zusammenfassung 
Eine große Anzahl reifer naiver B Lymphozyten mit einem ausgedehnten B 
Zellrezeptor Repertoire ist die Grundlage für eine angemessene 
Immunantwort im Falle einer Begegnung mit einem fremden Antigen in 
Mäusen und Menschen. Die Langlebigkeit reifer periphärer B Zellen in einer 
Größenordung von mehreren Wochen oder Monaten ist abhängig von 
mindestens zwei Überlebenssignalen, einem tonischen Signal, welches vom 
B Zellrezeptor ausgeht, und dem Zytokin B Zell aktivierender Faktor der TNF-
Familie (BAFF). 
Die Proteintyrosinkinase Syk steht im Zusammenhang mit Signaltransduktion 
vom B Zellrezeptor während früher Stadien der B Zellentwicklung sowie im 
Falle der B Zellrezeptorstimulation mit fremdem Antigen. Im Zuge dieser 
Arbeit wurde ein Mausmodell verwendet, in welchem Syk entweder spezifisch 
in der Familie der B Lymphozyten oder auf induzierbare Art und Weise durch 
einen äußeren Auslöser inaktiviert wurde. Die von dieser Untersuchung 
gewonnenen Ergebnisse lassen darauf schliessen, dass Syk unverzichtbar für 
die Vermittlung des tonischen B Zellrezeptorsignals ist, welches das 
Überleben reifer B Zellen ermöglicht.  
Die Untersuchung des Effekts von BAFF auf B Lymphozyten hatte sich bis 
dato auf dessen Überlebensfunktion beschränkt. Im Zuge der vorliegenden 
Arbeit wurde eine neue Rolle dieses Zytokins in der Erhaltung der 
Funktionstüchtigkeit von reifen periphären B Zellen entdeckt. BAFF hat 
Einfluss auf das Wachstum, den Metabolismus, den Energiehaushalt und die 
Regulierung des Zellzyklus in B Zellen. Diese physiologischen 
Veränderungen werden von mindestens zwei BAFF-induzierten Mechanismen 
vermittelt: einer erhöhten Expression der onkogenen Kinase Pim-2 zum 
einen, sowie der Aktivierung eines Signaltranduktionsweges, welcher sich um 
Phosphatidylinositol-3-Kinase (PI3K) und Akt dreht, zum anderen. Letzterer 
kontrolliert entscheidende Effektorproteine, einschliesslich 
Transkriptionsfaktoren der forkhead box O (FoxO) Familie sowie dem 
Hauptregulator des zellulären Metabolismus, mammalian target of rapamycin, 
deren Aktivierungszustand auf B Zellstimulation mit BAFF reagiert. Protein 
Kinase C β, ein Mitglied der klassischen Familie von PKCs, vermittelt die 
Aktivierung von Akt in Folge der B Zellstimulation mit BAFF und B Zellen aus 
PKCβ-defizienten Mäusen zeigen Anzeichen von Unsensitivität gegenüber 
BAFF-Stimulation. Misregulierte BAFF-abhängige Signaltransduktion ist mit 
verschiedenen B Zellpathologien in Mäusen und Menschen in Verbindung 
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gebracht worden, die sowohl Lymphopenie als auch Hyperplasie und 
Autoimmunität umfassen. Die Mitwirkung des PI3K-Akt 
Signaltransduktionsweges an den physiologischen Auswirkungen von BAFF 
auf B Lymphozyten, kann möglicherweise neue Wege eröffnen, durch die 
gezielt in pathologische BAFF-Effekte eingegriffen werden kann.  
 
 118 
7  References 
 
Abtahian, F.; Guerriero, A.; Sebzda, E.; Lu, M. M.; Zhou, R.; Mocsai, A.; Myers, E. 
E.; Huang, B.; Jackson, D. G.; Ferrari, V. A.; Tybulewicz, V.; Lowell, C. A.; 
Lepore, J. J.; Koretzky, G. A. and Kahn, M. L. (2003): Regulation of blood 
and lymphatic vascular separation by signaling proteins SLP-76 and Syk, 
Science 299 [5604], pp. 247-51. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12522250  
Ajiro, K. (2000): Histone H2B phosphorylation in mammalian apoptotic cells. An 
association with DNA fragmentation, J Biol Chem 275 [1], pp. 439-43. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=10617636  
Alessi, D. R.; Andjelkovic, M.; Caudwell, B.; Cron, P.; Morrice, N.; Cohen, P. and 
Hemmings, B. A. (1996): Mechanism of activation of protein kinase B by 
insulin and IGF-1, Embo J 15 [23], pp. 6541-51. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=8978681  
Amanna, I. J.; Dingwall, J. P. and Hayes, C. E. (2003): Enforced bcl-xL gene 
expression restored splenic B lymphocyte development in BAFF-R mutant 
mice, J Immunol 170 [9], pp. 4593-600. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12707337  
Andjelkovic, M.; Maira, S. M.; Cron, P.; Parker, P. J. and Hemmings, B. A. (1999): 
Domain swapping used to investigate the mechanism of protein kinase B 
regulation by 3-phosphoinositide-dependent protein kinase 1 and Ser473 
kinase, Mol Cell Biol 19 [7], pp. 5061-72. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=10373555  
Ashburner, M.; Ball, C. A.; Blake, J. A.; Botstein, D.; Butler, H.; Cherry, J. M.; 
Davis, A. P.; Dolinski, K.; Dwight, S. S.; Eppig, J. T.; Harris, M. A.; Hill, D. 
P.; Issel-Tarver, L.; Kasarskis, A.; Lewis, S.; Matese, J. C.; Richardson, J. E.; 
Ringwald, M.; Rubin, G. M. and Sherlock, G. (2000): Gene ontology: tool for 
the unification of biology. The Gene Ontology Consortium, Nat Genet 25 [1], 
pp. 25-9. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=10802651  
Avery, D. T.; Kalled, S. L.; Ellyard, J. I.; Ambrose, C.; Bixler, S. A.; Thien, M.; 
Brink, R.; Mackay, F.; Hodgkin, P. D. and Tangye, S. G. (2003): BAFF 
selectively enhances the survival of plasmablasts generated from human 
memory B cells, J Clin Invest 112 [2], pp. 286-97. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12865416  
Balendran, A.; Casamayor, A.; Deak, M.; Paterson, A.; Gaffney, P.; Currie, R.; 
Downes, C. P. and Alessi, D. R. (1999): PDK1 acquires PDK2 activity in the 
presence of a synthetic peptide derived from the carboxyl terminus of PRK2, 




Banfic, H.; Downes, C. P. and Rittenhouse, S. E. (1998): Biphasic activation of 
PKBalpha/Akt in platelets. Evidence for stimulation both by 
phosphatidylinositol 3,4-bisphosphate, produced via a novel pathway, and by 




Bannish, G.; Fuentes-Panana, E. M.; Cambier, J. C.; Pear, W. S. and Monroe, J. G. 
(2001): Ligand-independent signaling functions for the B lymphocyte antigen 
receptor and their role in positive selection during B lymphopoiesis, J Exp 
Med 194 [11], pp. 1583-96. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11733573  
Barata, J. T.; Silva, A.; Brandao, J. G.; Nadler, L. M.; Cardoso, A. A. and Boussiotis, 
V. A. (2004): Activation of PI3K is indispensable for interleukin 7-mediated 
viability, proliferation, glucose use, and growth of T cell acute lymphoblastic 
leukemia cells, J Exp Med 200 [5], pp. 659-69. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15353558  
Batten, M.; Groom, J.; Cachero, T. G.; Qian, F.; Schneider, P.; Tschopp, J.; 
Browning, J. L. and Mackay, F. (2000): BAFF mediates survival of peripheral 
immature B lymphocytes, J Exp Med 192 [10], pp. 1453-66. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11085747  
Bellacosa, A.; Testa, J. R.; Staal, S. P. and Tsichlis, P. N. (1991): A retroviral 
oncogene, akt, encoding a serine-threonine kinase containing an SH2-like 
region, Science 254 [5029], pp. 274-7. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=1833819  
Belting, M. (2003): Heparan sulfate proteoglycan as a plasma membrane carrier, 
Trends Biochem Sci 28 [3], pp. 145-51. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12633994  
Bennett, R. P.; Dalby, B. and Guy, P. M. (2002): Protein delivery using VP22, Nat 
Biotechnol 20 [1], p. 20. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11753353  
Bertrand, L.; Alessi, D. R.; Deprez, J.; Deak, M.; Viaene, E.; Rider, M. H. and Hue, 
L. (1999): Heart 6-phosphofructo-2-kinase activation by insulin results from 
Ser-466 and Ser-483 phosphorylation and requires 3-phosphoinositide-








Birle, D.; Bottini, N.; Williams, S.; Huynh, H.; deBelle, I.; Adamson, E. and Mustelin, 
 120 
T. (2002): Negative feedback regulation of the tumor suppressor PTEN by 




Bischof, D.; Elsawa, S. F.; Mantchev, G.; Yoon, J.; Michels, G. E.; Nilson, A.; Sutor, 
S. L.; Platt, J. L.; Ansell, S. M.; von Bulow, G. and Bram, R. J. (2006): 




Bishop, A. C.; Ubersax, J. A.; Petsch, D. T.; Matheos, D. P.; Gray, N. S.; Blethrow, 
J.; Shimizu, E.; Tsien, J. Z.; Schultz, P. G.; Rose, M. D.; Wood, J. L.; Morgan, 
D. O. and Shokat, K. M. (2000): A chemical switch for inhibitor-sensitive 
alleles of any protein kinase, Nature 407 [6802], pp. 395-401. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11014197  
Blair, J. A.; Rauh, D.; Kung, C.; Yun, C. H.; Fan, Q. W.; Rode, H.; Zhang, C.; Eck, 
M. J.; Weiss, W. A. and Shokat, K. M. (2007): Structure-guided development 
of affinity probes for tyrosine kinases using chemical genetics, Nat Chem Biol 
3 [4], pp. 229-38. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=17334377  
Bodmer, J. L.; Schneider, P. and Tschopp, J. (2002): The molecular architecture of the 
TNF superfamily, Trends Biochem Sci 27 [1], pp. 19-26. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11796220  
Bonizzi, G. and Karin, M. (2004): The two NF-kappaB activation pathways and their 




Bossen, C. and Schneider, P. (2006): BAFF, APRIL and their receptors: structure, 
function and signaling, Semin Immunol 18 [5], pp. 263-75. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=16914324  
Bouillet, P.; Metcalf, D.; Huang, D. C.; Tarlinton, D. M.; Kay, T. W.; Kontgen, F.; 
Adams, J. M. and Strasser, A. (1999): Proapoptotic Bcl-2 relative Bim 
required for certain apoptotic responses, leukocyte homeostasis, and to 
preclude autoimmunity, Science 286 [5445], pp. 1735-8. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=10576740  
Brognard, J.; Sierecki, E.; Gao, T. and Newton, A. C. (2007): PHLPP and a second 
isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by 
regulating distinct Akt isoforms, Mol Cell 25 [6], pp. 917-31. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=17386267  
Brumbaugh, K. M.; Binstadt, B. A.; Billadeau, D. D.; Schoon, R. A.; Dick, C. J.; Ten, 
R. M. and Leibson, P. J. (1997): Functional role for Syk tyrosine kinase in 





Brunet, A.; Bonni, A.; Zigmond, M. J.; Lin, M. Z.; Juo, P.; Hu, L. S.; Anderson, M. 
J.; Arden, K. C.; Blenis, J. and Greenberg, M. E. (1999): Akt promotes cell 
survival by phosphorylating and inhibiting a Forkhead transcription factor, 
Cell 96 [6], pp. 857-68. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=10102273  
Buerstedde, J. M. and Takeda, S. (1991): Increased ratio of targeted to random 




Bulina, M. E.; Chudakov, D. M.; Britanova, O. V.; Yanushevich, Y. G.; Staroverov, 
D. B.; Chepurnykh, T. V.; Merzlyak, E. M.; Shkrob, M. A.; Lukyanov, S. and 
Lukyanov, K. A. (2006): A genetically encoded photosensitizer, Nat 
Biotechnol 24 [1], pp. 95-9. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=16369538  
Burgering, B. M. and Kops, G. J. (2002): Cell cycle and death control: long live 
Forkheads, Trends Biochem Sci 27 [7], pp. 352-60. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12114024  
Cachero, T. G.; Schwartz, I. M.; Qian, F.; Day, E. S.; Bossen, C.; Ingold, K.; 
Tardivel, A.; Krushinskie, D.; Eldredge, J.; Silvian, L.; Lugovskoy, A.; 
Farrington, G. K.; Strauch, K.; Schneider, P. and Whitty, A. (2006): Formation 
of virus-like clusters is an intrinsic property of the tumor necrosis factor 




Carrington, J. C. and Dougherty, W. G. (1988): A viral cleavage site cassette: 
identification of amino acid sequences required for tobacco etch virus 
polyprotein processing, Proc Natl Acad Sci U S A 85 [10], pp. 3391-5. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=3285343  
Castigli, E.; Scott, S.; Dedeoglu, F.; Bryce, P.; Jabara, H.; Bhan, A. K.; Mizoguchi, E. 
and Geha, R. S. (2004): Impaired IgA class switching in APRIL-deficient 
mice, Proc Natl Acad Sci U S A 101 [11], pp. 3903-8. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=14988498  
Castigli, E.; Wilson, S. A.; Garibyan, L.; Rachid, R.; Bonilla, F.; Schneider, L. and 
Geha, R. S. (2005): TACI is mutant in common variable immunodeficiency 
and IgA deficiency, Nat Genet 37 [8], pp. 829-34. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=16007086  
Castigli, E.; Wilson, S. A.; Scott, S.; Dedeoglu, F.; Xu, S.; Lam, K. P.; Bram, R. J.; 
Jabara, H. and Geha, R. S. (2005): TACI and BAFF-R mediate isotype 




Chan, A. C.; van Oers, N. S.; Tran, A.; Turka, L.; Law, C. L.; Ryan, J. C.; Clark, E. 
A. and Weiss, A. (1994): Differential expression of ZAP-70 and Syk protein 
tyrosine kinases, and the role of this family of protein tyrosine kinases in TCR 
signaling, J Immunol 152 [10], pp. 4758-66. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=8176201  
Chao, D. T. and Korsmeyer, S. J. (1998): BCL-2 family: regulators of cell death, 
Annu Rev Immunol 16, pp. 395-419. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=9597135  
Chen, M. L.; Xu, P. Z.; Peng, X. D.; Chen, W. S.; Guzman, G.; Yang, X.; Di 
Cristofano, A.; Pandolfi, P. P. and Hay, N. (2006): The deficiency of Akt1 is 
sufficient to suppress tumor development in Pten+/- mice, Genes Dev 20 [12], 
pp. 1569-74. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=16778075  
Chen, W. S.; Xu, P. Z.; Gottlob, K.; Chen, M. L.; Sokol, K.; Shiyanova, T.; Roninson, 
I.; Weng, W.; Suzuki, R.; Tobe, K.; Kadowaki, T. and Hay, N. (2001): Growth 
retardation and increased apoptosis in mice with homozygous disruption of the 
Akt1 gene, Genes Dev 15 [17], pp. 2203-8. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11544177  
Cheng, A. M.; Rowley, B.; Pao, W.; Hayday, A.; Bolen, J. B. and Pawson, T. (1995): 
Syk tyrosine kinase required for mouse viability and B-cell development, 
Nature 378 [6554], pp. 303-6. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=7477353  
Cheung, W. L.; Ajiro, K.; Samejima, K.; Kloc, M.; Cheung, P.; Mizzen, C. A.; 
Beeser, A.; Etkin, L. D.; Chernoff, J.; Earnshaw, W. C. and Allis, C. D. 
(2003): Apoptotic phosphorylation of histone H2B is mediated by mammalian 
sterile twenty kinase, Cell 113 [4], pp. 507-17. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12757711  
Cho, H.; Thorvaldsen, J. L.; Chu, Q.; Feng, F. and Birnbaum, M. J. (2001): 
Akt1/PKBalpha is required for normal growth but dispensable for 




Choi, J. M.; Ahn, M. H.; Chae, W. J.; Jung, Y. G.; Park, J. C.; Song, H. M.; Kim, Y. 
E.; Shin, J. A.; Park, C. S.; Park, J. W.; Park, T. K.; Lee, J. H.; Seo, B. F.; 
Kim, K. D.; Kim, E. S.; Lee, D. H.; Lee, S. K. and Lee, S. K. (2006): 
Intranasal delivery of the cytoplasmic domain of CTLA-4 using a novel 
protein transduction domain prevents allergic inflammation, Nat Med 12 [5], 
pp. 574-9. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=16604087  
Chu, D. H.; van Oers, N. S.; Malissen, M.; Harris, J.; Elder, M. and Weiss, A. (1999): 
 123 
Pre-T cell receptor signals are responsible for the down-regulation of Syk 
protein tyrosine kinase expression, J Immunol 163 [5], pp. 2610-20. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=10453000  
Claudio, E.; Brown, K.; Park, S.; Wang, H. and Siebenlist, U. (2002): BAFF-induced 
NEMO-independent processing of NF-kappa B2 in maturing B cells, Nat 
Immunol 3 [10], pp. 958-65. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12352969  
Clayton, E.; Bardi, G.; Bell, S. E.; Chantry, D.; Downes, C. P.; Gray, A.; Humphries, 
L. A.; Rawlings, D.; Reynolds, H.; Vigorito, E. and Turner, M. (2002): A 
crucial role for the p110delta subunit of phosphatidylinositol 3-kinase in B cell 
development and activation, J Exp Med 196 [6], pp. 753-63. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12235209  
Colucci, F.; Turner, M.; Schweighoffer, E.; Guy-Grand, D.; Di Bartolo, V.; Salcedo, 
M.; Tybulewicz, V. L. and Di Santo, J. P. (1999): Redundant role of the Syk 
protein tyrosine kinase in mouse NK cell differentiation, J Immunol 163 [4], 
pp. 1769-74. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=10438908  
Condliffe, A. M.; Davidson, K.; Anderson, K. E.; Ellson, C. D.; Crabbe, T.; 
Okkenhaug, K.; Vanhaesebroeck, B.; Turner, M.; Webb, L.; Wymann, M. P.; 
Hirsch, E.; Ruckle, T.; Camps, M.; Rommel, C.; Jackson, S. P.; Chilvers, E. 
R.; Stephens, L. R. and Hawkins, P. T. (2005): Sequential activation of class 
IB and class IA PI3K is important for the primed respiratory burst of human 
but not murine neutrophils, Blood 106 [4], pp. 1432-40. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15878979  
Cordingley, M. G.; Callahan, P. L.; Sardana, V. V.; Garsky, V. M. and Colonno, R. J. 
(1990): Substrate requirements of human rhinovirus 3C protease for peptide 
cleavage in vitro, J Biol Chem 265 [16], pp. 9062-5. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=2160953  
Cornall, R. J.; Cheng, A. M.; Pawson, T. and Goodnow, C. C. (2000): Role of Syk in 
B-cell development and antigen-receptor signaling, Proc Natl Acad Sci U S A 
97 [4], pp. 1713-8. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=10677523  
Costello, P. S.; Turner, M.; Walters, A. E.; Cunningham, C. N.; Bauer, P. H.; 
Downward, J. and Tybulewicz, V. L. (1996): Critical role for the tyrosine 
kinase Syk in signalling through the high affinity IgE receptor of mast cells, 
Oncogene 13 [12], pp. 2595-605. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=9000133  
Couture, C.; Williams, S.; Gauthier, N.; Tailor, P. and Mustelin, T. (1997): Role of 
Tyr518 and Tyr519 in the regulation of catalytic activity and substrate 





Craxton, A.; Draves, K. E.; Gruppi, A. and Clark, E. A. (2005): BAFF regulates B 
cell survival by downregulating the BH3-only family member Bim via the 
ERK pathway, J Exp Med 202 [10], pp. 1363-74. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=16301744  
Craxton, A.; Jiang, A.; Kurosaki, T. and Clark, E. A. (1999): Syk and Bruton's 
tyrosine kinase are required for B cell antigen receptor-mediated activation of 
the kinase Akt, J Biol Chem 274 [43], pp. 30644-50. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=10521450  
Craxton, A.; Magaletti, D.; Ryan, E. J. and Clark, E. A. (2003): Macrophage- and 
dendritic cell--dependent regulation of human B-cell proliferation requires the 
TNF family ligand BAFF, Blood 101 [11], pp. 4464-71. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12531790  
Cross, D. A.; Alessi, D. R.; Cohen, P.; Andjelkovich, M. and Hemmings, B. A. 
(1995): Inhibition of glycogen synthase kinase-3 by insulin mediated by 
protein kinase B, Nature 378 [6559], pp. 785-9. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=8524413  
Crowley, M. T.; Costello, P. S.; Fitzer-Attas, C. J.; Turner, M.; Meng, F.; Lowell, C.; 
Tybulewicz, V. L. and DeFranco, A. L. (1997): A critical role for Syk in 
signal transduction and phagocytosis mediated by Fcgamma receptors on 
macrophages, J Exp Med 186 [7], pp. 1027-39. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=9314552  
Cyster, J. G. and Goodnow, C. C. (1995): Protein tyrosine phosphatase 1C negatively 
regulates antigen receptor signaling in B lymphocytes and determines 
thresholds for negative selection, Immunity 2 [1], pp. 13-24. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=7600299  
Datta, S. R.; Dudek, H.; Tao, X.; Masters, S.; Fu, H.; Gotoh, Y. and Greenberg, M. E. 
(1997): Akt phosphorylation of BAD couples survival signals to the cell-
intrinsic death machinery, Cell 91 [2], pp. 231-41. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=9346240  
Deckert, M.; Tartare-Deckert, S.; Couture, C.; Mustelin, T. and Altman, A. (1996): 
Functional and physical interactions of Syk family kinases with the Vav proto-
oncogene product, Immunity 5 [6], pp. 591-604. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=8986718  
Deckwerth, T. L. and Johnson, E. M., Jr. (1993): Temporal analysis of events 
associated with programmed cell death (apoptosis) of sympathetic neurons 
deprived of nerve growth factor, J Cell Biol 123 [5], pp. 1207-22. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=7503996  
del Peso, L.; Gonzalez-Garcia, M.; Page, C.; Herrera, R. and Nunez, G. (1997): 
Interleukin-3-induced phosphorylation of BAD through the protein kinase 




Deprez, J.; Vertommen, D.; Alessi, D. R.; Hue, L. and Rider, M. H. (1997): 
Phosphorylation and activation of heart 6-phosphofructo-2-kinase by protein 
kinase B and other protein kinases of the insulin signaling cascades, J Biol 
Chem 272 [28], pp. 17269-75. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=9211863  
Deregibus, M. C.; Cantaluppi, V.; Doublier, S.; Brizzi, M. F.; Deambrosis, I.; Albini, 
A. and Camussi, G. (2002): HIV-1-Tat protein activates phosphatidylinositol 
3-kinase/ AKT-dependent survival pathways in Kaposi's sarcoma cells, J Biol 
Chem 277 [28], pp. 25195-202. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11994280  
Derossi, D.; Calvet, S.; Trembleau, A.; Brunissen, A.; Chassaing, G. and Prochiantz, 
A. (1996): Cell internalization of the third helix of the Antennapedia 




Derossi, D.; Chassaing, G. and Prochiantz, A. (1998): Trojan peptides: the penetratin 
system for intracellular delivery, Trends Cell Biol 8 [2], pp. 84-7. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=9695814  
Di Cristofano, A.; Kotsi, P.; Peng, Y. F.; Cordon-Cardo, C.; Elkon, K. B. and 
Pandolfi, P. P. (1999): Impaired Fas response and autoimmunity in Pten+/- 
mice, Science 285 [5436], pp. 2122-5. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=10497129  
Di Cristofano, A.; Pesce, B.; Cordon-Cardo, C. and Pandolfi, P. P. (1998): Pten is 
essential for embryonic development and tumour suppression, Nat Genet 19 
[4], pp. 348-55. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=9697695  
Diehl, J. A.; Cheng, M.; Roussel, M. F. and Sherr, C. J. (1998): Glycogen synthase 
kinase-3beta regulates cyclin D1 proteolysis and subcellular localization, 
Genes Dev 12 [22], pp. 3499-511. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=9832503  
Dillon, S. R.; Gross, J. A.; Ansell, S. M. and Novak, A. J. (2006): An APRIL to 
remember: novel TNF ligands as therapeutic targets, Nat Rev Drug Discov 5 
[3], pp. 235-46. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=16474316  
Do, R. K.; Hatada, E.; Lee, H.; Tourigny, M. R.; Hilbert, D. and Chen-Kiang, S. 
(2000): Attenuation of apoptosis underlies B lymphocyte stimulator 





Dobenecker, M. W.; Schmedt, C.; Okada, M. and Tarakhovsky, A. (2005): The 
ubiquitously expressed Csk adaptor protein Cbp is dispensable for 
embryogenesis and T-cell development and function, Mol Cell Biol 25 [23], 
pp. 10533-42. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=16287865  
Dougherty, W. G.; Cary, S. M. and Parks, T. D. (1989): Molecular genetic analysis of 




Dutta, J.; Fan, Y.; Gupta, N.; Fan, G. and Gelinas, C. (2006): Current insights into the 




Easton, R. M.; Cho, H.; Roovers, K.; Shineman, D. W.; Mizrahi, M.; Forman, M. S.; 
Lee, V. M.; Szabolcs, M.; de Jong, R.; Oltersdorf, T.; Ludwig, T.; Efstratiadis, 
A. and Birnbaum, M. J. (2005): Role for Akt3/protein kinase Bgamma in 
attainment of normal brain size, Mol Cell Biol 25 [5], pp. 1869-78. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15713641  
Edinger, A. L. and Thompson, C. B. (2002): Akt maintains cell size and survival by 




Ehrhardt, C.; Marjuki, H.; Wolff, T.; Nurnberg, B.; Planz, O.; Pleschka, S. and 
Ludwig, S. (2006): Bivalent role of the phosphatidylinositol-3-kinase (PI3K) 
during influenza virus infection and host cell defence, Cell Microbiol 8 [8], 
pp. 1336-48. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=16882036  
Ehrmann, M.; Bolek, P.; Mondigler, M.; Boyd, D. and Lange, R. (1997): TnTIN and 
TnTAP: mini-transposons for site-specific proteolysis in vivo, Proc Natl Acad 
Sci U S A 94 [24], pp. 13111-5. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=9371808  
Elliott, G. and O'Hare, P. (1997): Intercellular trafficking and protein delivery by a 
herpesvirus structural protein, Cell 88 [2], pp. 223-33. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=9008163  
Embi, N.; Rylatt, D. B. and Cohen, P. (1980): Glycogen synthase kinase-3 from rabbit 
skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and 
phosphorylase kinase, Eur J Biochem 107 [2], pp. 519-27. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=6249596  
Enders, A.; Bouillet, P.; Puthalakath, H.; Xu, Y.; Tarlinton, D. M. and Strasser, A. 
(2003): Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim inhibits 
BCR stimulation-induced apoptosis and deletion of autoreactive B cells, J Exp 
 127 
Med 198 [7], pp. 1119-26. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=14517273  
Ezhevsky, S. A.; Nagahara, H.; Vocero-Akbani, A. M.; Gius, D. R.; Wei, M. C. and 
Dowdy, S. F. (1997): Hypo-phosphorylation of the retinoblastoma protein 
(pRb) by cyclin D:Cdk4/6 complexes results in active pRb, Proc Natl Acad 
Sci U S A 94 [20], pp. 10699-704. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=9380698  
Fawell, S.; Seery, J.; Daikh, Y.; Moore, C.; Chen, L. L.; Pepinsky, B. and Barsoum, J. 
(1994): Tat-mediated delivery of heterologous proteins into cells, Proc Natl 
Acad Sci U S A 91 [2], pp. 664-8. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=8290579  
Fayard, E.; Tintignac, L. A.; Baudry, A. and Hemmings, B. A. (2005): Protein kinase 
B/Akt at a glance, J Cell Sci 118 [Pt 24], pp. 5675-8. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=16339964  
Feng, J.; Park, J.; Cron, P.; Hess, D. and Hemmings, B. A. (2004): Identification of a 
PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein 
kinase, J Biol Chem 279 [39], pp. 41189-96. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15262962  
Fiser, A. and Sali, A. (2003): Modeller: generation and refinement of homology-based 
protein structure models, Methods Enzymol 374, pp. 461-91. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=14696385  
Flaherty, D. M.; Hinde, S. L.; Monick, M. M.; Powers, L. S.; Bradford, M. A.; 
Yarovinsky, T. and Hunninghake, G. W. (2004): Adenovirus vectors activate 
survival pathways in lung epithelial cells, Am J Physiol Lung Cell Mol 
Physiol 287 [2], pp. L393-401. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15107295  
Forster, I. and Rajewsky, K. (1990): The bulk of the peripheral B-cell pool in mice is 
stable and not rapidly renewed from the bone marrow, Proc Natl Acad Sci U S 
A 87 [12], pp. 4781-4. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=2352948  
Fox, C. J.; Hammerman, P. S.; Cinalli, R. M.; Master, S. R.; Chodosh, L. A. and 
Thompson, C. B. (2003): The serine/threonine kinase Pim-2 is a 




Frankel, A. D. and Pabo, C. O. (1988): Cellular uptake of the tat protein from human 
immunodeficiency virus, Cell 55 [6], pp. 1189-93. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=2849510  
Franzoso, G.; Carlson, L.; Xing, L.; Poljak, L.; Shores, E. W.; Brown, K. D.; 
Leonardi, A.; Tran, T.; Boyce, B. F. and Siebenlist, U. (1997): Requirement 
 128 




Fruman, D. A. (2004): Towards an understanding of isoform specificity in 
phosphoinositide 3-kinase signalling in lymphocytes, Biochem Soc Trans 32 
[Pt 2], pp. 315-9. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15046598  
Fruman, D. A.; Snapper, S. B.; Yballe, C. M.; Davidson, L.; Yu, J. Y.; Alt, F. W. and 
Cantley, L. C. (1999): Impaired B cell development and proliferation in 




Fuentes-Panana, E. M.; Bannish, G.; van der Voort, D.; King, L. B. and Monroe, J. G. 
(2005): Ig alpha/Ig beta complexes generate signals for B cell development 
independent of selective plasma membrane compartmentalization, J Immunol 
174 [3], pp. 1245-52. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15661879  
Fukuda, M.; Gotoh, I.; Gotoh, Y. and Nishida, E. (1996): Cytoplasmic localization of 
mitogen-activated protein kinase kinase directed by its NH2-terminal, leucine-
rich short amino acid sequence, which acts as a nuclear export signal, J Biol 
Chem 271 [33], pp. 20024-8. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=8702720  
Furlong, M. T.; Mahrenholz, A. M.; Kim, K. H.; Ashendel, C. L.; Harrison, M. L. and 
Geahlen, R. L. (1997): Identification of the major sites of autophosphorylation 
of the murine protein-tyrosine kinase Syk, Biochim Biophys Acta 1355 [2], 
pp. 177-90. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=9042338  
Futaki, S.; Suzuki, T.; Ohashi, W.; Yagami, T.; Tanaka, S.; Ueda, K. and Sugiura, Y. 
(2001): Arginine-rich peptides. An abundant source of membrane-permeable 
peptides having potential as carriers for intracellular protein delivery, J Biol 
Chem 276 [8], pp. 5836-40. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11084031  
Gao, J.; Zoller, K. E.; Ginsberg, M. H.; Brugge, J. S. and Shattil, S. J. (1997): 
Regulation of the pp72syk protein tyrosine kinase by platelet integrin alpha IIb 
beta 3, Embo J 16 [21], pp. 6414-25. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=9351824  
Gao, T.; Furnari, F. and Newton, A. C. (2005): PHLPP: a phosphatase that directly 
dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth, Mol 
Cell 18 [1], pp. 13-24. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15808505  
Garofalo, R. S.; Orena, S. J.; Rafidi, K.; Torchia, A. J.; Stock, J. L.; Hildebrandt, A. 
 129 
L.; Coskran, T.; Black, S. C.; Brees, D. J.; Wicks, J. R.; McNeish, J. D. and 
Coleman, K. G. (2003): Severe diabetes, age-dependent loss of adipose tissue, 
and mild growth deficiency in mice lacking Akt2/PKB beta, J Clin Invest 112 
[2], pp. 197-208. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12843127  
Gavin, A. L.; Ait-Azzouzene, D.; Ware, C. F. and Nemazee, D. (2003): DeltaBAFF, 
an alternate splice isoform that regulates receptor binding and biopresentation 




Gavin, A. L.; Duong, B.; Skog, P.; Ait-Azzouzene, D.; Greaves, D. R.; Scott, M. L. 
and Nemazee, D. (2005): deltaBAFF, a splice isoform of BAFF, opposes full-
length BAFF activity in vivo in transgenic mouse models, J Immunol 175 [1], 
pp. 319-28. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15972664  
Gerdes, J. (1990): Ki-67 and other proliferation markers useful for 
immunohistological diagnostic and prognostic evaluations in human 
malignancies, Semin Cancer Biol 1 [3], pp. 199-206. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=2103495  
Gong, Q.; White, L.; Johnson, R.; White, M.; Negishi, I.; Thomas, M. and Chan, A. 
C. (1997): Restoration of thymocyte development and function in zap-70-/- 
mice by the Syk protein tyrosine kinase, Immunity 7 [3], pp. 369-77. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=9324357  
Gorelik, L.; Cutler, A. H.; Thill, G.; Miklasz, S. D.; Shea, D. E.; Ambrose, C.; Bixler, 
S. A.; Su, L.; Scott, M. L. and Kalled, S. L. (2004): Cutting edge: BAFF 
regulates CD21/35 and CD23 expression independent of its B cell survival 
function, J Immunol 172 [2], pp. 762-6. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=14707045  
Gorelik, L.; Gilbride, K.; Dobles, M.; Kalled, S. L.; Zandman, D. and Scott, M. L. 
(2003): Normal B cell homeostasis requires B cell activation factor production 
by radiation-resistant cells, J Exp Med 198 [6], pp. 937-45. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12975458  
Gottlob, K.; Majewski, N.; Kennedy, S.; Kandel, E.; Robey, R. B. and Hay, N. 
(2001): Inhibition of early apoptotic events by Akt/PKB is dependent on the 
first committed step of glycolysis and mitochondrial hexokinase, Genes Dev 
15 [11], pp. 1406-18. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11390360  
Green, M. and Loewenstein, P. M. (1988): Autonomous functional domains of 
chemically synthesized human immunodeficiency virus tat trans-activator 




Grillot, D. A.; Merino, R.; Pena, J. C.; Fanslow, W. C.; Finkelman, F. D.; Thompson, 
C. B. and Nunez, G. (1996): bcl-x exhibits regulated expression during B cell 
development and activation and modulates lymphocyte survival in transgenic 
mice, J Exp Med 183 [2], pp. 381-91. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=8627151  
Gritti, C.; Dastot, H.; Soulier, J.; Janin, A.; Daniel, M. T.; Madani, A.; Grimber, G.; 
Briand, P.; Sigaux, F. and Stern, M. H. (1998): Transgenic mice for MTCP1 
develop T-cell prolymphocytic leukemia, Blood 92 [2], pp. 368-73. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=9657733  
Groom, J.; Kalled, S. L.; Cutler, A. H.; Olson, C.; Woodcock, S. A.; Schneider, P.; 
Tschopp, J.; Cachero, T. G.; Batten, M.; Wheway, J.; Mauri, D.; Cavill, D.; 
Gordon, T. P.; Mackay, C. R. and Mackay, F. (2002): Association of 
BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's 
syndrome, J Clin Invest 109 [1], pp. 59-68. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11781351  
Gross, J. A.; Dillon, S. R.; Mudri, S.; Johnston, J.; Littau, A.; Roque, R.; Rixon, M.; 
Schou, O.; Foley, K. P.; Haugen, H.; McMillen, S.; Waggie, K.; Schreckhise, 
R. W.; Shoemaker, K.; Vu, T.; Moore, M.; Grossman, A. and Clegg, C. H. 
(2001): TACI-Ig neutralizes molecules critical for B cell development and 
autoimmune disease. impaired B cell maturation in mice lacking BLyS, 
Immunity 15 [2], pp. 289-302. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11520463  
Gross, J. A.; Johnston, J.; Mudri, S.; Enselman, R.; Dillon, S. R.; Madden, K.; Xu, 
W.; Parrish-Novak, J.; Foster, D.; Lofton-Day, C.; Moore, M.; Littau, A.; 
Grossman, A.; Haugen, H.; Foley, K.; Blumberg, H.; Harrison, K.; 
Kindsvogel, W. and Clegg, C. H. (2000): TACI and BCMA are receptors for a 
TNF homologue implicated in B-cell autoimmune disease, Nature 404 [6781], 
pp. 995-9. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=10801128  
Grossmann, M.; Metcalf, D.; Merryfull, J.; Beg, A.; Baltimore, D. and Gerondakis, S. 
(1999): The combined absence of the transcription factors Rel and RelA leads 




Grossmann, M.; O'Reilly, L. A.; Gugasyan, R.; Strasser, A.; Adams, J. M. and 
Gerondakis, S. (2000): The anti-apoptotic activities of Rel and RelA required 
during B-cell maturation involve the regulation of Bcl-2 expression, Embo J 
19 [23], pp. 6351-60. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11101508  
Guertin, D. A.; Stevens, D. M.; Thoreen, C. C.; Burds, A. A.; Kalaany, N. Y.; Moffat, 
J.; Brown, M.; Fitzgerald, K. J. and Sabatini, D. M. (2006): Ablation in mice 
of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is 
required for signaling to Akt-FOXO and PKCalpha, but not S6K1, Dev Cell 
 131 
11 [6], pp. 859-71. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=17141160  
Guillou, H.; Lecureuil, C.; Anderson, K. E.; Suire, S.; Ferguson, G. J.; Ellson, C. D.; 
Gray, A.; Divecha, N.; Hawkins, P. T. and Stephens, L. R. (2007): Use of the 
GRP1 PH domain as a tool to measure the relative levels of PtdIns(3,4,5)P3 
through a protein-lipid overlay approach, J Lipid Res 48 [3], pp. 726-32. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=17130283  
Guo, B.; Kato, R. M.; Garcia-Lloret, M.; Wahl, M. I. and Rawlings, D. J. (2000): 
Engagement of the human pre-B cell receptor generates a lipid raft-dependent 
calcium signaling complex, Immunity 13 [2], pp. 243-53. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=10981967  
Hammerman, P. S.; Fox, C. J.; Birnbaum, M. J. and Thompson, C. B. (2005): Pim and 
Akt oncogenes are independent regulators of hematopoietic cell growth and 
survival, Blood 105 [11], pp. 4477-83. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15705789  
Hammerman, P. S.; Fox, C. J. and Thompson, C. B. (2004): Beginnings of a signal-
transduction pathway for bioenergetic control of cell survival, Trends 
Biochem Sci 29 [11], pp. 586-92. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15501677  
Hardie, D. G. (2005): New roles for the LKB1-->AMPK pathway, Curr Opin Cell 
Biol 17 [2], pp. 167-73. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15780593  
Hardy, R. R. (2006): B-1 B cell development, J Immunol 177 [5], pp. 2749-54. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=16920907  
Hardy, R. R. and Hayakawa, K. (2001): B cell development pathways, Annu Rev 
Immunol 19, pp. 595-621. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11244048  
Hariton-Gazal, E.; Rosenbluh, J.; Graessmann, A.; Gilon, C. and Loyter, A. (2003): 
Direct translocation of histone molecules across cell membranes, J Cell Sci 
116 [Pt 22], pp. 4577-86. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=14576351  
Harless, S. M.; Lentz, V. M.; Sah, A. P.; Hsu, B. L.; Clise-Dwyer, K.; Hilbert, D. M.; 
Hayes, C. E. and Cancro, M. P. (2001): Competition for BLyS-mediated 
signaling through Bcmd/BR3 regulates peripheral B lymphocyte numbers, 
Curr Biol 11 [24], pp. 1986-9. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11747827  
Hatada, E. N.; Do, R. K.; Orlofsky, A.; Liou, H. C.; Prystowsky, M.; MacLennan, I. 
C.; Caamano, J. and Chen-Kiang, S. (2003): NF-kappa B1 p50 is required for 
BLyS attenuation of apoptosis but dispensable for processing of NF-kappa B2 




Healy, J. I. and Goodnow, C. C. (1998): Positive versus negative signaling by 
lymphocyte antigen receptors, Annu Rev Immunol 16, pp. 645-70. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=9597145  
Hennessy, B. T.; Smith, D. L.; Ram, P. T.; Lu, Y. and Mills, G. B. (2005): Exploiting 
the PI3K/AKT pathway for cancer drug discovery, Nat Rev Drug Discov 4 
[12], pp. 988-1004. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=16341064  
Horng, T.; Barton, G. M. and Medzhitov, R. (2001): TIRAP: an adapter molecule in 
the Toll signaling pathway, Nat Immunol 2 [9], pp. 835-41. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11526399  
Hoyer, K. K.; French, S. W.; Turner, D. E.; Nguyen, M. T.; Renard, M.; Malone, C. 
S.; Knoetig, S.; Qi, C. F.; Su, T. T.; Cheroutre, H.; Wall, R.; Rawlings, D. J.; 
Morse, H. C., 3rd and Teitell, M. A. (2002): Dysregulated TCL1 promotes 
multiple classes of mature B cell lymphoma, Proc Natl Acad Sci U S A 99 
[22], pp. 14392-7. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12381789  
Hsia, C. Y.; Cheng, S.; Owyang, A. M.; Dowdy, S. F. and Liou, H. C. (2002): c-Rel 
regulation of the cell cycle in primary mouse B lymphocytes, Int Immunol 14 
[8], pp. 905-16. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12147627  
Hsu, B. L.; Harless, S. M.; Lindsley, R. C.; Hilbert, D. M. and Cancro, M. P. (2002): 
Cutting edge: BLyS enables survival of transitional and mature B cells 
through distinct mediators, J Immunol 168 [12], pp. 5993-6. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12055205  
Huang, X.; Di Liberto, M.; Cunningham, A. F.; Kang, L.; Cheng, S.; Ely, S.; Liou, H. 
C.; Maclennan, I. C. and Chen-Kiang, S. (2004): Homeostatic cell-cycle 
control by BLyS: Induction of cell-cycle entry but not G1/S transition in 




Huse, M. and Kuriyan, J. (2002): The conformational plasticity of protein kinases, 
Cell 109 [3], pp. 275-82. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12015977  
Hutchcroft, J. E.; Harrison, M. L. and Geahlen, R. L. (1991): B lymphocyte activation 
is accompanied by phosphorylation of a 72-kDa protein-tyrosine kinase, J Biol 
Chem 266 [23], pp. 14846-9. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=1869521  
Ingold, K.; Zumsteg, A.; Tardivel, A.; Huard, B.; Steiner, Q. G.; Cachero, T. G.; 
Qiang, F.; Gorelik, L.; Kalled, S. L.; Acha-Orbea, H.; Rennert, P. D.; 
 133 
Tschopp, J. and Schneider, P. (2005): Identification of proteoglycans as the 
APRIL-specific binding partners, J Exp Med 201 [9], pp. 1375-83. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15851487  
Ittah, M.; Miceli-Richard, C.; Eric Gottenberg, J.; Lavie, F.; Lazure, T.; Ba, N.; 
Sellam, J.; Lepajolec, C. and Mariette, X. (2006): B cell-activating factor of 
the tumor necrosis factor family (BAFF) is expressed under stimulation by 
interferon in salivary gland epithelial cells in primary Sjogren's syndrome, 
Arthritis Res Ther 8 [2], p. R51. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=16507175  
Jacinto, E.; Facchinetti, V.; Liu, D.; Soto, N.; Wei, S.; Jung, S. Y.; Huang, Q.; Qin, J. 
and Su, B. (2006): SIN1/MIP1 maintains rictor-mTOR complex integrity and 




Jacinto, E.; Loewith, R.; Schmidt, A.; Lin, S.; Ruegg, M. A.; Hall, A. and Hall, M. N. 
(2004): Mammalian TOR complex 2 controls the actin cytoskeleton and is 
rapamycin insensitive, Nat Cell Biol 6 [11], pp. 1122-8. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15467718  
Janeway, C.A.; Travers, P.; Walport, M. and Shlomchik, M (2001): Immunobiology, 
5th. ed., Garland Publishing. 
Jay, D. G. (1988): Selective destruction of protein function by chromophore-assisted 
laser inactivation, Proc Natl Acad Sci U S A 85 [15], pp. 5454-8. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=3399501  
Jay, D. G. and Sakurai, T. (1999): Chromophore-assisted laser inactivation (CALI) to 
elucidate cellular mechanisms of cancer, Biochim Biophys Acta 1424 [2-3], 
pp. M39-48. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=10528153  
Jo, D.; Nashabi, A.; Doxsee, C.; Lin, Q.; Unutmaz, D.; Chen, J. and Ruley, H. E. 
(2001): Epigenetic regulation of gene structure and function with a cell-
permeable Cre recombinase, Nat Biotechnol 19 [10], pp. 929-33. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11581657  
Johnson, S. A.; Pleiman, C. M.; Pao, L.; Schneringer, J.; Hippen, K. and Cambier, J. 
C. (1995): Phosphorylated immunoreceptor signaling motifs (ITAMs) exhibit 
unique abilities to bind and activate Lyn and Syk tyrosine kinases, J Immunol 
155 [10], pp. 4596-603. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=7594458  
Jou, S. T.; Carpino, N.; Takahashi, Y.; Piekorz, R.; Chao, J. R.; Carpino, N.; Wang, 
D. and Ihle, J. N. (2002): Essential, nonredundant role for the 
phosphoinositide 3-kinase p110delta in signaling by the B-cell receptor 




Kalled, S. L. (2006): Impact of the BAFF/BR3 axis on B cell survival, germinal 




Kang, S. M.; Narducci, M. G.; Lazzeri, C.; Mongiovi, A. M.; Caprini, E.; Bresin, A.; 
Martelli, F.; Rothstein, J.; Croce, C. M.; Cooper, M. D. and Russo, G. (2005): 




Kawai, T.; Adachi, O.; Ogawa, T.; Takeda, K. and Akira, S. (1999): 
Unresponsiveness of MyD88-deficient mice to endotoxin, Immunity 11 [1], 
pp. 115-22. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=10435584  
Kawakami, Y.; Nishimoto, H.; Kitaura, J.; Maeda-Yamamoto, M.; Kato, R. M.; 
Littman, D. R.; Leitges, M.; Rawlings, D. J. and Kawakami, T. (2004): Protein 
kinase C betaII regulates Akt phosphorylation on Ser-473 in a cell type- and 
stimulus-specific fashion, J Biol Chem 279 [46], pp. 47720-5. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15364915  
Kayagaki, N.; Yan, M.; Seshasayee, D.; Wang, H.; Lee, W.; French, D. M.; Grewal, I. 
S.; Cochran, A. G.; Gordon, N. C.; Yin, J.; Starovasnik, M. A. and Dixit, V. 
M. (2002): BAFF/BLyS receptor 3 binds the B cell survival factor BAFF 
ligand through a discrete surface loop and promotes processing of NF-
kappaB2, Immunity 17 [4], pp. 515-24. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12387744  
Keshvara, L. M.; Isaacson, C. C.; Yankee, T. M.; Sarac, R.; Harrison, M. L. and 
Geahlen, R. L. (1998): Syk- and Lyn-dependent phosphorylation of Syk on 
multiple tyrosines following B cell activation includes a site that negatively 
regulates signaling, J Immunol 161 [10], pp. 5276-83. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=9820500  
Keshvara, L. M.; Isaacson, C.; Harrison, M. L. and Geahlen, R. L. (1997): Syk 
activation and dissociation from the B-cell antigen receptor is mediated by 
phosphorylation of tyrosine 130, J Biol Chem 272 [16], pp. 10377-81. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=9099676  
Khaled, A. R. and Durum, S. K. (2002): Lymphocide: cytokines and the control of 
lymphoid homeostasis, Nat Rev Immunol 2 [11], pp. 817-30. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12415306  
Khare, S. D.; Sarosi, I.; Xia, X. Z.; McCabe, S.; Miner, K.; Solovyev, I.; Hawkins, N.; 
Kelley, M.; Chang, D.; Van, G.; Ross, L.; Delaney, J.; Wang, L.; Lacey, D.; 
Boyle, W. J. and Hsu, H. (2000): Severe B cell hyperplasia and autoimmune 





Kiefer, F.; Brumell, J.; Al-Alawi, N.; Latour, S.; Cheng, A.; Veillette, A.; Grinstein, 
S. and Pawson, T. (1998): The Syk protein tyrosine kinase is essential for 
Fcgamma receptor signaling in macrophages and neutrophils, Mol Cell Biol 
18 [7], pp. 4209-20. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=9632805  
Kim, D. T.; Mitchell, D. J.; Brockstedt, D. G.; Fong, L.; Nolan, G. P.; Fathman, C. G.; 
Engleman, E. G. and Rothbard, J. B. (1997): Introduction of soluble proteins 
into the MHC class I pathway by conjugation to an HIV tat peptide, J 
Immunol 159 [4], pp. 1666-8. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=9257826  
Kim, S.; Jung, Y.; Kim, D.; Koh, H. and Chung, J. (2000): Extracellular zinc activates 
p70 S6 kinase through the phosphatidylinositol 3-kinase signaling pathway, J 
Biol Chem 275 [34], pp. 25979-84. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=10851233  
Kimura, T.; Sakamoto, H.; Appella, E. and Siraganian, R. P. (1996): Conformational 
changes induced in the protein tyrosine kinase p72syk by tyrosine 
phosphorylation or by binding of phosphorylated immunoreceptor tyrosine-
based activation motif peptides, Mol Cell Biol 16 [4], pp. 1471-8. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=8657120  
Knight, Z. A. and Shokat, K. M. (2007): Chemical genetics: where genetics and 
pharmacology meet, Cell 128 [3], pp. 425-30. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=17289560  
Kobayashi, T.; Nakamura, S.; Taniguchi, T. and Yamamura, H. (1990): Purification 
and characterization of a cytosolic protein-tyrosine kinase from porcine 
spleen, Eur J Biochem 188 [3], pp. 535-40. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=2331984  
Kong, G. H.; Bu, J. Y.; Kurosaki, T.; Shaw, A. S. and Chan, A. C. (1995): 
Reconstitution of Syk function by the ZAP-70 protein tyrosine kinase, 
Immunity 2 [5], pp. 485-92. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=7538440  
Kovacina, K. S.; Park, G. Y.; Bae, S. S.; Guzzetta, A. W.; Schaefer, E.; Birnbaum, M. 
J. and Roth, R. A. (2003): Identification of a proline-rich Akt substrate as a 
14-3-3 binding partner, J Biol Chem 278 [12], pp. 10189-94. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12524439  
Kraus, M.; Alimzhanov, M. B.; Rajewsky, N. and Rajewsky, K. (2004): Survival of 
resting mature B lymphocytes depends on BCR signaling via the Igalpha/beta 
heterodimer, Cell 117 [6], pp. 787-800. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15186779  
Krautwald, S.; Ziegler, E.; Tiede, K.; Pust, R. and Kunzendorf, U. (2004): 
Transduction of the TAT-FLIP fusion protein results in transient resistance to 
 136 
Fas-induced apoptosis in vivo, J Biol Chem 279 [42], pp. 44005-11. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15304499  
Krepinsky, J. C.; Li, Y.; Chang, Y.; Liu, L.; Peng, F.; Wu, D.; Tang, D.; Scholey, J. 
and Ingram, A. J. (2005): Akt mediates mechanical strain-induced collagen 
production by mesangial cells, J Am Soc Nephrol 16 [6], pp. 1661-72. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15814837  
Kuhn, R.; Schwenk, F.; Aguet, M. and Rajewsky, K. (1995): Inducible gene targeting 
in mice, Science 269 [5229], pp. 1427-9. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=7660125  
Kurosaki, T. (2002): Regulation of B-cell signal transduction by adaptor proteins, Nat 
Rev Immunol 2 [5], pp. 354-63. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12033741  
Kurosaki, T.; Johnson, S. A.; Pao, L.; Sada, K.; Yamamura, H. and Cambier, J. C. 
(1995): Role of the Syk autophosphorylation site and SH2 domains in B cell 
antigen receptor signaling, J Exp Med 182 [6], pp. 1815-23. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=7500027  
Kurosaki, T.; Takata, M.; Yamanashi, Y.; Inazu, T.; Taniguchi, T.; Yamamoto, T. and 
Yamamura, H. (1994): Syk activation by the Src-family tyrosine kinase in the 
B cell receptor signaling, J Exp Med 179 [5], pp. 1725-9. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=7513017  
Kuwahara, K.; Kawai, T.; Mitsuyoshi, S.; Matsuo, Y.; Kikuchi, H.; Imajoh-Ohmi, S.; 
Hashimoto, E.; Inui, S.; Cooper, M. D. and Sakaguchi, N. (1996): Cross-
linking of B cell antigen receptor-related structure of pre-B cell lines induces 
tyrosine phosphorylation of p85 and p110 subunits and activation of 
phosphatidylinositol 3-kinase, Int Immunol 8 [8], pp. 1273-85. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=8918697  
Lam, K. P.; Kuhn, R. and Rajewsky, K. (1997): In vivo ablation of surface 
immunoglobulin on mature B cells by inducible gene targeting results in rapid 
cell death, Cell 90 [6], pp. 1073-83. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=9323135  
Latour, S.; Zhang, J.; Siraganian, R. P. and Veillette, A. (1998): A unique insert in the 
linker domain of Syk is necessary for its function in immunoreceptor 
signalling, Embo J 17 [9], pp. 2584-95. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=9564041  
Law, C. L.; Chandran, K. A.; Sidorenko, S. P. and Clark, E. A. (1996): Phospholipase 
C-gamma1 interacts with conserved phosphotyrosyl residues in the linker 




Law, C. L.; Sidorenko, S. P.; Chandran, K. A.; Draves, K. E.; Chan, A. C.; Weiss, A.; 
 137 
Edelhoff, S.; Disteche, C. M. and Clark, E. A. (1994): Molecular cloning of 
human Syk. A B cell protein-tyrosine kinase associated with the surface 




Law, D. A.; Chan, V. W.; Datta, S. K. and DeFranco, A. L. (1993): B-cell antigen 
receptor motifs have redundant signalling capabilities and bind the tyrosine 
kinases PTK72, Lyn and Fyn, Curr Biol 3 [10], pp. 645-57. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15335855  
Leitges, M.; Schmedt, C.; Guinamard, R.; Davoust, J.; Schaal, S.; Stabel, S. and 
Tarakhovsky, A. (1996): Immunodeficiency in protein kinase cbeta-deficient 
mice, Science 273 [5276], pp. 788-91. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=8670417  
Lentz, V. M.; Cancro, M. P.; Nashold, F. E. and Hayes, C. E. (1996): Bcmd governs 
recruitment of new B cells into the stable peripheral B cell pool in the 
A/WySnJ mouse, J Immunol 157 [2], pp. 598-606. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=8752907  
Lesley, R.; Xu, Y.; Kalled, S. L.; Hess, D. M.; Schwab, S. R.; Shu, H. B. and Cyster, 
J. G. (2004): Reduced competitiveness of autoantigen-engaged B cells due to 
increased dependence on BAFF, Immunity 20 [4], pp. 441-53. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15084273  
Lindsten, T.; Ross, A. J.; King, A.; Zong, W. X.; Rathmell, J. C.; Shiels, H. A.; 
Ulrich, E.; Waymire, K. G.; Mahar, P.; Frauwirth, K.; Chen, Y.; Wei, M.; Eng, 
V. M.; Adelman, D. M.; Simon, M. C.; Ma, A.; Golden, J. A.; Evan, G.; 
Korsmeyer, S. J.; MacGregor, G. R. and Thompson, C. B. (2000): The 
combined functions of proapoptotic Bcl-2 family members bak and bax are 




Lissy, N. A.; Van Dyk, L. F.; Becker-Hapak, M.; Vocero-Akbani, A.; Mendler, J. H. 
and Dowdy, S. F. (1998): TCR antigen-induced cell death occurs from a late 
G1 phase cell cycle check point, Immunity 8 [1], pp. 57-65. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=9462511  
Litinskiy, M. B.; Nardelli, B.; Hilbert, D. M.; He, B.; Schaffer, A.; Casali, P. and 
Cerutti, A. (2002): DCs induce CD40-independent immunoglobulin class 
switching through BLyS and APRIL, Nat Immunol 3 [9], pp. 822-9. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12154359  
Liu, Y.; Shah, K.; Yang, F.; Witucki, L. and Shokat, K. M. (1998): Engineering Src 
family protein kinases with unnatural nucleotide specificity, Chem Biol 5 [2], 




Liu, Y.; Xu, L.; Opalka, N.; Kappler, J.; Shu, H. B. and Zhang, G. (2002): Crystal 
structure of sTALL-1 reveals a virus-like assembly of TNF family ligands, 
Cell 108 [3], pp. 383-94. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11853672  
Loder, F.; Mutschler, B.; Ray, R. J.; Paige, C. J.; Sideras, P.; Torres, R.; Lamers, M. 
C. and Carsetti, R. (1999): B cell development in the spleen takes place in 
discrete steps and is determined by the quality of B cell receptor-derived 
signals, J Exp Med 190 [1], pp. 75-89. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=10429672  
Lomo, J.; Smeland, E. B.; Krajewski, S.; Reed, J. C. and Blomhoff, H. K. (1996): 
Expression of the Bcl-2 homologue Mcl-1 correlates with survival of 
peripheral blood B lymphocytes, Cancer Res 56 [1], pp. 40-3. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=8548771  
Lucast, L. J.; Batey, R. T. and Doudna, J. A. (2001): Large-scale purification of a 
stable form of recombinant tobacco etch virus protease, Biotechniques 30 [3], 
pp. 544-6, 548, 550 passim. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11252791  
Lum, J. J.; DeBerardinis, R. J. and Thompson, C. B. (2005): Autophagy in metazoans: 




Lundberg, M. and Johansson, M. (2001): Is VP22 nuclear homing an artifact?, Nat 
Biotechnol 19 [8], pp. 713-4. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11479552  
Lupher, M. L., Jr.; Rao, N.; Lill, N. L.; Andoniou, C. E.; Miyake, S.; Clark, E. A.; 
Druker, B. and Band, H. (1998): Cbl-mediated negative regulation of the Syk 
tyrosine kinase. A critical role for Cbl phosphotyrosine-binding domain 




Mackay, F. and Leung, H. (2006): The role of the BAFF/APRIL system on T cell 
function, Semin Immunol 18 [5], pp. 284-9. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=16931039  
Mackay, F.; Schneider, P.; Rennert, P. and Browning, J. (2003): BAFF AND APRIL: 
a tutorial on B cell survival, Annu Rev Immunol 21, pp. 231-64. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12427767  
Mackay, F.; Sierro, F.; Grey, S. T. and Gordon, T. P. (2005): The BAFF/APRIL 
system: an important player in systemic rheumatic diseases, Curr Dir 




Mackay, F.; Woodcock, S. A.; Lawton, P.; Ambrose, C.; Baetscher, M.; Schneider, 
P.; Tschopp, J. and Browning, J. L. (1999): Mice transgenic for BAFF develop 
lymphocytic disorders along with autoimmune manifestations, J Exp Med 190 
[11], pp. 1697-710. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=10587360  




Maehama, T. and Dixon, J. E. (1998): The tumor suppressor, PTEN/MMAC1, 
dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-
trisphosphate, J Biol Chem 273 [22], pp. 13375-8. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=9593664  
Majewski, N.; Nogueira, V.; Bhaskar, P.; Coy, P. E.; Skeen, J. E.; Gottlob, K.; 
Chandel, N. S.; Thompson, C. B.; Robey, R. B. and Hay, N. (2004): 
Hexokinase-mitochondria interaction mediated by Akt is required to inhibit 




Mao, X.; Fujiwara, Y.; Chapdelaine, A.; Yang, H. and Orkin, S. H. (2001): Activation 
of EGFP expression by Cre-mediated excision in a new ROSA26 reporter 
mouse strain, Blood 97 [1], pp. 324-6. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11133778  
Marek, K. W. and Davis, G. W. (2002): Transgenically encoded protein 
photoinactivation (FlAsH-FALI): acute inactivation of synaptotagmin I, 
Neuron 36 [5], pp. 805-13. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12467585  
Marino, M.; Acconcia, F. and Trentalance, A. (2003): Biphasic estradiol-induced 
AKT phosphorylation is modulated by PTEN via MAP kinase in HepG2 cells, 
Mol Biol Cell 14 [6], pp. 2583-91. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12808053  
Marks, K. M.; Braun, P. D. and Nolan, G. P. (2004): A general approach for chemical 
labeling and rapid, spatially controlled protein inactivation, Proc Natl Acad 
Sci U S A 101 [27], pp. 9982-7. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15218100  
Marsin, A. S.; Bertrand, L.; Rider, M. H.; Deprez, J.; Beauloye, C.; Vincent, M. F.; 
Van den Berghe, G.; Carling, D. and Hue, L. (2000): Phosphorylation and 
activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis 
during ischaemia, Curr Biol 10 [20], pp. 1247-55. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11069105  
Martin, D. E. and Hall, M. N. (2005): The expanding TOR signaling network, Curr 




Martin, F. and Chan, A. C. (2006): B cell immunobiology in disease: evolving 
concepts from the clinic, Annu Rev Immunol 24, pp. 467-96. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=16551256  




Matsui, H.; Tomizawa, K.; Lu, Y. F. and Matsushita, M. (2003): Protein Therapy: in 
vivo protein transduction by polyarginine (11R) PTD and subcellular targeting 
delivery, Curr Protein Pept Sci 4 [2], pp. 151-7. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12678854  
Maurer, U.; Charvet, C.; Wagman, A. S.; Dejardin, E. and Green, D. R. (2006): 
Glycogen synthase kinase-3 regulates mitochondrial outer membrane 
permeabilization and apoptosis by destabilization of MCL-1, Mol Cell 21 [6], 
pp. 749-60. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=16543145  
Mecklenbrauker, I.; Kalled, S. L.; Leitges, M.; Mackay, F. and Tarakhovsky, A. 
(2004): Regulation of B-cell survival by BAFF-dependent PKCdelta-mediated 
nuclear signalling, Nature 431 [7007], pp. 456-61. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15361883  
Mecklenbrauker, I.; Saijo, K.; Zheng, N. Y.; Leitges, M. and Tarakhovsky, A. (2002): 
Protein kinase Cdelta controls self-antigen-induced B-cell tolerance, Nature 
416 [6883], pp. 860-5. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11976686  
Meffre, E. and Nussenzweig, M. C. (2002): Deletion of immunoglobulin beta in 




Mendoza, M. C. and Blenis, J. (2007): PHLPPing it off: phosphatases get in the Akt, 
Mol Cell 25 [6], pp. 798-800. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=17386258  
Merino, R.; Ding, L.; Veis, D. J.; Korsmeyer, S. J. and Nunez, G. (1994): 
Developmental regulation of the Bcl-2 protein and susceptibility to cell death 
in B lymphocytes, Embo J 13 [3], pp. 683-91. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=8313913  
Miller, D. J. and Hayes, C. E. (1991): Phenotypic and genetic characterization of a 
unique B lymphocyte deficiency in strain A/WySnJ mice, Eur J Immunol 21 




Mocsai, A.; Abram, C. L.; Jakus, Z.; Hu, Y.; Lanier, L. L. and Lowell, C. A. (2006): 
Integrin signaling in neutrophils and macrophages uses adaptors containing 




Monroe, J. G. (2006): ITAM-mediated tonic signalling through pre-BCR and BCR 
complexes, Nat Rev Immunol 6 [4], pp. 283-94. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=16557260  
Moore, P. A.; Belvedere, O.; Orr, A.; Pieri, K.; LaFleur, D. W.; Feng, P.; Soppet, D.; 
Charters, M.; Gentz, R.; Parmelee, D.; Li, Y.; Galperina, O.; Giri, J.; Roschke, 
V.; Nardelli, B.; Carrell, J.; Sosnovtseva, S.; Greenfield, W.; Ruben, S. M.; 
Olsen, H. S.; Fikes, J. and Hilbert, D. M. (1999): BLyS: member of the tumor 




Moreaux, J.; Legouffe, E.; Jourdan, E.; Quittet, P.; Reme, T.; Lugagne, C.; Moine, P.; 
Rossi, J. F.; Klein, B. and Tarte, K. (2004): BAFF and APRIL protect 
myeloma cells from apoptosis induced by interleukin 6 deprivation and 
dexamethasone, Blood 103 [8], pp. 3148-57. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15070697  
Morse, H. C., 3rd (1992): Genetic nomenclature for loci controlling surface antigens 
of mouse hemopoietic cells, J Immunol 149 [10], pp. 3129-34. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=1431091  
Motoyama, N.; Wang, F.; Roth, K. A.; Sawa, H.; Nakayama, K.; Nakayama, K.; 
Negishi, I.; Senju, S.; Zhang, Q.; Fujii, S. and et al. (1995): Massive cell death 
of immature hematopoietic cells and neurons in Bcl-x-deficient mice, Science 
267 [5203], pp. 1506-10. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=7878471  
Mukhopadhyay, A.; Ni, J.; Zhai, Y.; Yu, G. L. and Aggarwal, B. B. (1999): 
Identification and characterization of a novel cytokine, THANK, a TNF 
homologue that activates apoptosis, nuclear factor-kappaB, and c-Jun NH2-
terminal kinase, J Biol Chem 274 [23], pp. 15978-81. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=10347144  
Myer, D. L.; Bahassi el, M. and Stambrook, P. J. (2005): The Plk3-Cdc25 circuit, 
Oncogene 24 [2], pp. 299-305. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15640846  
Nada, S.; Okada, M.; MacAuley, A.; Cooper, J. A. and Nakagawa, H. (1991): Cloning 
of a complementary DNA for a protein-tyrosine kinase that specifically 





Nagahara, H.; Vocero-Akbani, A. M.; Snyder, E. L.; Ho, A.; Latham, D. G.; Lissy, N. 
A.; Becker-Hapak, M.; Ezhevsky, S. A. and Dowdy, S. F. (1998): 
Transduction of full-length TAT fusion proteins into mammalian cells: TAT-
p27Kip1 induces cell migration, Nat Med 4 [12], pp. 1449-52. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=9846587  
Naldini, L.; Blomer, U.; Gallay, P.; Ory, D.; Mulligan, R.; Gage, F. H.; Verma, I. M. 
and Trono, D. (1996): In vivo gene delivery and stable transduction of 
nondividing cells by a lentiviral vector, Science 272 [5259], pp. 263-7. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=8602510  
Nardelli, B.; Belvedere, O.; Roschke, V.; Moore, P. A.; Olsen, H. S.; Migone, T. S.; 
Sosnovtseva, S.; Carrell, J. A.; Feng, P.; Giri, J. G. and Hilbert, D. M. (2001): 
Synthesis and release of B-lymphocyte stimulator from myeloid cells, Blood 
97 [1], pp. 198-204. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11133761  
Neal, J. W. and Clipstone, N. A. (2001): Glycogen synthase kinase-3 inhibits the 
DNA binding activity of NFATc, J Biol Chem 276 [5], pp. 3666-73. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11063740  
Newton, A. C. (2001): Protein kinase C: structural and spatial regulation by 
phosphorylation, cofactors, and macromolecular interactions, Chem Rev 101 
[8], pp. 2353-64. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11749377  
Nishio, M.; Endo, T.; Tsukada, N.; Ohata, J.; Kitada, S.; Reed, J. C.; Zvaifler, N. J. 
and Kipps, T. J. (2005): Nurselike cells express BAFF and APRIL, which can 
promote survival of chronic lymphocytic leukemia cells via a paracrine 
pathway distinct from that of SDF-1alpha, Blood 106 [3], pp. 1012-20. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15860672  
Nitschke, L. (2005): The role of CD22 and other inhibitory co-receptors in B-cell 
activation, Curr Opin Immunol 17 [3], pp. 290-7. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15886119  
Noguchi, M.; Ropars, V.; Roumestand, C. and Suizu, F. (2007): Proto-oncogene 
TCL1: more than just as a coactivator for Akt, Faseb J. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=17360849  
O'Connor, B. P.; Raman, V. S.; Erickson, L. D.; Cook, W. J.; Weaver, L. K.; Ahonen, 
C.; Lin, L. L.; Mantchev, G. T.; Bram, R. J. and Noelle, R. J. (2004): BCMA 
is essential for the survival of long-lived bone marrow plasma cells, J Exp 
Med 199 [1], pp. 91-8. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=14707116  
Ohata, J.; Zvaifler, N. J.; Nishio, M.; Boyle, D. L.; Kalled, S. L.; Carson, D. A. and 
Kipps, T. J. (2005): Fibroblast-like synoviocytes of mesenchymal origin 
express functional B cell-activating factor of the TNF family in response to 




Okkenhaug, K.; Bilancio, A.; Farjot, G.; Priddle, H.; Sancho, S.; Peskett, E.; Pearce, 
W.; Meek, S. E.; Salpekar, A.; Waterfield, M. D.; Smith, A. J. and 
Vanhaesebroeck, B. (2002): Impaired B and T cell antigen receptor signaling 
in p110delta PI 3-kinase mutant mice, Science 297 [5583], pp. 1031-4. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12130661  
Okkenhaug, K. and Vanhaesebroeck, B. (2003): PI3K in lymphocyte development, 
differentiation and activation, Nat Rev Immunol 3 [4], pp. 317-30. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12669022  
Oliver, P. M.; Vass, T.; Kappler, J. and Marrack, P. (2006): Loss of the proapoptotic 
protein, Bim, breaks B cell anergy, J Exp Med 203 [3], pp. 731-41. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=16520387  
Opferman, J. T.; Letai, A.; Beard, C.; Sorcinelli, M. D.; Ong, C. C. and Korsmeyer, S. 
J. (2003): Development and maintenance of B and T lymphocytes requires 
antiapoptotic MCL-1, Nature 426 [6967], pp. 671-6. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=14668867  
Osmond, D. G. (1993): The turnover of B-cell populations, Immunol Today 14 [1], 
pp. 34-7. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=8442861  
Pani, G.; Kozlowski, M.; Cambier, J. C.; Mills, G. B. and Siminovitch, K. A. (1995): 
Identification of the tyrosine phosphatase PTP1C as a B cell antigen receptor-
associated protein involved in the regulation of B cell signaling, J Exp Med 
181 [6], pp. 2077-84. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=7539038  




Parks, T. D.; Howard, E. D.; Wolpert, T. J.; Arp, D. J. and Dougherty, W. G. (1995): 
Expression and purification of a recombinant tobacco etch virus NIa 
proteinase: biochemical analyses of the full-length and a naturally occurring 
truncated proteinase form, Virology 210 [1], pp. 194-201. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=7793070  
Peitz, M.; Pfannkuche, K.; Rajewsky, K. and Edenhofer, F. (2002): Ability of the 
hydrophobic FGF and basic TAT peptides to promote cellular uptake of 
recombinant Cre recombinase: a tool for efficient genetic engineering of 
mammalian genomes, Proc Natl Acad Sci U S A 99 [7], pp. 4489-94. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11904364  
Pelletier, M.; Thompson, J. S.; Qian, F.; Bixler, S. A.; Gong, D.; Cachero, T.; 
Gilbride, K.; Day, E.; Zafari, M.; Benjamin, C.; Gorelik, L.; Whitty, A.; 
Kalled, S. L.; Ambrose, C. and Hsu, Y. M. (2003): Comparison of soluble 
 144 
decoy IgG fusion proteins of BAFF-R and BCMA as antagonists for BAFF, J 
Biol Chem 278 [35], pp. 33127-33. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12796483  
Peng, T.; Golub, T. R. and Sabatini, D. M. (2002): The immunosuppressant 
rapamycin mimics a starvation-like signal distinct from amino acid and 
glucose deprivation, Mol Cell Biol 22 [15], pp. 5575-84. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12101249  
Peng, X. D.; Xu, P. Z.; Chen, M. L.; Hahn-Windgassen, A.; Skeen, J.; Jacobs, J.; 
Sundararajan, D.; Chen, W. S.; Crawford, S. E.; Coleman, K. G. and Hay, N. 
(2003): Dwarfism, impaired skin development, skeletal muscle atrophy, 
delayed bone development, and impeded adipogenesis in mice lacking Akt1 
and Akt2, Genes Dev 17 [11], pp. 1352-65. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12782654  
Perkins, D. N.; Pappin, D. J.; Creasy, D. M. and Cottrell, J. S. (1999): Probability-
based protein identification by searching sequence databases using mass 
spectrometry data, Electrophoresis 20 [18], pp. 3551-67. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=10612281  
Persad, S.; Attwell, S.; Gray, V.; Mawji, N.; Deng, J. T.; Leung, D.; Yan, J.; 
Sanghera, J.; Walsh, M. P. and Dedhar, S. (2001): Regulation of protein 
kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase: critical 
roles for kinase activity and amino acids arginine 211 and serine 343, J Biol 
Chem 276 [29], pp. 27462-9. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11313365  




Pillai, S.; Cariappa, A. and Moran, S. T. (2005): Marginal zone B cells, Annu Rev 
Immunol 23, pp. 161-96. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15771569  
Plas, D. R.; Rathmell, J. C. and Thompson, C. B. (2002): Homeostatic control of 
lymphocyte survival: potential origins and implications, Nat Immunol 3 [6], 
pp. 515-21. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12032565  
Plas, D. R.; Talapatra, S.; Edinger, A. L.; Rathmell, J. C. and Thompson, C. B. 
(2001): Akt and Bcl-xL promote growth factor-independent survival through 




Plas, D. R. and Thompson, C. B. (2002): Cell metabolism in the regulation of 




Plas, D. R. and Thompson, C. B. (2003): Akt activation promotes degradation of 




Plas, D. R. and Thompson, C. B. (2005): Akt-dependent transformation: there is more 
to growth than just surviving, Oncogene 24 [50], pp. 7435-42. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=16288290  
Podsypanina, K.; Ellenson, L. H.; Nemes, A.; Gu, J.; Tamura, M.; Yamada, K. M.; 
Cordon-Cardo, C.; Catoretti, G.; Fisher, P. E. and Parsons, R. (1999): 
Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems, 
Proc Natl Acad Sci U S A 96 [4], pp. 1563-8. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=9990064  
Poe, J. C.; Hasegawa, M. and Tedder, T. F. (2001): CD19, CD21, and CD22: 
multifaceted response regulators of B lymphocyte signal transduction, Int Rev 
Immunol 20 [6], pp. 739-62. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11913948  
Qian, Y.; Qin, J.; Cui, G.; Naramura, M.; Snow, E. C.; Ware, C. F.; Fairchild, R. L.; 
Omori, S. A.; Rickert, R. C.; Scott, M.; Kotzin, B. L. and Li, X. (2004): Act1, 
a negative regulator in CD40- and BAFF-mediated B cell survival, Immunity 
21 [4], pp. 575-87. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15485634  
Rahman, Z. S. and Manser, T. (2004): B cells expressing Bcl-2 and a signaling-
impaired BAFF-specific receptor fail to mature and are deficient in the 




Rajewsky, K. (1996): Clonal selection and learning in the antibody system, Nature 
381 [6585], pp. 751-8. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=8657279  
Rajfur, Z.; Roy, P.; Otey, C.; Romer, L. and Jacobson, K. (2002): Dissecting the link 
between stress fibres and focal adhesions by CALI with EGFP fusion proteins, 
Nat Cell Biol 4 [4], pp. 286-93. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11912490  
Rathmell, J. C.; Farkash, E. A.; Gao, W. and Thompson, C. B. (2001): IL-7 enhances 




Rathmell, J. C.; Vander Heiden, M. G.; Harris, M. H.; Frauwirth, K. A. and 
Thompson, C. B. (2000): In the absence of extrinsic signals, nutrient 
utilization by lymphocytes is insufficient to maintain either cell size or 
 146 
viability, Mol Cell 6 [3], pp. 683-92. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11030347  
Rickert, R. C.; Roes, J. and Rajewsky, K. (1997): B lymphocyte-specific, Cre-
mediated mutagenesis in mice, Nucleic Acids Res 25 [6], pp. 1317-8. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=9092650  
Robey, R. B. and Hay, N. (2006): Mitochondrial hexokinases, novel mediators of the 




Rojas, M.; Donahue, J. P.; Tan, Z. and Lin, Y. Z. (1998): Genetic engineering of 




Rolink, A. G.; Schaniel, C.; Andersson, J. and Melchers, F. (2001): Selection events 
operating at various stages in B cell development, Curr Opin Immunol 13 [2], 
pp. 202-7. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11228414  
Rolink, A. G.; Tschopp, J.; Schneider, P. and Melchers, F. (2002): BAFF is a survival 




Roschke, V.; Sosnovtseva, S.; Ward, C. D.; Hong, J. S.; Smith, R.; Albert, V.; Stohl, 
W.; Baker, K. P.; Ullrich, S.; Nardelli, B.; Hilbert, D. M. and Migone, T. S. 
(2002): BLyS and APRIL form biologically active heterotrimers that are 
expressed in patients with systemic immune-based rheumatic diseases, J 
Immunol 169 [8], pp. 4314-21. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12370363  
Rowley, R. B.; Burkhardt, A. L.; Chao, H. G.; Matsueda, G. R. and Bolen, J. B. 
(1995): Syk protein-tyrosine kinase is regulated by tyrosine-phosphorylated Ig 
alpha/Ig beta immunoreceptor tyrosine activation motif binding and 
autophosphorylation, J Biol Chem 270 [19], pp. 11590-4. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=7538118  
Ruggero, D. and Sonenberg, N. (2005): The Akt of translational control, Oncogene 24 
[50], pp. 7426-34. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=16288289  
Saijo, K.; Mecklenbrauker, I.; Santana, A.; Leitger, M.; Schmedt, C. and 
Tarakhovsky, A. (2002): Protein kinase C beta controls nuclear factor kappaB 
activation in B cells through selective regulation of the IkappaB kinase alpha, 




Saijo, K.; Schmedt, C.; Su, I. H.; Karasuyama, H.; Lowell, C. A.; Reth, M.; Adachi, 
T.; Patke, A.; Santana, A. and Tarakhovsky, A. (2003): Essential role of Src-
family protein tyrosine kinases in NF-kappaB activation during B cell 
development, Nat Immunol 4 [3], pp. 274-9. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12563261  
Sakai, K.; Nakamura, S.; Sada, K.; Kobayashi, T.; Uno, H. and Yamamura, H. (1988): 
Characterization of partially purified cytosolic protein-tyrosine kinase from 
porcine spleen, Biochem Biophys Res Commun 152 [3], pp. 1123-30. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=3377769  
Sakurai, D.; Hase, H.; Kanno, Y.; Kojima, H.; Okumura, K. and Kobata, T. (2006): 




Salzer, U.; Chapel, H. M.; Webster, A. D.; Pan-Hammarstrom, Q.; Schmitt-Graeff, 
A.; Schlesier, M.; Peter, H. H.; Rockstroh, J. K.; Schneider, P.; Schaffer, A. 
A.; Hammarstrom, L. and Grimbacher, B. (2005): Mutations in TNFRSF13B 
encoding TACI are associated with common variable immunodeficiency in 
humans, Nat Genet 37 [8], pp. 820-8. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=16007087  
Sambrook, J.; Fritsch, E. F. and Maniatis, T. (1989): Molecular Cloning: A 
Laboratory Manual, Second Edition. ed., Cold Spring Harbor Laboratory 
Press. 
Sancak, Y.; Thoreen, C. C.; Peterson, T. R.; Lindquist, R. A.; Kang, S. A.; Spooner, 
E.; Carr, S. A. and Sabatini, D. M. (2007): PRAS40 is an insulin-regulated 
inhibitor of the mTORC1 protein kinase, Mol Cell 25 [6], pp. 903-15. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=17386266  
Sansal, I. and Sellers, W. R. (2004): The biology and clinical relevance of the PTEN 
tumor suppressor pathway, J Clin Oncol 22 [14], pp. 2954-63. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15254063  
Saouaf, S. J.; Mahajan, S.; Rowley, R. B.; Kut, S. A.; Fargnoli, J.; Burkhardt, A. L.; 
Tsukada, S.; Witte, O. N. and Bolen, J. B. (1994): Temporal differences in the 
activation of three classes of non-transmembrane protein tyrosine kinases 
following B-cell antigen receptor surface engagement, Proc Natl Acad Sci U S 
A 91 [20], pp. 9524-8. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=7524079  
Sarbassov, D. D.; Ali, S. M.; Kim, D. H.; Guertin, D. A.; Latek, R. R.; Erdjument-
Bromage, H.; Tempst, P. and Sabatini, D. M. (2004): Rictor, a novel binding 
partner of mTOR, defines a rapamycin-insensitive and raptor-independent 




Sarbassov, D. D.; Guertin, D. A.; Ali, S. M. and Sabatini, D. M. (2005): 
 148 
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex, 
Science 307 [5712], pp. 1098-101. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15718470  
Sasaki, Y.; Casola, S.; Kutok, J. L.; Rajewsky, K. and Schmidt-Supprian, M. (2004): 
TNF family member B cell-activating factor (BAFF) receptor-dependent and -




Sasaki, Y.; Derudder, E.; Hobeika, E.; Pelanda, R.; Reth, M.; Rajewsky, K. and 
Schmidt-Supprian, M. (2006): Canonical NF-kappaB activity, dispensable for 
B cell development, replaces BAFF-receptor signals and promotes B cell 
proliferation upon activation, Immunity 24 [6], pp. 729-39. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=16782029  
Scapini, P.; Carletto, A.; Nardelli, B.; Calzetti, F.; Roschke, V.; Merigo, F.; Tamassia, 
N.; Pieropan, S.; Biasi, D.; Sbarbati, A.; Sozzani, S.; Bambara, L. and 
Cassatella, M. A. (2005): Proinflammatory mediators elicit secretion of the 
intracellular B-lymphocyte stimulator pool (BLyS) that is stored in activated 




Schamel, W. W. and Reth, M. (2000): Monomeric and oligomeric complexes of the B 
cell antigen receptor, Immunity 13 [1], pp. 5-14. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=10933390  
Schiemann, B.; Gommerman, J. L.; Vora, K.; Cachero, T. G.; Shulga-Morskaya, S.; 
Dobles, M.; Frew, E. and Scott, M. L. (2001): An essential role for BAFF in 
the normal development of B cells through a BCMA-independent pathway, 
Science 293 [5537], pp. 2111-4. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11509691  
Schneider, P.; MacKay, F.; Steiner, V.; Hofmann, K.; Bodmer, J. L.; Holler, N.; 
Ambrose, C.; Lawton, P.; Bixler, S.; Acha-Orbea, H.; Valmori, D.; Romero, 
P.; Werner-Favre, C.; Zubler, R. H.; Browning, J. L. and Tschopp, J. (1999): 
BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell 
growth, J Exp Med 189 [11], pp. 1747-56. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=10359578  
Schneider, P.; Takatsuka, H.; Wilson, A.; Mackay, F.; Tardivel, A.; Lens, S.; 
Cachero, T. G.; Finke, D.; Beermann, F. and Tschopp, J. (2001): Maturation 
of marginal zone and follicular B cells requires B cell activating factor of the 
tumor necrosis factor family and is independent of B cell maturation antigen, J 
Exp Med 194 [11], pp. 1691-7. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11733583  
Schwarze, S. R.; Ho, A.; Vocero-Akbani, A. and Dowdy, S. F. (1999): In vivo protein 
transduction: delivery of a biologically active protein into the mouse, Science 
 149 
285 [5433], pp. 1569-72. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=10477521  
Schwarze, S. R.; Hruska, K. A. and Dowdy, S. F. (2000): Protein transduction: 
unrestricted delivery into all cells?, Trends Cell Biol 10 [7], pp. 290-5. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=10856932  
Schwenk, F.; Baron, U. and Rajewsky, K. (1995): A cre-transgenic mouse strain for 
the ubiquitous deletion of loxP-flanked gene segments including deletion in 
germ cells, Nucleic Acids Res 23 [24], pp. 5080-1. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=8559668  
Schwenk, F.; Sauer, B.; Kukoc, N.; Hoess, R.; Muller, W.; Kocks, C.; Kuhn, R. and 
Rajewsky, K. (1997): Generation of Cre recombinase-specific monoclonal 
antibodies, able to characterize the pattern of Cre expression in cre-transgenic 
mouse strains, J Immunol Methods 207 [2], pp. 203-12. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=9368647  
Sears, R.; Nuckolls, F.; Haura, E.; Taya, Y.; Tamai, K. and Nevins, J. R. (2000): 
Multiple Ras-dependent phosphorylation pathways regulate Myc protein 
stability, Genes Dev 14 [19], pp. 2501-14. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11018017  
Sebastiaan Winkler, G.; Lacomis, L.; Philip, J.; Erdjument-Bromage, H.; Svejstrup, J. 
Q. and Tempst, P. (2002): Isolation and mass spectrometry of transcription 
factor complexes, Methods 26 [3], pp. 260-9. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12054882  
Senftleben, U.; Cao, Y.; Xiao, G.; Greten, F. R.; Krahn, G.; Bonizzi, G.; Chen, Y.; 
Hu, Y.; Fong, A.; Sun, S. C. and Karin, M. (2001): Activation by IKKalpha of 
a second, evolutionary conserved, NF-kappa B signaling pathway, Science 
293 [5534], pp. 1495-9. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11520989  
Seoane, J.; Le, H. V.; Shen, L.; Anderson, S. A. and Massague, J. (2004): Integration 
of Smad and forkhead pathways in the control of neuroepithelial and 
glioblastoma cell proliferation, Cell 117 [2], pp. 211-23. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15084259  
Seshasayee, D.; Valdez, P.; Yan, M.; Dixit, V. M.; Tumas, D. and Grewal, I. S. 
(2003): Loss of TACI causes fatal lymphoproliferation and autoimmunity, 




Sherr, C. J. and Roberts, J. M. (1999): CDK inhibitors: positive and negative 
regulators of G1-phase progression, Genes Dev 13 [12], pp. 1501-12. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=10385618  
Sherr, C. J. and Roberts, J. M. (2004): Living with or without cyclins and cyclin-
 150 
dependent kinases, Genes Dev 18 [22], pp. 2699-711. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15545627  
Shiota, C.; Woo, J. T.; Lindner, J.; Shelton, K. D. and Magnuson, M. A. (2006): 
Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 
is essential for fetal growth and viability, Dev Cell 11 [4], pp. 583-9. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=16962829  
Shu, H. B.; Hu, W. H. and Johnson, H. (1999): TALL-1 is a novel member of the 




Shulga-Morskaya, S.; Dobles, M.; Walsh, M. E.; Ng, L. G.; MacKay, F.; Rao, S. P.; 
Kalled, S. L. and Scott, M. L. (2004): B cell-activating factor belonging to the 
TNF family acts through separate receptors to support B cell survival and T 
cell-independent antibody formation, J Immunol 173 [4], pp. 2331-41. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15294946  
Siebenlist, U.; Brown, K. and Claudio, E. (2005): Control of lymphocyte development 
by nuclear factor-kappaB, Nat Rev Immunol 5 [6], pp. 435-45. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15905862  
Sohn, H. W.; Gu, H. and Pierce, S. K. (2003): Cbl-b negatively regulates B cell 
antigen receptor signaling in mature B cells through ubiquitination of the 
tyrosine kinase Syk, J Exp Med 197 [11], pp. 1511-24. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12771181  
Stahl, M.; Dijkers, P. F.; Kops, G. J.; Lens, S. M.; Coffer, P. J.; Burgering, B. M. and 
Medema, R. H. (2002): The forkhead transcription factor FoxO regulates 




Stambolic, V.; Suzuki, A.; de la Pompa, J. L.; Brothers, G. M.; Mirtsos, C.; Sasaki, 
T.; Ruland, J.; Penninger, J. M.; Siderovski, D. P. and Mak, T. W. (1998): 
Negative regulation of PKB/Akt-dependent cell survival by the tumor 
suppressor PTEN, Cell 95 [1], pp. 29-39. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=9778245  
Stamos, J.; Sliwkowski, M. X. and Eigenbrot, C. (2002): Structure of the epidermal 
growth factor receptor kinase domain alone and in complex with a 4-
anilinoquinazoline inhibitor, J Biol Chem 277 [48], pp. 46265-72. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12196540  
Stefani, G.; Fraser, C. E.; Darnell, J. C. and Darnell, R. B. (2004): Fragile X mental 
retardation protein is associated with translating polyribosomes in neuronal 




Stroffekova, K.; Proenza, C. and Beam, K. G. (2001): The protein-labeling reagent 
FLASH-EDT2 binds not only to CCXXCC motifs but also non-specifically to 
endogenous cysteine-rich proteins, Pflugers Arch 442 [6], pp. 859-66. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11680618  
Su, I. H.; Dobenecker, M. W.; Dickinson, E.; Oser, M.; Basavaraj, A.; Marqueron, R.; 
Viale, A.; Reinberg, D.; Wulfing, C. and Tarakhovsky, A. (2005): Polycomb 
group protein ezh2 controls actin polymerization and cell signaling, Cell 121 
[3], pp. 425-36. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15882624  
Su, T. T.; Guo, B.; Kawakami, Y.; Sommer, K.; Chae, K.; Humphries, L. A.; Kato, R. 
M.; Kang, S.; Patrone, L.; Wall, R.; Teitell, M.; Leitges, M.; Kawakami, T. 
and Rawlings, D. J. (2002): PKC-beta controls I kappa B kinase lipid raft 
recruitment and activation in response to BCR signaling, Nat Immunol 3 [8], 
pp. 780-6. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12118249  
Suzuki, A.; de la Pompa, J. L.; Stambolic, V.; Elia, A. J.; Sasaki, T.; del Barco 
Barrantes, I.; Ho, A.; Wakeham, A.; Itie, A.; Khoo, W.; Fukumoto, M. and 
Mak, T. W. (1998): High cancer susceptibility and embryonic lethality 
associated with mutation of the PTEN tumor suppressor gene in mice, Curr 
Biol 8 [21], pp. 1169-78. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=9799734  
Suzuki, A.; Yamaguchi, M. T.; Ohteki, T.; Sasaki, T.; Kaisho, T.; Kimura, Y.; 
Yoshida, R.; Wakeham, A.; Higuchi, T.; Fukumoto, M.; Tsubata, T.; Ohashi, 
P. S.; Koyasu, S.; Penninger, J. M.; Nakano, T. and Mak, T. W. (2001): T cell-
specific loss of Pten leads to defects in central and peripheral tolerance, 
Immunity 14 [5], pp. 523-34. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11371355  
Suzuki, H.; Terauchi, Y.; Fujiwara, M.; Aizawa, S.; Yazaki, Y.; Kadowaki, T. and 
Koyasu, S. (1999): Xid-like immunodeficiency in mice with disruption of the 




Takata, M.; Sabe, H.; Hata, A.; Inazu, T.; Homma, Y.; Nukada, T.; Yamamura, H. 
and Kurosaki, T. (1994): Tyrosine kinases Lyn and Syk regulate B cell 
receptor-coupled Ca2+ mobilization through distinct pathways, Embo J 13 [6], 
pp. 1341-9. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=8137818  
Tanabe, T.; Oyamada, M.; Fujita, K.; Dai, P.; Tanaka, H. and Takamatsu, T. (2005): 
Multiphoton excitation-evoked chromophore-assisted laser inactivation using 
green fluorescent protein, Nat Methods 2 [7], pp. 503-5. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15973419  
Tangye, S. G.; Bryant, V. L.; Cuss, A. K. and Good, K. L. (2006): BAFF, APRIL and 
 152 
human B cell disorders, Semin Immunol 18 [5], pp. 305-17. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=16916610  
Taniguchi, T.; Kobayashi, T.; Kondo, J.; Takahashi, K.; Nakamura, H.; Suzuki, J.; 
Nagai, K.; Yamada, T.; Nakamura, S. and Yamamura, H. (1991): Molecular 
cloning of a porcine gene syk that encodes a 72-kDa protein-tyrosine kinase 




Tardivel, A.; Tinel, A.; Lens, S.; Steiner, Q. G.; Sauberli, E.; Wilson, A.; Mackay, F.; 
Rolink, A. G.; Beermann, F.; Tschopp, J. and Schneider, P. (2004): The anti-
apoptotic factor Bcl-2 can functionally substitute for the B cell survival but not 
for the marginal zone B cell differentiation activity of BAFF, Eur J Immunol 
34 [2], pp. 509-18. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=14768056  
Taylor, J. A.; Karas, J. L.; Ram, M. K.; Green, O. M. and Seidel-Dugan, C. (1995): 
Activation of the high-affinity immunoglobulin E receptor Fc epsilon RI in 




Tee, A. R. and Blenis, J. (2005): mTOR, translational control and human disease, 
Semin Cell Dev Biol 16 [1], pp. 29-37. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15659337  
Thien, M.; Phan, T. G.; Gardam, S.; Amesbury, M.; Basten, A.; Mackay, F. and 
Brink, R. (2004): Excess BAFF rescues self-reactive B cells from peripheral 
deletion and allows them to enter forbidden follicular and marginal zone 
niches, Immunity 20 [6], pp. 785-98. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15189742  
Thomas, M. D.; Kremer, C. S.; Ravichandran, K. S.; Rajewsky, K. and Bender, T. P. 
(2005): c-Myb is critical for B cell development and maintenance of follicular 
B cells, Immunity 23 [3], pp. 275-86. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=16169500  
Thome, M. (2004): CARMA1, BCL-10 and MALT1 in lymphocyte development and 
activation, Nat Rev Immunol 4 [5], pp. 348-59. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15122200  
Thome, M.; Duplay, P.; Guttinger, M. and Acuto, O. (1995): Syk and ZAP-70 
mediate recruitment of p56lck/CD4 to the activated T cell receptor/CD3/zeta 
complex, J Exp Med 181 [6], pp. 1997-2006. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=7539035  
Thompson, J. S.; Bixler, S. A.; Qian, F.; Vora, K.; Scott, M. L.; Cachero, T. G.; 
Hession, C.; Schneider, P.; Sizing, I. D.; Mullen, C.; Strauch, K.; Zafari, M.; 
Benjamin, C. D.; Tschopp, J.; Browning, J. L. and Ambrose, C. (2001): 
 153 
BAFF-R, a newly identified TNF receptor that specifically interacts with 
BAFF, Science 293 [5537], pp. 2108-11. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11509692  
Thompson, J. S.; Schneider, P.; Kalled, S. L.; Wang, L.; Lefevre, E. A.; Cachero, T. 
G.; MacKay, F.; Bixler, S. A.; Zafari, M.; Liu, Z. Y.; Woodcock, S. A.; Qian, 
F.; Batten, M.; Madry, C.; Richard, Y.; Benjamin, C. D.; Browning, J. L.; 
Tsapis, A.; Tschopp, J. and Ambrose, C. (2000): BAFF binds to the tumor 
necrosis factor receptor-like molecule B cell maturation antigen and is 
important for maintaining the peripheral B cell population, J Exp Med 192 [1], 
pp. 129-35. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=10880534  
Toker, A. and Newton, A. C. (2000): Akt/protein kinase B is regulated by 




Tolar, P.; Sohn, H. W. and Pierce, S. K. (2005): The initiation of antigen-induced B 
cell antigen receptor signaling viewed in living cells by fluorescence 
resonance energy transfer, Nat Immunol 6 [11], pp. 1168-76. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=16200067  
Tomayko, M. M. and Cancro, M. P. (1998): Long-lived B cells are distinguished by 
elevated expression of A1, J Immunol 160 [1], pp. 107-11. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=9551962  
Tour, O.; Meijer, R. M.; Zacharias, D. A.; Adams, S. R. and Tsien, R. Y. (2003): 
Genetically targeted chromophore-assisted light inactivation, Nat Biotechnol 
21 [12], pp. 1505-8. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=14625562  
Trescol-Biemont, M. C.; Verschelde, C.; Cottalorda, A. and Bonnefoy-Berard, N. 
(2004): Regulation of A1/Bfl-1 expression in peripheral splenic B cells, 
Biochimie 86 [4-5], pp. 287-94. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15194232  
Tschopp, O.; Yang, Z. Z.; Brodbeck, D.; Dummler, B. A.; Hemmings-Mieszczak, M.; 
Watanabe, T.; Michaelis, T.; Frahm, J. and Hemmings, B. A. (2005): Essential 
role of protein kinase B gamma (PKB gamma/Akt3) in postnatal brain 




Turner, M.; Gulbranson-Judge, A.; Quinn, M. E.; Walters, A. E.; MacLennan, I. C. 
and Tybulewicz, V. L. (1997): Syk tyrosine kinase is required for the positive 
selection of immature B cells into the recirculating B cell pool, J Exp Med 186 




Turner, M.; Mee, P. J.; Costello, P. S.; Williams, O.; Price, A. A.; Duddy, L. P.; 
Furlong, M. T.; Geahlen, R. L. and Tybulewicz, V. L. (1995): Perinatal 
lethality and blocked B-cell development in mice lacking the tyrosine kinase 
Syk, Nature 378 [6554], pp. 298-302. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=7477352  
Turner, M.; Schweighoffer, E.; Colucci, F.; Di Santo, J. P. and Tybulewicz, V. L. 
(2000): Tyrosine kinase SYK: essential functions for immunoreceptor 
signalling, Immunol Today 21 [3], pp. 148-54. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=10689303  
Tyagi, M.; Rusnati, M.; Presta, M. and Giacca, M. (2001): Internalization of HIV-1 
tat requires cell surface heparan sulfate proteoglycans, J Biol Chem 276 [5], 
pp. 3254-61. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11024024  
Uhlmann, F.; Wernic, D.; Poupart, M. A.; Koonin, E. V. and Nasmyth, K. (2000): 
Cleavage of cohesin by the CD clan protease separin triggers anaphase in 
yeast, Cell 103 [3], pp. 375-86. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11081625  
van Oers, N. S. and Weiss, A. (1995): The Syk/ZAP-70 protein tyrosine kinase 




Vander Haar, E.; Lee, S. I.; Bandhakavi, S.; Griffin, T. J. and Kim, D. H. (2007): 
Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40, Nat 
Cell Biol 9 [3], pp. 316-23. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=17277771  
Vander Heiden, M. G.; Plas, D. R.; Rathmell, J. C.; Fox, C. J.; Harris, M. H. and 
Thompson, C. B. (2001): Growth factors can influence cell growth and 




Vanhaesebroeck, B. and Alessi, D. R. (2000): The PI3K-PDK1 connection: more than 
just a road to PKB, Biochem J 346 Pt 3, pp. 561-76. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=10698680  
Veis, D. J.; Sorenson, C. M.; Shutter, J. R. and Korsmeyer, S. J. (1993): Bcl-2-
deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, 
and hypopigmented hair, Cell 75 [2], pp. 229-40. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=8402909  
Veldhoen, M.; Magee, A. I.; Penha-Goncalves, M. N. and Stockinger, B. (2005): 
Transduction of naive CD4 T cells with kinase-deficient Lck-HIV-Tat fusion 
protein dampens T cell activation and provokes a switch to regulatory 




Viniegra, J. G.; Martinez, N.; Modirassari, P.; Losa, J. H.; Parada Cobo, C.; Lobo, V. 
J.; Luquero, C. I.; Alvarez-Vallina, L.; Ramon y Cajal, S.; Rojas, J. M. and 
Sanchez-Prieto, R. (2005): Full activation of PKB/Akt in response to insulin 




Virgilio, L.; Lazzeri, C.; Bichi, R.; Nibu, K.; Narducci, M. G.; Russo, G.; Rothstein, J. 
L. and Croce, C. M. (1998): Deregulated expression of TCL1 causes T cell 
leukemia in mice, Proc Natl Acad Sci U S A 95 [7], pp. 3885-9. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=9520462  
Vocero-Akbani, A.; Lissy, N. A. and Dowdy, S. F. (2000): Transduction of full-length 
Tat fusion proteins directly into mammalian cells: analysis of T cell receptor 
activation-induced cell death, Methods Enzymol 322, pp. 508-21. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=10914043  
von Bulow, G. U.; van Deursen, J. M. and Bram, R. J. (2001): Regulation of the T-
independent humoral response by TACI, Immunity 14 [5], pp. 573-82. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11371359  
Wadia, J. S.; Stan, R. V. and Dowdy, S. F. (2004): Transducible TAT-HA fusogenic 
peptide enhances escape of TAT-fusion proteins after lipid raft 
macropinocytosis, Nat Med 10 [3], pp. 310-5. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=14770178  
Walmsley, M. J.; Ooi, S. K.; Reynolds, L. F.; Smith, S. H.; Ruf, S.; Mathiot, A.; 
Vanes, L.; Williams, D. A.; Cancro, M. P. and Tybulewicz, V. L. (2003): 
Critical roles for Rac1 and Rac2 GTPases in B cell development and 
signaling, Science 302 [5644], pp. 459-62. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=14564011  
Warburg, O. (1956): On respiratory impairment in cancer cells, Science 124 [3215], 
pp. 269-70. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=13351639  
Warburg, O.; Posener, K. and Negelein, E. (1924): Ueber den Stoffwechsel der 
Tumoren, Biochemische Zeitschrift 152, pp. 319-344. 
Welcker, M.; Singer, J.; Loeb, K. R.; Grim, J.; Bloecher, A.; Gurien-West, M.; 
Clurman, B. E. and Roberts, J. M. (2003): Multisite phosphorylation by Cdk2 
and GSK3 controls cyclin E degradation, Mol Cell 12 [2], pp. 381-92. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=14536078  
Wender, P. A.; Mitchell, D. J.; Pattabiraman, K.; Pelkey, E. T.; Steinman, L. and 
Rothbard, J. B. (2000): The design, synthesis, and evaluation of molecules that 
enable or enhance cellular uptake: peptoid molecular transporters, Proc Natl 




Willis, S. N. and Adams, J. M. (2005): Life in the balance: how BH3-only proteins 
induce apoptosis, Curr Opin Cell Biol 17 [6], pp. 617-25. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=16243507  
Woodland, R. T.; Schmidt, M. R. and Thompson, C. B. (2006): BLyS and B cell 
homeostasis, Semin Immunol 18 [5], pp. 318-26. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=16931037  
Woodside, D. G.; Obergfell, A.; Leng, L.; Wilsbacher, J. L.; Miranti, C. K.; Brugge, 
J. S.; Shattil, S. J. and Ginsberg, M. H. (2001): Activation of Syk protein 
tyrosine kinase through interaction with integrin beta cytoplasmic domains, 
Curr Biol 11 [22], pp. 1799-804. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11719224  
Wullschleger, S.; Loewith, R. and Hall, M. N. (2006): TOR signaling in growth and 
metabolism, Cell 124 [3], pp. 471-84. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=16469695  
Xiao, G.; Harhaj, E. W. and Sun, S. C. (2001): NF-kappaB-inducing kinase regulates 
the processing of NF-kappaB2 p100, Mol Cell 7 [2], pp. 401-9. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11239468  
Xu, L. G. and Shu, H. B. (2002): TNFR-associated factor-3 is associated with BAFF-
R and negatively regulates BAFF-R-mediated NF-kappa B activation and IL-
10 production, J Immunol 169 [12], pp. 6883-9. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12471121  
Xu, L. G.; Wu, M.; Hu, J.; Zhai, Z. and Shu, H. B. (2002): Identification of 
downstream genes up-regulated by the tumor necrosis factor family member 
TALL-1, J Leukoc Biol 72 [2], pp. 410-6. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12149433  
Xu, S. and Lam, K. P. (2001): B-cell maturation protein, which binds the tumor 
necrosis factor family members BAFF and APRIL, is dispensable for humoral 
immune responses, Mol Cell Biol 21 [12], pp. 4067-74. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11359913  
Yamada, T.; Taniguchi, T.; Yang, C.; Yasue, S.; Saito, H. and Yamamura, H. (1993): 
Association with B-cell-antigen receptor with protein-tyrosine kinase p72syk 




Yan, M.; Brady, J. R.; Chan, B.; Lee, W. P.; Hsu, B.; Harless, S.; Cancro, M.; Grewal, 
I. S. and Dixit, V. M. (2001): Identification of a novel receptor for B 
lymphocyte stimulator that is mutated in a mouse strain with severe B cell 




Yan, M.; Wang, H.; Chan, B.; Roose-Girma, M.; Erickson, S.; Baker, T.; Tumas, D.; 
Grewal, I. S. and Dixit, V. M. (2001): Activation and accumulation of B cells 
in TACI-deficient mice, Nat Immunol 2 [7], pp. 638-43. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11429549  
Yanagi, S.; Inatome, R.; Takano, T. and Yamamura, H. (2001): Syk expression and 
novel function in a wide variety of tissues, Biochem Biophys Res Commun 
288 [3], pp. 495-8. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=11676469  
Yang, J.; Cron, P.; Good, V. M.; Thompson, V.; Hemmings, B. A. and Barford, D. 
(2002): Crystal structure of an activated Akt/protein kinase B ternary complex 
with GSK3-peptide and AMP-PNP, Nat Struct Biol 9 [12], pp. 940-4. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=12434148  
Yang, Q.; Inoki, K.; Ikenoue, T. and Guan, K. L. (2006): Identification of Sin1 as an 
essential TORC2 component required for complex formation and kinase 
activity, Genes Dev 20 [20], pp. 2820-32. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=17043309  
Yang, Z. Z.; Tschopp, O.; Baudry, A.; Dummler, B.; Hynx, D. and Hemmings, B. A. 
(2004): Physiological functions of protein kinase B/Akt, Biochem Soc Trans 
32 [Pt 2], pp. 350-4. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15046607  
Yang, Z. Z.; Tschopp, O.; Hemmings-Mieszczak, M.; Feng, J.; Brodbeck, D.; 
Perentes, E. and Hemmings, B. A. (2003): Protein kinase B alpha/Akt1 




Yankee, T. M.; Keshvara, L. M.; Sawasdikosol, S.; Harrison, M. L. and Geahlen, R. 
L. (1999): Inhibition of signaling through the B cell antigen receptor by the 
protooncogene product, c-Cbl, requires Syk tyrosine 317 and the c-Cbl 
phosphotyrosine-binding domain, J Immunol 163 [11], pp. 5827-35. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=10570266  
Yusuf, I.; Zhu, X.; Kharas, M. G.; Chen, J. and Fruman, D. A. (2004): Optimal B-cell 
proliferation requires phosphoinositide 3-kinase-dependent inactivation of 
FOXO transcription factors, Blood 104 [3], pp. 784-7. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=15069012  
Zeeberg, B. R.; Feng, W.; Wang, G.; Wang, M. D.; Fojo, A. T.; Sunshine, M.; 
Narasimhan, S.; Kane, D. W.; Reinhold, W. C.; Lababidi, S.; Bussey, K. J.; 
Riss, J.; Barrett, J. C. and Weinstein, J. N. (2003): GoMiner: a resource for 




Zeitlmann, L.; Knorr, T.; Knoll, M.; Romeo, C.; Sirim, P. and Kolanus, W. (1998): T 
 158 
cell activation induced by novel gain-of-function mutants of Syk and ZAP-70, 
J Biol Chem 273 [25], pp. 15445-52. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=9624129  
Zhang, J.; Berenstein, E. H.; Evans, R. L. and Siraganian, R. P. (1996): Transfection 
of Syk protein tyrosine kinase reconstitutes high affinity IgE receptor-
mediated degranulation in a Syk-negative variant of rat basophilic leukemia 
RBL-2H3 cells, J Exp Med 184 [1], pp. 71-9. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=8691151  
Zhukovsky, E. A.; Lee, J. O.; Villegas, M.; Chan, C.; Chu, S. and Mroske, C. (2004): 
TNF ligands: is TALL-1 a trimer or a virus-like cluster?, Nature 427 [6973], 
pp. 413-4; discussion 414. URL: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&
dopt=Citation&list_uids=14749821  
Zoller, K. E.; MacNeil, I. A. and Brugge, J. S. (1997): Protein tyrosine kinases Syk 
and ZAP-70 display distinct requirements for Src family kinases in immune 







I would like to thank Prof. Dr. Alexander Tarakhovsky for the opportunity to 
work in his laboratory, for the freedom to conduct my own research and for his 
advice and support whenever it was needed. I am very grateful to Prof. Dr. 
Peter-Michael Kloetzel for his supervision of my PhD thesis project. I would 
also like to thank Prof. Dr. Wolfgang Lockau, Prof. Dr. Rudolf Ehwald, Prof. 
Dr. Harald Saumweber and Prof. Dr. Elke Dittmann for their willingness to 
take an interest in my work and participate in my thesis committee. 
Various people have contributed to the work presented here: I am indebted to 
Hediye Erdjument-Bromage and Paul Tempst of the Molecular Biology 
Program at the Memorial Sloan-Kettering Cancer Center for collaboration on 
the mass-spectrometric identification of PI3K p110δ, to the Genomics Core 
Laboratory at the Memorial Sloan-Kettering Cancer Center under the direction 
of Agnes Viale for help with gene expression analysis by microarray and to 
Klara Velinzon of the Flow Cytometry Resource Center at The Rockefeller 
University for help with cell sorting. My analysis of Syk function in B cells was 
made possible through the previous work of Christian Schmedt who 
generated the Syk conditional knock-out. I also thank Ed Clark, Jennifer 
Doudna, Michael Ehrmann, André Hoelz and Clifford Lowell for the respective 
reagents mentioned in this study. 
I would like to thank the past and present members of the Tarakhovsky 
laboratory, in particular Marc-Werner Dobenecker, Ingrid Mecklenbräuker, 
Kaoru Saijo, Angela Santana, Sukhvinder Sahota and I-hsin Su for 
discussions and scientific guidance, generous technical advice and for making 
work in the lab an enjoyable experience.  
The Boehringer Ingelheim Fonds provided generous financial support for this 
endeavour. 
Last but not least, I am grateful to my family and friends who have always 
remained loyal to me despite my poor communication efforts. I think of you 
way more often than I give you a chance to realize. André, you know what you 




Ich versichere, daß ich die von mir vorgelegte Dissertation selbständig 
angefertigt und die verwendeten Quellen und Hilfsmittel vollständig 
angegeben habe, daß diese Dissertation noch keiner anderen Fakultät oder 
Universität zur Prüfung vorgelegen hat und daß sie, abgesehen von den 
unten angegebenen Teilpublikationen, noch nicht veröffentlicht worden ist. 
Die Bestimmungen dieser Promotionsordnung sind mir bekannt. 
 
Teilpublikationen: 
Saijo K, Schmedt C, Su IH, Karasuyama H, Lowell CA, Reth M, Adachi T, 
Patke A, Santana A, Tarakhovsky A. Essential role of Src-family protein 
tyrosine kinases in NF-kappaB activation during B cell development. Nat 
Immunol. 2003 Mar;4(3):274-9. 
Patke A, Mecklenbrauker I, Tarakhovsky A. Survival signaling in resting B 
cells. Curr Opin Immunol. 2004 Apr;16(2):251-5. Review. 
Patke A, Mecklenbrauker I, Erdjument-Bromage H, Tempst P, Tarakhovsky 
A. BAFF controls B cell metabolic fitness through a PKC beta- and Akt-
dependent mechanism. J Exp Med. 2006 Oct 30;203(11):2551-62. 
 







Diploma thesis: „Untersuchung des Einfluß von Proteinkinase C auf die 
Antigenrezeptor und Phorbolester induzierte Aktivierung von NF-κB und JNK 
in B-lymphoiden Zellen“. Freie Universität Berlin, 2001 
Krappmann D, Patke A, Heissmeyer V, Scheidereit C. B-cell receptor- and 
phorbol ester-induced NF-kappaB and c-Jun N-terminal kinase activation in B 
cells requires novel protein kinase C's. Mol Cell Biol. 2001 Oct;21(19):6640-
50. 
Saijo K, Schmedt C, Su IH, Karasuyama H, Lowell CA, Reth M, Adachi T, 
Patke A, Santana A, Tarakhovsky A. Essential role of Src-family protein 
tyrosine kinases in NF-kappaB activation during B cell development. Nat 
Immunol. 2003 Mar;4(3):274-9. Epub 2003 Feb 3. 
Patke A, Mecklenbrauker I, Tarakhovsky A. Survival signaling in resting B 
cells. Curr Opin Immunol. 2004 Apr;16(2):251-5. Review. 
Siegel R, Kim U, Patke A, Yu X, Ren X, Tarakhovsky A, Roeder RG. 
Nontranscriptional regulation of SYK by the coactivator OCA-B is required at 
multiple stages of B cell development. Cell. 2006 May 19;125(4):761-74. 
Patke A, Mecklenbrauker I, Erdjument-Bromage H, Tempst P, Tarakhovsky 
A. BAFF controls B cell metabolic fitness through a PKC beta- and Akt-
dependent mechanism. J Exp Med. 2006 Oct 30;203(11):2551-62. 
 








Table 5: Gene IDs corresponding to the GO categories in figure 9B 
(Cluster 1) and C (Cluster 2) 
GO category Gene ID 
  
Cluster 1  
cellular carbohydrate 
catabolism 
Aldoc, Tpi1, Pkm2, Pfkl, Pfkp, Pgam1 
monosaccharide metabolism Aldoc, Galk1, Tpi1, Fabp5, Pkm2, Pfkl, Pfkp, 
Pgam1 
monosaccharide catabolism Aldoc, Tpi1, Pkm2, Pfkp, Pfkl, Pgam1 
alcohol catabolism Aldoc, Tpi1, Pkm2, Pfkl, Pfkp, Pgam1 
hexose catabolism Aldoc, Tpi1, Pkm2, Pfkl, Pfkp, Pgam1 
hexose metabolism Galk1, Aldoc, Tpi1, Fabp5, Pkm2, Pfkl, Pfkp, 
Pgam1 
glucose metabolism Aldoc, Tpi1, Fabp5, Pkm2, Pfkl, Pfkp, Pgam1 
glucose catabolism Aldoc, Tpi1, Pkm2, Pfkl, Pfkp, Pgam1 
glycolysis Aldoc, Tpi1, Pkm2, Pfkl, Pfkp, Pgam1 
  
Cluster 2  
cell cycle Kntc1, 2810406C15Rik, Cdkn3, Cdk4, Bub1b, 
Esco2, Rad51, Dmwd, Espl1, Ccnb1, Mybl2, 
Aurka, Csks2, E2f7, Mki67, Gmnn, Tfdp1, 
Wwox, Chek1, Ect2, Nek2, Kif11, Cdc20, 
Cenph, Sycp3,Cdca5, Stmn1, Ccnd2, Uhrf2, 
Sfn, Uhrf1, Sspn, Brrn1, Ccnf, Tacc3, Mcm3, 
E2f1, Myc, Incenp 
regulation of cell cycle Cdkn3, Cdk4, Ccnd2, Sfn, Sspn, Ccnb1, Mybl2, 
Ccnf, Gmnn, Tacc3, Tfdp1, E2f1, Chek1, 
Wwox, Myc, Ect2 
mitotic cell cycle Cdc20, Kntc1, Cenph, 2810406C15Rik, Sycp3, 
Cdc5a, Bub1b, Stmn1, Brrn1, Ccnb1, Aurka, 
Ccnf, Tfdp1, Chek1, Nek2, Incenp 
meiotic cell cycle Sycp3, Rad51, Cks2, Mki67, Dmwd, Nek2, 
Espl1 
M phase Cdc20, Kntc1, Cenph, 2810406C15Rik, Sycp3, 
Cdc5a, Bub1b, Stmn1, Rad51, Dmwd, Espl1, 
Brrn1, Ccnb1, Cks2, Ccnf, Mki67, Nek2, Incenp
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chromosome segregation Cenph, 2810406C15Rik, Brrn1, Top2a, Espl1, 
Nek2 
regulation of progression 
through cell cycle 
Cdkn3, Cdk4, Ccnd2, Sfn, Sspn, Ccnb1, Mybl2, 
Ccnf, Gmnn, Tacc3, Tfdp1, Chek1, Wwox, 
E2f1, Myc, Ect2 
M phase of mitotic cell cycle Cdc20, Kntc1, Cenph, 2810406C15Rik, Sycp3, 
Cdc5a, Bub1b, Stmn1, Brrn1, Ccnb1, Ccnf, 
Nek2, Incenp 
M phase of meiotic cell cycle Sycp3, Cks2, Rad51, Mki67, Dmwd, Nek2 
mitosis Cdc20, Kntc1, Cenph, 2810406C15Rik, Sycp3, 
Cdc5a, Bub1b, Stmn1, Brrn1, Ccnb1, Ccnf, 
Nek2, Incenp 
meiosis Sycp3, Rad51, Cks2, Mki67, Dmwd, Nek2, 
Espl1 
chromosome condensation 2810406C15Rik, Brrn1, Top2a 
mitotic sister chromatid 
segregation 
2810406C15Rik, Brrn1, Nek2 
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